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Abstract 
Poly L-Lactic acid (PLLA) is a versatile established biodegradable polymer 
used in biomedical engineering. The characteristic properties (stiffness, 
topology and biodegradation) of PLLA are ideal for regeneration applications in 
vivo, providing a biocompatible microenvironment to in situ cells and allowing 
for gradual transfer of mechanical stress to the engineering tissue via 
controllable polymer degradation. However, inefficient adsorption of key 
biological factors, including the extracellular matrix component fibronectin 
(FN), hinder its use as a cellular microenvironment.  Poly(ethyl acrylate) (PEA) 
has been shown to induce spontaneous organisation of FN into physiological-like 
fibrils, exposing binding motifs critical for cell adhesion, differentiation and the 
binding of growth factors (GF). Thus, here we present a novel chemical process 
to polymerise functional PEA brushes, able to drive FN fibrillogenesis, onto PLLA. 
The produced surface initiated atomic transfer radical polymerisation system 
(SI-ATRP), allows control of surface biofunctionality while maintaining PLLA bulk 
properties such as degradability profile and mechanical strength. Production of 
a molecularly thin PEA brush coating onto PLLA providing additional functionality 
to the widely utilised backbone biomaterial. The process outlined is shown to be 
highly tuneable, taking place in 3 distinct optimized steps; aminolysis, initiator 
immobilisation and polymerisation. Initial functionalisation via aminolysis and 
subsequent immobilisation of the bromine based initiator occur in 2 separate 
reaction processes, named as a 2-pot system. Here we also present initial 
production of a streamlined 1-pot SI-ATRP system, performing aminolysis and 
initiator immobilisation within the same reaction vessel, a 1-pot system. These 
processes, alongside further potential variations to the system, highlight the 
resilience and highly modifiable nature of this surface modification technology. 
Neither of these processes are shown to significantly impact on the bulk physical 
properties of the backbone PLLA, as measured primarily via enzymatic 
degradation with proteinase K and atomic force microscopy (AFM) 
nanoindentation. Alongside surface characterisation utilising AFM, X-ray 
photoelectron spectroscopy (XPS) and water contact angle (WCA) to measure 
PEA grafting, we investigated the biological activity of modified surfaces in 
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terms of FN adsorption and cellular response. Produced PEA brushes were shown 
to retain the functionality of driving fibrillogenesis triggering FN organisation 
into physiological-like fibrils, which allow for enhanced cellular adhesion, 
growth factor binding and differentiation of myoblast C2C12 cells and human 
mesenchymal stem cells. Translation of this system into 3D, by printing medical 
grade PLLA scaffolds and modifying their surface, has shown that this process is 
scalable and functional for use in implantable biomaterials. The results 
demonstrate the potential of this technology to engineer controlled 
microenvironments to tune cell fate via biologically active surface modification 
of an otherwise bioinert biodegradable polymer gaining wide use in tissue 
engineering applications. 
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1.1. Tissue engineering 
 
Tissue engineering, being an interdisciplinary field, requires the utilisation 
of several disciplines, including engineering and biological principles, for the 
maintenance or replacement of tissue function (Howard, Buttery et al. 2008). 
Synergy of techniques from these disciplines allows for the ability to mimic in vivo 
cellular environments, allowing for controlled cellular differentiation post 
implantation and regeneration of damaged tissues (Langer and Vacanti 1993). In 
fact, by employing interdisciplinary modification techniques materials can be 
developed that are able to mimic biological environments, regulating cellular 
interactions on and in these materials. Biomimicry, the recreation or imitation of 
biological systems, utilises the physical characteristics of bulk materials, such as 
polymers, and the functionality of biological systems for modelling or modulation 
of cellular interactions for use in tissue engineering. These biomimetic materials 
vary considerably in application, specificity and complexity, but predominantly 
aim to improve material-cellular interactions in vivo or provide an in vitro model 
for tissues found within the body (Green and Elisseeff 2016). 
1.1.1. Bone fracture healing 
 
Bone fractures and other tissue defects are a prevalent issue in medicine 
throughout the world (Perez, Kouroupis et al. 2018).  There are approximately >6 
million fractures per year in the US and >3.5 in the six largest European countries 
(France, Germany, Italy, Spain, Sweden and the UK) (Einhorn 1995, Hernlund, 
Svedbom et al. 2013). In the EU, it is estimated that in 2010 26,300 life-years were 
lost due to incidental fractures and the total number of fractures in the future 
will rise by 28% to 4.5 million by 2025 (Hernlund, Svedbom et al. 2013). In 2010 
the mortality rate associated with bone defects was estimated to be 43,000 people 
in the European Union, highlighting the severity and the need for the development 
of improved treatments of these issues in our current age (Hernlund, Svedbom et 
al. 2013).While certain bone tissue defects, such as simple fractures, can be 
treated by the host over time or by medical professionals, other conditions such 
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as critical bone defects, generally a fracture of more than 2 cm in length or over 
half the circumference of the bone (Watanabe, Harada et al. 2016), require more 
extensive medical intervention to regenerate form and function of the broken 
bone. Generally, fracture healing takes place within the first 2 months post-injury; 
however, contributing factors can inhibit or even fully stop this process, resulting 
in delayed union or even stopping of any bone union forming. Non-union defects 
result from approximately 10% of fractures (Einhorn 1995); the risk of these 
developing can be increased from a variety of factors; dietary habits, pre-existing 
ailments, fracture site movement or the location of the break, all have 
contributing factors to the severity and thus level of treatment required to 
regenerate the tissue (Castillo, Bosse et al. 2005, Tzioupis and Giannoudis 2007, 
Kostenuik and Mirza 2017, Westrick, Hamilton et al. 2017). In some situations a 
combination of these issues can contribute to delaying the union of the bone 
during medical treatment, which can result in infection, or fracture site 
polytrauma and non-union of the fractured bone, in these cases loss of function 
or the appendage can be the only option for conventional medicine (Gomez-
Barrena, Rosset et al. 2015, Cheng, Alba-Perez et al. 2019). Typically non-union 
fractures require an increased level of medical care to treat and healthcare 
resources (Morshed 2014), therefore the development and optimisation of 
regenerative medicine treatments for critical bone defects are vital.  
 
 
 
Treatments for non-union breaks include synthetic grafts, autographs and 
allographs; these are the current standard for replacement of bone defects of 
such a size that inhibits natural regrowth. Generally, the gold standard for critical 
bone defect repair involves grafting bone from another unaffected area of the 
patient to replace the lost tissue. This is due to these bone fragments possessing 
inherent osteoinductive and osteoconductive properties while avoiding any 
histocompatibility issues. Allografts, tissue grafts from non-genetically identical 
donors, can result in rejection of the implanted tissue or even disease 
transmission. While autografts are predominantly utilised, they still present 
distinct issues post implantation such as donor site morbidity, limited availability, 
infection, nerve damage and surgical complications (Younger and Chapman 1989, 
Perez, Kouroupis et al. 2018). These issues cumulate in a total graft rejection rate 
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of 60% (Soucacos, Dailiana et al. 2006), resulting in non-unions and subsequent 
late grafting fractures; this highlights the need for improved tissue engineering 
alternatives to improve biocompatibility, availability and osteo-regeneration of 
synthetic grafts.    
 
Bone tissue engineering has produced a variety of regenerative medicine 
products, synthetic grafts, aiming to facilitate regeneration of growth and 
function caused by a variety of ailments. Polymer products are commercially used 
as a clinical bone fixation scaffold, such as FIXSORB® (Takiron Co.) or NEOFIX 
(Gunze Ltd.), due to the high modulus, long controllable degradation time and 
gradual transfer of mechanical stress to the in situ cellular system while removing 
the need for a secondary operation to remove conventional metal pins, sutures or 
anchors (Ulery, Nair et al. 2011). However these materials, while providing 
mechanical support over controllable time-points, do not encourage cellular 
regeneration of the bone tissue, as autografts or allografts would. These systems 
also have the potential for treatment of degradative bone tissue diseases, such as 
osteoporosis, allowing for implantation and regeneration or strengthening of 
defective areas (Yu, Tang et al. 2015). Therefore there is the need for 
development of tissue engineering solutions and augmentations to establish 
material treatments for bone tissue defects or fractures.    
1.2. Biomaterials 
 
Biomaterials offer an approach to treating damage or loss of tissues by 
providing a framework for the replacement and regeneration of functions of the 
affected biological systems (Rincon Lasprilla, Rueda Martinez et al. 2011). 
Biomaterials have been used in many aspects of regenerative medicine from the 
creation of artificial organs to implanted drug delivery systems (Khandare and 
Minko 2006, Zadpoor and Malda 2017). Typically three types of biomaterial are 
used in tissue engineering: ceramics, natural and synthetic polymers. Generally 
ceramics, characterised by their high Young’s modulus and brittle topography, are 
used for osteogenic regeneration. Ceramic biomaterials, such as scaffolds utilising 
hydroxyapatite (HA) and tri-calcium phosphate, possess chemical compositions 
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and structures very similar to those of natural mineral deposits and are therefore 
highly biocompatible (Hench 1993, Ambrosio, Sahota et al. 2001). However, the 
inherent rigidity of ceramics limits their utilisation in tissue regeneration; the 
brittleness and handling issues impact on the processability and variability for 
defined application for a given implantation. Also bone produced in established 
ceramic scaffolds are unable to facilitate the same degree of mechanical loading 
or biodegradability as native in situ tissue (Wang 2003). Polymer-based 
biomaterials are a growing field of research due to their wide array of physical 
properties and potential biomedical applications (Iaquinta, Mazzoni et al. 2019). 
Biomedical research utilises a wide range of polymers, either biodegradable or 
biostable, for a variety of applications due to the versatility, availability and 
established modification techniques. Naturally derived polymers, such as collagen 
or alginate scaffolds, are inherently biodegradable, biologically active and exhibit 
very good cellular interactions, however poor processability and reproducibility 
produce scaffolds with small control over the mechanical properties and 
translation into clinical use (O'Brien 2011). Synthetic polymers, such as poly lactic 
acid (PLA) or poly (ethylene glycol) (PEG), are more readily processed than natural 
polymers providing a greater control of degradability, mechanical properties and 
presentation of functional groups. In general, biomaterials provide a highly 
tuneable and expandable alternative to current regenerative medical 
technologies, having an approximate market value of 134.3 billion USD (Prasad, 
Bazaka et al. 2017), which is ever growing and developing.  
 
1.2.1. Synthetic polymers 
  
The use of synthetic polymers provides the most variable and controllable 
platform for tissue engineering. Biomedical polymers should have appropriate 
mechanical properties mimicking the surrounding tissue for the intended use, 
degrade in a predicted timeframe so as to transfer mechanical and biological 
function to the recovering tissue and ideally have a high affinity for or express 
biological signals relevant to the intended use (Ulery, Nair et al. 2011). These 
definitions are not fully comprehensive and certain exceptions are present in  
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specific circumstances; one example is in the use of biostable materials which are 
non-degradable within the body that are able to provide long-term structural and 
functional support (Lozano Picazo, Perez Garnes et al. 2015). One established 
characteristic is that as a biomaterial the polymer must not provoke an 
inflammatory or harmful response from the surrounding tissue and should produce 
non-toxic degradation products which are readily excreted naturally by the host. 
 
1.2.2. Biomaterials for tissue engineering 
 
Biomaterials are often utilised as cellular scaffolds or mechanical support 
systems within the body to facilitate regeneration of tissue function (O'Brien 
2011). Cells have been shown to respond to three main factors within implanted 
systems: mechanical forces, micro/nanoscale topographical features and 
biochemical signalling (Figure 1.1). These factors directly influence initial 
adhesion, differentiation, viability and functionality of cells (Mason, Califano et 
al. 2012, Anderson, Sahoo et al. 2016). Modulation of specific material 
characteristics such as stiffness can drastically alter the application of biomimetic 
materials, from silk-based gels for soft tissue regeneration to stiffer polymer 
scaffolds for bone regeneration (Polo-Corrales, Latorre-Esteves et al. 2014, Wang, 
Wang et al. 2016). Mimicry of physiological elastic moduli, as found in vivo, has 
been shown to directly mediate cellular responses. Materials with different 
stiffness induce differentiation of cells to different linages: 0.1-1 kPa neurogenic, 
8-17 kPa myogenic or 25-40 kPa osteogenic (Discher, Janmey et al. 2005, Zhang 
2012).  Therefore, appropriate materials and modification techniques must be 
employed when designing materials for specific tissue-associated regenerative 
medicine approaches. 
7 
 
 
Figure 1.1. Material surface interactions. Chemistry, stiffness and topography 
control cellular interactions; focal adhesion formation is shown here. Red shows 
cellular adhesion sites and stimuli resulting in either high adhesive (blue) or low 
adhesive (green) phenotypes. From Anderson et al, 2016, Mesenchymal Stem Cell 
Fate: Applying Biomaterials for Control of Stem Cell Behaviour.  
 
 The physical properties of biomaterials are dependent on their chemical 
structure and their constituent functional groups. Through controlled chemical 
reactions and the introduction of biological factors, the surface activity and 
chemical properties of a given biomaterial can be refined and attuned for desired 
applications (Khan, Tanaka et al. 2015).  Therefore, current biomedical research 
utilises modification of biodegradable polymers to manufacture implantable 
microenvironments for cells; these microenvironments present selected 
biochemical signals (Xu, Yang et al. 2011), optimal topologies and mechanical 
properties corresponding to the tissue damaged (Dalby, Gadegaard et al. 2007, 
Mason, Califano et al. 2012, Mpoyi, Cantini et al. 2016). Cell-material interactions 
have been shown to be modulated by the inclusion and presentation of simple 
chemical functional groups on biomaterials (Curran, Chen et al. 2005, Curran, 
Chen et al. 2006, Benoit, Schwartz et al. 2008, Phillips, Petrie et al. 2010), 
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highlighting the potential for improvement of already established biomaterials via 
chemical modification techniques. However, certain methodologies of processing 
polymers so as to alter the surface properties can indirectly change the chemical 
characteristics of the original material, therefore altering the effectiveness of the 
biomaterial for the intended application (Zhu, Gao et al. 2004). Hence, careful 
consideration must be used in the surface modification of biomaterials to induce 
favourable chemical reactions.   
 
Nanoscale topographical surface features have been shown to influence 
cellular phenotypes, both genomic and proteomic, when presented on 
biomaterials (Xiao, Jiang et al. 2002, Dalby, Hart et al. 2008). For example, 
research has shown that by presenting surfaces with nano-pits of varying degrees 
of symmetry or disorder cell differentiation can be influenced in a tuneable 
manner (Dalby, Gadegaard et al. 2007). This topographical influence has been 
shown to translate to influence protein interactions with cells, where ECM 
components adsorbed onto these disordered surface features are able to induce a 
higher degree of cellular adhesion and differentiation (Mpoyi, Cantini et al. 2016).   
 
One of the first vital interactions for any biomaterial is the initial contact 
and adhesion of the cultured cells; for example, it has been shown that without 
proper material-cell interfaces stem cells undergo apoptosis through a process 
known as anoikis (Dalby, Gadegaard et al. 2014). Cellular adhesion dictates the 
tensile signalling pathways, such as extracellular signal-regulated kinase (ERK), 
and is able to directly regulate cellular transcription and subsequently phenotype 
(Anderson, Sahoo et al. 2016). Therefore, a major consideration when developing 
biomaterials for biomedical applications must be to facilitate cell adhesion to 
ensure high viability and functionality of cells. Thus, it is vital that biomaterials 
are developed or modified to facilitate cellular adhesion via chemical, 
topographical and stiffness mechanisms.  
 
In general, biomaterials present the potential to create a vast array of 
tissue engineering solutions and models. Their myriad of modern uses, such as 
structurally supportive sutures, cellular-filled implants or model systems for drug 
discovery, are constantly evolving and, by way of surface modification, continually 
improving. Research and development of polymer surface modification techniques 
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is a growing field of biomedical engineering (Khan, Tanaka et al. 2015, Khan and 
Tanaka 2017), one key aspect of this being the improvement of current processing 
techniques, modifying or adding functionality to materials while maintaining other 
favourable material properties.  
 
1.2.3. 2D vs. 3D 
 
Traditionally the majority of cellular cultures utilised for tissue engineering 
has been performed on 2D biomaterials, however more modern research has aimed 
to translate this work to 3D microenvironments (Li and Kilian 2015). The aim is to 
improve the currently poor translatability of in vitro cellular treatments 
performed within laboratories to clinical applications in regenerative medicine 
(Hollister and Murphy 2011). In vivo, the cellular microenvironment consists of the 
3D surroundings of the cells, including the extracellular matrix, which the 
traditional 2D in vitro cell culture models are unable to accurately re-create; this 
results in misleading or non-predicted results when this form of 2D biomedical 
research is applied  in vivo (Edmondson, Broglie et al. 2014). Therefore, by 
adapting established techniques to facilitate cellular interactions with 
biomaterials, such as adhesion, from flat 2D biomaterial surfaces to 3D scaffolds, 
the degree of biomimicry can be improved by better simulating the in situ 
microenvironments as would be sensed by cells. Through this translation several 
2D techniques have been utilised in 3D systems including; in vitro modelling of the 
central nervous system for therapeutically drug development (Hopkins, DeSimone 
et al. 2015), lithographic patterning  for micro-engineering extracellular matrices 
(Li and Kilian 2015) and modelling of cancer mechanotransduction mechanisms 
(Lee, Chang et al. 2019). These types of studies have shown that 2D methodologies 
can be successfully translated into 3D systems and this is able to improve the 
accuracy, effectiveness and reliability of these techniques. Indeed, It has been 
shown that cell morphology and physiology are drastically altered when cultured 
in 3D comparatively to 2D culture environments (Benya and Shaffer 1982, 
Baharvand, Hashemi et al. 2006), due to the increased dimension of cellular 
interactions with other cells, ECM and material surfaces.  
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The use of hydrogels and 3D polymer scaffolds has emerged as a 
methodology to culture cells within 3D microenvironments. These hydrogels 
consist of crosslinked networks of hydrophilic polymers possessing binding domains 
for cells within a hydrated 3D environment (El-Sherbiny and Yacoub 2013). 
However, their intrinsic hydrated composition in certain cases limits their 
propensity for higher stiffness osteogenic regenerative applications (Caliari and 
Burdick 2016). To solve this, several hydrogel systems for increasing hydrogel 
stiffness and osteogenic differentiation have been developed (Engler, Sen et al. 
2006, Khetan, Guvendiren et al. 2013, Wen, Vincent et al. 2014, Tozzi, De Mori et 
al. 2016). 3D polymer scaffolds can be produced via several methodologies: 
electrospinning, extrusion or 3D printing to name a few (Barry, Silva et al. 2005, 
Corey, Gertz et al. 2008, Serra, Mateos-Timoneda et al. 2013, Frydrych, Roman et 
al. 2015, Ravi, Shiakolas et al. 2017). These scaffolds made primarily of bulk 
polymer are able to maintain similar physical characteristics as their 2D 
counterparts while presenting cells with a 3D surface area to interact with. 3D 
printing in particular provides the potential for fine control of fibre size, pore 
volume and architecture, allowing for controlled mechanical properties that 
support cell growth post implantation and tuneable degradation times (Carletti, 
Motta et al. 2011). In fact, synthetic polymer scaffolds have been proposed as 
alternatives to allograft and autografts, (Takahashi and Tabata 2004, Li, Liu et al. 
2012, Polo-Corrales, Latorre-Esteves et al. 2014) providing similar osteogenic 
regeneration.  
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1.3. Extracellular matrix 
 
Within tissue cells are surrounded by a complex 3D extracellular matrix (ECM) 
which regulates both cell viability and differentiation state (Frantz, Stewart et al. 
2010, Mason, Califano et al. 2012). ECMs can vary in chemical and physical 
properties that in turn alter the growth and activity of the cells they encompass. 
Typically ECMs are composed of a selected recipe of water, proteins and 
polysaccharides, dictated biochemically and mechanically by the cellular 
component and surrounding microenvironments, producing a specialised cellular 
environment optimised for the tissue it inhabits. This extracellular 
microenvironment can possess an intricate variety of topographical, biochemical 
and physical areas within the same region and dictates the properties of the tissue 
and even the organ.  
 
The ECM regulates a variety of cellular behaviours through four main pathways; 
biophysical anchorage of the cell, mechano-transduction, biochemical receptor 
binding and presentation of growth factors (Figure 1.2).  The composition of the 
ECM dictates the surrounding stiffness and elasticity, and it provides the ability to 
regulate water and homeostasis not only of the cellular environment, but also of 
the produced tissue. ECM factors are also able to directly control cellular function 
by presenting biochemical signals, such as growth factors, which interact with 
cell-surface receptors to induce intercellular signal transduction and regulate 
gene transduction (Frantz, Stewart et al. 2010). Through these mechanical, 
biological and chemical signals, cell functionality and differentiation state can be 
regulated. Conversely cells are able to remodel and mediate the composition and 
characteristics of the ECM to further mediate cellular and tissue function. This 
process involves the degradation of the ECM, primarily by matrix 
metalloproteinases (MMPs), produced as either soluble or cell-membrane-
anchored proteinases by cells which function within the extra-cellular space to 
enzymatically degrade ECM proteins.(Bonnans, Chou et al. 2014) This allows for 
these matrix components to be replaced, in most cases by in situ cells to remodel 
their surrounding ECM. 
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Figure 1.2. Extracellular matrix-mediated regulation of cellular behaviour. 
This figure shows various ways by which the ECM can modulate cell behaviour and 
fate, depending on the characteristics and composition of surrounding ECM. Cells 
can bind different ECM-bound receptors or co-receptors receiving mechanical 
stimuli (red, orange and black). Cellular anchorage (red) influence various 
biological functions by directing positionality of the given cell. Focal adhesion 
formation (black) and subsequent actin filament formation provides mechano-
transduction between cells and the ECM. Growth factors bound to ECM 
components or soluble within the ECM can chemically signal cells (orange and 
cyan). Cells themselves can remodel the ECM via producing enzymes.  From 
Gattazzo F, Urciulo A, Bonaldo P., 2014, Extracellular matrix: A dynamic 
microenvironment for stem cell niche.  
 
 
Genetic abnormalities of the ECM result in a range of syndromes that can be 
incredibly harmful to the host tissue (Jarvelainen, Sainio et al. 2009). Research 
has shown that without the structural support and biochemical signalling provided 
by the ECM, cells in vitro become de-differentiated and lose viability, making 
them unsuitable for tissue engineering purposes. Due to these issues, different 
bioreactor and synthetic support scaffold approaches have been developed to 
emulate the ECM in vitro (Xu, Yang et al. 2011, Fourel, Valat et al. 2016). These 
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studies have shown that with the addition of key ECM proteins, a degree of the 
physical and chemical functions as found in situ can be maintained and developed 
in vitro. These advancements in biomimetics have developed more sustainable 
cellular populations which maintain differentiation states for longer. Biomimetic 
materials have also been developed to drive cellular differentiation, expressing 
selected biological factors to signal cells to differentiate to specific lineages (Liu 
and Roy 2005, Liu, Tian et al. 2010, Wang, Wang et al. 2016). Within tissue 
engineering applications 3D environments, such as polymeric scaffolds or 
hydrogels, are utilised to provide cells with provisional ECM environments for 
modelling or regeneration of tissue. Therefore, the understanding and 
characterisation of ECM properties is vital in the development and improvement 
of biomimetic tissue engineering systems.     
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1.4. Fibronectin 
 
One vital extracellular matrix component is fibronectin (FN); this protein 
has been shown to control many cellular functions including adhesion, migration, 
differentiation and growth (Pankov and Yamada 2002).  Fibronectin is a 
glycoprotein with the molecular weight of ~250 kDa and is generally found as 
dimers consisting of a number of three variations of spliced functional domains 
(FN I, II and III) (Figure 1.3). The constituents of the dimer regulate cellular and 
ECM component interactions, which in turn greatly influence cellular adhesion, 
viability and differentiation state. FN contains multiple binding domains 
implicated in interactions with ECM components such as collagen (FNII1-2) and FN 
matrix forming complexes (FNI1-5) (Pankov and Yamada 2002, Singh, Carraher et 
al. 2010). FN possesses binding sites for many functional proteins such as 
integrins and growth factors. Integrin binding sites such as the RGD (Arg-Gly-Asp) 
domain found at FNIII10 and the PHSRN (Pro-His-Ser-Arg-Asn) synergy domain 
(FNIII9) can induce cell mediated FN assembly which produce focal adhesion with 
cells producing a favourable binding site for cell attachment (Cantini, González-
García et al. 2012). Binding sites for growth factors, such as Bone Morphogenic 
protein 2 (BMP-2), are located in the FNIII12-14 sequence and can drive cellular 
proliferation and osteogenic differentiation (Zhao, Harris et al. 2002, Llopis-
Hernandez, Cantini et al. 2016). These GF regions are able to directly influence 
cellular interactions and therefore cell fate. The availability of these binding 
sites on FN is regulated by the physical conformation of the molecule, as 
explained in the following paragraphs (sections 1.4.1. and 1.4.2.). 
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Figure 1.3. Fibronectin molecule deconstructed.  The diagram shows the 
different FN molecules and their corresponding integrin-interacting, enzymatic 
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degradation, ligand interacting and fibrillogenesis sites. From Pankov and 
Yamada, 2002, Fibronectin at a glance.   
 
1.4.1. Cell-mediated fibrillogenesis 
 
FN has been observed to exist in either a globular or fibril conformation and 
these secondary structures of FN directly regulate the availability and activation 
of the functional domains. The majority of FN found within the body is found 
within ECMs in fibril form, deposited via cell-mediated fibrillogenesis; however, 
other FN molecules found circulating in blood plasma are found in globular or 
“closed” conformation, which is regarded as its non-active form (Pankov and 
Yamada 2002) (Figure 1.4). Cell-mediated fibrillogenesis has been described as 
a “knitting” function of cells to assemble an FN-rich ECM around themselves 
(Hynes 1999); this refers to the direct cell-surface receptor mediated 
reorganisation of the ECM in general and more specifically to the reorganisation 
of ECM-bound FN fibrils. Usually, cell-mediated fibrillogenesis initiates due to 
α5β1 integrin binding of the FN RGD and PHSRN synergy sites with cell receptors. 
Multiple integrins binding on a single cell; causes contractile clustering of FN 
therefore producing high local concentrations of FN. This promotes self-
association and fibrillogenesis while translating mechano-transduction via 
receptor cytoplasmic domain interactions to the actin cytoskeleton 
(Schwarzbauer and Sechler 1999, Mao and Schwarzbauer 2005, Singh, Carraher 
et al. 2010, Schwarzbauer and DeSimone 2011, Lemmon and Weinberg 2017). 
While this is the most common mechanism by which cells mediate fibrillogenesis, 
other processes have been shown to support this matrix formation (Wierzbicka-
Patynowski, Mao et al. 2004).  
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Figure 1.4. Fibronectin secondary structure. A) Globular FN, in solution, 
showing a series of independently folded domains coiled into a compact 
composition. B) FN assembled into extended filaments, the elongated fibrils 
exposing the RGD domain (labelled by arrows on both A and B) for recognition by 
cells. Taken from Hynes, 1999, the dynamic dialogue between cells and matrices: 
Implications of FN’s elasticity. Copyright 1999 National Academy of Sciences. 
 
1.4.2. Cell-free fibrillogenesis 
 
FN fibrillogenesis can be induced in the absence of cells via a variety of 
methodologies; chemical, physical or surface-mediated assembly has been 
shown to form artificial FN matrices. Chemical treatment of plasma FN by 
reducing agents such as dithiothreitol (DTT) has been shown to stimulate 
decoupling of the disulphide-stabilized globular domains and induction of non-
covalent assembly of FN networks (Williams, Janmey et al. 1983). Lower 
concentrations of DTT and strong oxidants have also shown the ability to induce 
intramolecular bonding of FN through the type I and II repeats and sulphide 
terminal region respectively (Vartio 1986, Sakai, Fujii et al. 1994). Other 
chemical-based methodologies to disrupt or denature the globular conformation 
of FN have been shown to drive self-assembly. For example the addition of 
guanidine as a denaturant or of the anionic molecule heparin show that the 
disruption of globular FN molecule either by chemical denaturing or electrostatic 
interactions is able to drive the favourable formation of FN fibrils (Cantini, 
González-García et al. 2012, Llopis-Hernandez, Cantini et al. 2015). This process 
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of unfolding, and predominantly subsequent fibril formation, can be further 
demonstrated by the application of mechanical tension onto FN globular 
molecules (Brown, Blunn et al. 1994, Zhong, Chrzanowska-Wodnicka et al. 1998, 
Ulmer, Geiger et al. 2008). Studies have shown that by mechanically disrupting 
the globular conformation, for example by domain separation of lipid bilayers or 
creating regions of extreme hydrophobicity differences (Baneyx and Vogel 1999, 
Ulmer, Geiger et al. 2008), the physical elongation of the FN molecule can 
expose the cryptic binding domains required for self-assembly, producing FN 
fibrils.  
 
Material-driven fibrillogenesis occurs upon adsorption of FN on selected 
material surfaces (Salmeron-Sanchez, Rico et al. 2011, Cantini, González-García 
et al. 2012, Llopis-Hernandez, Cantini et al. 2016); this is dependent on the 
ability of the surface chemistry to disrupt the globular conformation of FN, as 
with the other synthetic methodologies. The adsorption of FN onto hydrophilic 
or negatively charged surfaces has been shown to facilitate the elongation of 
globular FN molecules (Nelea and Kaartinen 2010). Certain polymer surfaces, 
such as poly (ethyl acrylate), possess highly molecularly mobile, functional side 
chains which favour adsorption of FN in an extended conformation and 
consequent fibril formation (Salmeron-Sanchez, Rico et al. 2011). This is thought 
to occur due to the hydrophobic regions of FN interacting with the ethyl side 
chains of PEA, supplemented by the net negative charge of the bulk polymer, 
producing physical disruption of the globular conformation allowing FN 
molecules to orientate themselves into a favourable fibril conformation (Cantini, 
Gonzalez-Garcia et al. 2012). As previously described in cell-mediated and other 
synthetic fibrillogenesis mechanisms, the non-globular single elongated strands 
of FN would then be able to interact freely to form fibrils and networks enabling 
the favourable cellular interactions with FN binding motifs such as the PHSRN or 
growth factor binding domains. Material-driven fibrillogenesis presents the 
ability to develop biomaterial surfaces able to drive the re-organisation of the 
secondary structure of FN and therefore the expression of multiple cryptic 
binding domains that allow for enhanced cellular interactions. 
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1.4.3. Integrin binding 
 
Cells sense their immediate environment via biochemical and physical cues, 
which lead to signalling-regulated cell function, differentiation and viability. 
Signal transduction of these cues is instigated by cell adhesion receptors known 
as integrins. These transmembrane heterodimeric proteins interact with ECM 
components and cells, translating external mechanical cues to intracellular 
structures (Schwartz 2010) (Figure 1.5). Integrin binding is dictated by the 
composition and combination of two type I transmembrane glycoproteins, α and 
β. These proteins generally consist of extracellular elongated stalks that traverse 
cellular membranes, globular ligand binding domains (Xiong, Stehle et al. 2001) 
and cytoplasmic tails which predominantly binds cytoskeletal and signalling 
proteins (Hughes, DiazGonzalez et al. 1996, Calderwood, Fujioka et al. 2003). 
High variability in the amino acid make-up of each individual α and β subunit, 
their components and different combinations of each subunit allow for a vast 
array of specific cellular binding to be dictated by integrins. Typically, α and β 
extracellular globular regions bind specific domains in the ECM, transmitting 
precise signals through the cytoplasmic tail, potentially to recruit actin binding 
filaments or produce a signalling cascade to the nucleus.  
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Figure 1.5. Integrin binding extracellular matrix components initiating focal 
adhesion complexes and actin filament formation. From Cell Adhesion, Cell 
Communication, Nature Education, 2010, found at 
https://www.nature.com/scitable/topicpage/cell-adhesion-and-cell-
communication-14050486. (Last accessed 24/04/19) 
 
 
As one of the most abundant ECM proteins, FN has been shown to possess 
amino acid sequences corresponding to dozens of these integrin receptor 
families (Plow, Haas et al. 2000).  These FN cell recognition sequences are found 
at several sites (Figure 1.3.); some of these sites include RGD on cellular FNIII10, 
LDV and REDV on alternatively splices variant FNV and an EDGIHEL sequence 
found on EDA alternatively spliced FN (Pankov and Yamada 2002). Generally the 
best known of these sequences is the RGD domain, which interacts with, e.g., 
α5β1 integrins; this domain is not exclusively presented by FN, but can be found 
in other extracellular membrane proteins such as vitronectin and fibrinogen. The 
R residue fits into the cleft of a β-propeller inserted into the α subunit while the 
D residue is cationically bound within a von Willebrand factor A-domain in the β 
subunit (Humphries, Byron et al. 2006). This binding domain-integrin interaction 
has been shown to be important in controlling cellular adhesion. The binding of 
this domain is dependent on the FN secondary structure, regulating the 3D 
presentation of the RGD motif, and promoted and enhanced by secondary site 
21 
 
binding of the synergy domain. The synergy site is able to promote RGD binding 
of cells by interacting with the α5 subunit; although this synergistic binding of 
both domains enhances cellular adhesion, it is not required (Redick, Settles et 
al. 2000). In fact, it has been shown that while the PHSRN synergy site has no 
integrin binding activity of its own, it is able to synergistically improve RGD-
mediated cellular binding 100 fold (Obara, Kang et al. 1988, Kimizuka, Ohdate 
et al. 1991, Aota, Nomizu et al. 1994, Redick, Settles et al. 2000). The exposure 
of these two binding domains for α5β1 integrin interactions is dependent on their 
relative distance and orientation to each other as well as the secondary 
conformation of FN (Bachman, Nicosia et al. 2015). These cryptic sites are 
favourably presented by FN fibrils.  
 
 
α5β1 integrin recognition of the RGD and PHSRN FN motifs allows mechano-
transduction of force stimuli from the ECM to the cell, producing contractile 
dependant cellular phenotypes. Upon integrin receptor binding and clustering, the 
accumulation of integrins at sites of high concentrations of RGD domains, as would 
be present with FN fibril networks (Takagi and Springer 2002, Calderwood 2004, 
Takahashi, Leiss et al. 2007), occurs and the assembly of intracellular multiprotein 
structures is triggered (Figure 1.6). These structures are generally referred to as 
focal adhesions (FAs). Initially, the N-terminal region of talin, an antiparallel 
homodimeric actin cross-linking protein (Critchley 2004), interacts with the 
intracellular component of the β integrin subunit, while the C-terminal actively 
binds to actin (Anthis and Campbell 2011). This interaction, and subsequent 
employment of kindlin proteins (Meves, Stremmel et al. 2009), which have been 
shown to aid in the activation of integrins (Calderwood, Campbell et al. 2013), 
provide a protein “anchor” that both stabilize the integrin and provide a biological 
initiator for protein recruitment. Other stabilizing proteins such as vinculin, which 
possesses a globular head N-terminal domain able to interact with the rod 
structure of talin and α-actinin and a tail region that can bind F-actin (Critchley 
2004), are able to bind to this “anchor”. The presence of vinculin has been shown 
to increase the size of FAs and reduce their rate of turnover. Inhibition of 
contractility induces loss of vinculin co–localised with FAs (Humphries, Wang et 
al. 2007, Wolfenson, Bershadsky et al. 2011).  The C-terminal tail of vinculin is 
able to bind actin, strengthening the interactions with talin, acting as a bridge or 
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molecular clutch, transducing forces from the ECM-bound integrins to the actin 
cytoskeleton (Elosegui-Artola, Oria et al. 2016). Focal adhesion kinases (FAKs) are 
subsequently recruited to further stabilize and control the turnover of the FAs. 
The presence of FAK, recruited due to phosphorylation of Tyr397 in response to 
integrin clustering, and the subsequent binding with another kinase protein Src 
are able to phosphorylate and dephosphorylate key focal adhesion proteins (Webb, 
Donais et al. 2004). Through this mechanism, FAK is able to regulate the adhesion 
dynamics in response to alterations in ECM and signalling via growth factors. Focal 
adhesions transmit traction force between cells and ECMs: through these focal 
points the actin cytoskeleton of the cells is able to directly respond to and exert 
force on the ECM (Wozniak, Modzelewska et al. 2004). These structures range from 
small immature sites, less than 1 micron in size, to more mature FAs which can be 
from 1 to 10 microns long.  
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Figure 1.6. Focal adhesion and subsequent actin filament formation induced 
by RGD binding of α5β1 integrins (circled in black).  Inspired by educational 
images from Mechanobiology Institute National University of Singapore (MBI), 
 Sruthi Jagannathan, MBInfor sponsored by Mechanobiology Institute, 
National University of Singapore. Found at https://www.mechanobio.info/what-
is-mechanosignaling/what-is-the-extracellular-matrix-and-the-basal-
lamina/what-are-focal-adhesions/what-are-mature-focal-adhesions-composed-
of/. (last accessed 24/04/19) 
 
 
1.4.4 Growth factors 
 
Growth factors (GFs) are signalling proteins that stimulate cell growth, 
differentiation, survival and tissue repair. FN has been found to bind and present 
growth factors to cells, predominantly occurring on the 12th – 14th type III repeats 
(Martino and Hubbell 2010). These domains possess high affinity heparin-binding 
domains (Pankov and Yamada 2002), which many growth factors, such as fibroblast 
growth factors and vascular endothelial growth factors have been found to bind 
to through their affinity to heparin and heparin sulfate (Bossard, Van den Berghe 
et al. 2004, Wijelath, Rahman et al. 2006, Kirkpatrick and Selleck 2007). Growth 
factor binding to various ECM components produces similar transduction pathways 
to integrin binding (Hynes 2002, Lin, Ren et al. 2011), the function of this binding 
can vary. In certain cases ECM components act as a reservoir of soluble growth 
factors, able to locally release these morphogens upon degradation, allowing for 
an established gradient within the ECM (Hynes 2002, Zhu and Clark 2014). 
However, some ECM bound GFs maintained as solid-phase ligands induce different 
cellular signals compared to their soluble counterparts (Mohammadi, Olsen et al. 
2005, Zhu and Clark 2014). Both these methodologies locally release or present 
GF to associated cellular receptors to induce morphogenesis. 
 
In certain cases it has been shown that bound GF is able to stabilize and 
actively present GFs to cells more favourably than when these morphogens are in 
solution (Kuhl and GriffithCima 1997, Llopis-Hernandez, Cantini et al. 2016). In 
particular cases, these tethered GFs are not internalized by the cell upon contact, 
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restricting the area of interaction to the surface and allowing prolonged cellular 
signalling (Platt, Roman et al. 2009, Rodrigues, Blair et al. 2013, Zhu and Clark 
2014). Additionally, growth factor binding domains have been shown to synergies 
with integrin binding to enhance cellular viability and interactions (Hynes 2002, 
Lin, Ren et al. 2011, Donnelly, Dalby et al. 2018), even facilitating additional 
integrin-dependant signalling pathway activation (Fourel, Valat et al. 2016, 
Donnelly, Salmeron-Sanchez et al. 2018). These cross talk interactions may be 
dependent on membrane proximity interactions or cooperative downstream signal 
transduction pathways (Lin, Ren et al. 2011, Zhu and Clark 2014). It has been 
reported that certain GFs, e.g. Vascular endothelial growth factor (VEGF), require 
both integrin binding (α5β1) proximal to growth factor receptor binding (VEGFR2) 
on FN to facilitate full activation of the GF (Borges, Jan et al. 2000). Therefore 
by either the absorption or presentation of GF in collaboration with integrin-
mediated interaction, FN is able to regulate and drive cellular morphogenesis via 
GF cellular signalling pathways (Dalby, Garcia et al. 2018).   
 
1.5. Stem cells 
 
Stem cells are characterised by their ability to self-renew and capacity to 
differentiate into a variety of cell lineages. Within this subset of cells there are 
further classification definitions which correlate to the differentiation potential 
of the cells; for example embryonic stem cells (ESCs) are able commit to any 
lineage (pluripotency), while adult stem cells (ASCs) or progenitor cells are more 
lineage-defined and can only differentiate into specific cell types (multipotency) 
(Nadig 2009). These stem cells are naturally found within defined biological 
niches (Figure 1.7), which either induce retention of these cells stem-like 
characteristics via quiescence or stimulate differentiation to specific lineages 
via signalling (Donnelly, Salmeron-Sanchez et al. 2018).  Stem cell niches are 
specialized microenvironments with defined extrinsic physical and functional 
factors that regulate stem cell behaviour (Schofield 1978, Donnelly, Salmeron-
Sanchez et al. 2018). Many ASC subsets have distinct niches: haematopoietic 
stem cells close to endosteum and/or sinusioidal blood vessels within bone 
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marrow, epithelial stem cells in the bulge of hair follicles, and neural stem cells 
within subgranular and subventricular zones of the central nervous system to 
name a few (Morrison and Spradling 2008). Stem cell populations within these 
niches are either maintained or driven to differentiate for tissue development 
or regeneration in response to a diverse range of signals. Certain characteristics 
of stem cell niches are conserved by most stem cell microenvironments; such as 
certain heterologous cell-cell interactions, cellular responses to tissue damage 
or ligand and mechanical properties presented by ECM components can be 
observed in several, if not all, stem cell niches (Lane, Williams et al. 2014). 
Through this tight regulation, the stem cell populations can be utilised by the 
body to compensate for and repair local damaged tissues or can be maintained 
in a state of propagation or quiescence (Jones and Wagers 2008).  
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Figure 1.7. Stem cell niche factors shown to regulate cell fate. Stem cell 
population maintenance and cues to differentiate are tightly controlled by their 
inhabited niches; the niches themselves are specifically made-up of a variety of 
complex heterotypic, dynamic structures which provide physical, ECM, 
inflammatory, secretory cellular hypoxia and metabolic factors. From Lane et al, 
2014, Modulating the stem cell niche for tissue Regeneration Nature, 32; 8 
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1.5.1. Mesenchymal stem cells 
  
Tissue engineering has utilised a variety of stem cells for many years, 
primarily due to their pluripotency and ability to regenerate damaged tissues, 
and their propensity for signal-induced responses, be it to mechanical, biological 
or chemical cues. In bone tissue repair, stem cells allow full regeneration of the 
damaged tissue and intracellular signalling to surrounding tissue to promote 
healing. The most commonly utilised stem cell types are Mesenchymal stem cells 
(MSCs); these cells are found within a variety of different stem cell niches, 
including bone marrow, adipose tissue and within the eye close to the corneal 
limbus (Donnelly, Salmeron-Sanchez et al. 2018). These adherent fibroblast-like 
cells are able to differentiate into a variety of cells, including osteoblasts, 
adipose, myoblasts, myocytes and chondrocytes both in situ and in vitro 
(Dominici, Le Blanc et al. 2006, Phinney and Prockop 2007) (Figure 1.8). 
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Figure 1.8. MSC within bone marrow is able to self-renew or differentiate 
into a variety of cell types through ectoderm, mesoderm or endoderm 
lineages.  From Uccelli and Pistoia, 2008, Mesenchymal stem cells in health and 
disease, Nature Reviews Immunology volume 8, pages 726–736 (2008) 
  
 
1.5.2. Osteogenic differentiation 
 
The fate of MSCs is tightly regulated by factors of their niche; hence, modern 
biomedical engineering has employed several methodologies to emulate these 
factors and use MSCs in tissue engineering. These biomimicry approaches can be 
chemical (e.g. presentation of selected chemical groups to cells on self-assembled 
monolayers (Ulman 1996, Badia, Lennox et al. 2000, Sotiropoulou, Perez et al. 
2006, Phillips, Petrie et al. 2010, Greenbaum, Hsu et al. 2013)), 
topographical/spatial (e.g., presenting varying densities of cellular binding 
domains (Kilian, Bugarija et al. 2010, Fernandez-Yague, Abbah et al. 2015)), or 
mechanical (e.g. culturing stem cells within hydrogels of controlled stiffness 
(Mayer 2005, Engler, Sen et al. 2006, Bhushan 2009, Huh, Torisawa et al. 2012, 
Donnelly, Smith et al. 2017))  and have shown that, by modifying established 
biomaterials, MSC fate can be driven and controlled for specific applications in 
tissue engineering, such as bone regeneration. For example, topographical 
modulation via roughness of poly caprolactone (PCL) surfaces was used to probe 
the relationship between cell fate and surface smoothness in basal media, not 
containing any growth factors or osteogenic inducers. The modified surface 
conformation was shown to increase COL1 synthesis and alkaline phosphatase 
(ALP) expression, an effector protein responsible for the mineralization of the ECM 
(Marom, Shur et al. 2005), comparatively to flat controls (Faia-Torres, Charnley 
et al. 2015). ALP acts as a metalloenzyme in the hydrolysis of phosphomonoesters, 
forming a serine phosphate intermediate which reacts with water at high pHs 
releasing inorganic phosphate from the enzyme (E Golub and Boesze-Battaglia 
2007). The enzyme is found bound to the plasma membrane by its C-terminal via 
a phosphatidyl inositol-glycophospholipid (Harrison, Shapiro et al. 1995). The 
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process of mineralization or calcification of the ECM represents a major stage in 
osteoblast activity in primary bone formation (Schindeler, McDonald et al. 2008). 
This process highlights the presence of mature osteoblasts that allow this ECM 
remodelling, indicating the successful differentiation of osteoprogenitors (MSC) 
cells. Therefore by staining or quantifying the mineralization of the ECM 
surrounding stem cells grown in vitro MSC differentiation into osteoblasts can be 
determined (Al-Jarsha, Moulisova et al. 2018, Hay, Rodrigo-Navarro et al. 2018). 
Other markers of osteogenic differentiation of MSC cells include osteopontin 
(OPN), an early stage marker, and osteocalcin (OCN), a late stage marker (Aubin 
2001). These non-collagenous proteins have been shown to be present in bone 
matrix and due to the high density of aspartic acid and glutameric acid residues 
within their primary amino sequence are able to bind calcium ions with a high 
affinity (Oldberg, Franzen et al. 1988). Therefore, it is thought that these bone 
matrix proteins are selectively produced by osteoblasts as a bridge to 
hydroxyapatite, a naturally occurring mineral found in bone, during different 
stages of bone formation (Hauschka, Lian et al. 1989, Sodek, Ganss et al. 2000, 
Noda and Denhardt 2008).  
 
Growth factors are also able to drive differentiation of MSCs. One key subset of 
growth factors known to regulate osteogenic differentiation are bone morphogenic 
proteins (BMPs). These GFs are found throughout the body and have been shown 
to be critical for all organ systems (Wang, Green et al. 2014). However, they were 
first discovered due to the ability of certain BMPs to induce bone formation; for 
example bone morphogenic protein 2 (BMP-2) is a dimeric member of the 
transforming growth factor-β (TGF-β) family of proteins, excreted by cells and 
bound to components of the ECM, such as FN. MSCs are able to bind dimeric BMP-
2 through cell surface BMP-receptors (BMPRI and BMPRII) forming 
heterotetrameric complexes, which initiate osteogenic signal transduction. BMP-
2 treatment has successfully been utilised for bone regenerative tissue 
engineering purposes (Lee, Silva et al. 2011), however due to low efficiency of 
this GF in solution, a result of ineffective GF presentation to cells, high 
concentrations of BMP-2 are required. These high concentrations of BMP-2 used 
with conventional biomaterials are costly and have been shown to have potential 
adverse side effects within these systems. Therefore, current research aims to 
optimise the presentation of BMP-2 therefore lowering the concentrations 
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required for successful osteogenesis in tissue engineering. (James, LaChaud et al. 
2016). 
 
1.6. Poly L-Lactic Acid 
 
Poly L-Lactic acid (PLLA) is a hydrophobic semi-crystalline polyester with a 
melting point of 174-184oC and a glass transition temperature of 60-65oC (Auras 
2010, Rincon Lasprilla, Rueda Martinez et al. 2011). The PLLA polymer is made 
of L-lactic acid (LA) monomers (Figure 1.9), whereas poly D-lactic acid (PDLA), 
its optimal isomer and poly L/D-lactic acid (PLDLA) a blend are either, comprise 
solely or partially of D-lactic acid monomers. The polymer can be manufactured 
at different molecular weights and processing temperatures which allow the 
production of different forms of PLLA with diverse physical properties 
(Nampoothiri, Nair et al. 2010, Savioli Lopes, Jardini et al. 2012). These 
variations allow for a wide range of poly lactic acid polymers to be produced for 
different applications. PLLA degrades within the human body to produce the 
non-toxic degradation products; water, carbon dioxide and lactic acid which are 
processed by the Krebs cycle and excreted through urine. The reagents required 
to synthesis PLLA are widely available and cost effective, allowing PLLA to be a 
very accessible biomaterial. 
 
Figure 1.9.  Structural formula of poly L-lactic acid.  
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1.6.1. Properties 
PLLA has been used as a biodegradable polymer for many years (Zhu, Gao 
et al. 2004); key characteristics of this polymer, its biocompatibility, availability 
and controllable degradation within the body, make it a versatile and useful 
resource for regenerative medicine (He, Wang et al. 2013). PLLA is able to 
maintain certain aspects of its characteristic mechanical properties, such as high 
tensile strength (4.8 GPa), even after alterations and processing. However, it 
can alternatively be processed to produce a soft or elastic materials, therefore 
it can be used as both a rigid and a plastic biomaterial (Farah, Anderson et al. 
2016). This flexibility has allowed it to be used in many different types of 
biomaterial. The mechanical characteristics of PLLA can be changed by altering 
the molecular weight of the pure polymer, by co-polymerising it with other 
polymers or by adding chemical reagents such a plasticisers. The mechanical 
properties and chemical composition regulate the appropriate use as a 
biomaterial and biodegradation of PLLA devices; for example, PLLA can be 
processed to have a degradation time of between 6 months to 5 years (Suuronen, 
Pohjonen et al. 1998). This variation allows for a wide scope of PLLA applications 
within the body, from drug delivery applications to long-term bone fixation. In 
some cases improved mechanical properties such as impact strength and tensile 
strength are needed for bone fixation; in these instances PLLA can be 
strengthened with copolymerisation with D-lactide or other polymers, such as 
co-polymerisation with glycolic acid to form Poly Lactic-co-glycolic acid (PLGA) 
(Haers, Suuronen et al. 1999, Makadia and Siegel 2011).  PLLA can also be used 
in polymer-based hydrogel scaffolds used for regeneration of tissues (Hiemstra, 
Zhong et al. 2006); in this case lactide is usually co-polymerised with other more 
hydrophilic polymers to produce the water swollen 3D structure (Basu, Kunduru 
et al. 2016). These variations have allowed PLLA to be applied in various tissue 
engineering applications, from rigid scaffolds for bone regeneration to soft tissue 
regeneration for cartilage repair (Rosenzweig, Carelli et al. 2015). 
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1.6.2. PLLA in cell culture 
 
While PLLA is incredibly useful as mechanical support for regeneration, one 
obstacle in utilising PLLA as a cellular environment for implantation is the limited 
cellular adhesion due to poor adsorption and expression of key biological signals. 
Implantable porous scaffolds usually contain pluripotent cells or biological 
signalling molecules to enlist cells to the site of regeneration (Zhu, Gao et al. 
2004, Auras 2010, Rincon Lasprilla, Rueda Martinez et al. 2011, Savioli Lopes, 
Jardini et al. 2012, He, Wang et al. 2013, Frydrych, Roman et al. 2015, Liu, Tian 
et al. 2015). Due to inefficient ECM protein adsorption, PLLA is often modified 
before surgical implantation for regenerative medicine purposes (Zhu, Gao et al. 
2004, Xu, Yang et al. 2011). For example, PLLA scaffolds can either be pre-
seeded with donor cells before implantation or be preloaded with relevant 
proteins corresponding to the tissue surrounding the intended implant. These 
steps to improve cell-surface interactions are necessary, as this is the first point 
of contact with the in vivo environment of the body (Zhu, Gao et al. 2004). 
However, PLLA is not an ideal biomaterial for adhesion of certain ECM 
components, such as FN, as it is unable to drive the formation of protein fibrils 
that would facilitate enhanced cellular interactions (Zhu, Gao et al. 2004). 
Therefore, several surface modification techniques have been proposed to 
improve this initial interaction and the subsequent cell adhesion and growth. 
These methods include UV irradiation (Zhu, Zhang et al. 2002), plasma treatment 
(Chen and Su 2011, Jacobs, Declercq et al. 2013) ,  surface entrapment (Meng, 
Wang et al. 2004), alkaline treatment (Kramer, Kunkemoeller et al. 2014) and 
SI-ATRP (Xu, Yang et al. 2011). The aim of these procedures is to directly add 
protein, alter the surface characteristics or co-polymerise more bioactive 
polymers onto the surface of PLLA to increase implant effectiveness. 
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1.7. Poly (Ethyl Acrylate) 
 
 
Poly (Ethyl Acrylate) (PEA) is an acrylic ester polymer; it has a glass 
transition temperature of -23 oC and tensile strength of 0.23 MPa (Figure 1.10). 
PEA is biostable in vivo and is non-degradable. Therefore it is able to provide 
long-term structural support to the mechanical properties of the tissue when 
PEA is utilised in copolymer systems as a non-degrading elastic polymer (Lozano 
Picazo, Perez Garnes et al. 2015). 
 
Figure 1.10.  Structural formula of poly (ethyl acrylate).  
 
1.7.1. PEA in biomedical engineering 
 
PEA is hydrophobic, at physiological temperatures it is biostable and 
possess elastomeric characteristics. Another benefit of PEA in biomedical 
engineering is its good biological behaviour and protein interactions; when FN is 
coated onto the polymer, PEA is able to organise FN into physiological-like 
fibrillar networks; this facilitates initial cellular adhesion and the formation of 
focal adhesions (Salmeron-Sanchez, Rico et al. 2011, Cantini, González-García 
et al. 2012, Llopis-Hernandez, Rico et al. 2013, Vanterpool, Cantini et al. 2014). 
PEA is able to induce material-driven fibrillogenesis due to the mobility and 
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composition of functional groups in the polymer, which facilitate unfolding of 
the FN molecule. This exposes functional binding sites for cellular adhesion and 
growth factors binding such as BMP-2 (Bathawab, Bennett et al. 2016, Llopis-
Hernandez, Cantini et al. 2016, Moulisova, Gonzalez-Garcia et al. 2017). Within 
our group we have shown that by plasma treating decellularized bone fragments 
with PEA, fibrillogenesis of FN is able to favourably increased presentation of 
the FNIII12–14  growth factor and FNIII9 synergy binding domains, allowing for 
ultralow doses of growth factors for critical bone defect regeneration (Cheng, 
Alba-Perez et al. 2019). This control over the conformation and activity of FN 
allows for the selective adhesion and phenotypical responsiveness of a variety of 
cells types (Lozano Picazo, Perez Garnes et al. 2015, Donnelly, Dalby et al. 
2018). However, PEA has been shown to be non-biodegradable (Lozano Picazo, 
Perez Garnes et al. 2015), which is a limiting factor in its use in biomedical 
engineering applications. Therefore, strategies are needed to produce 
nanometrically thin functional PEA coatings on biodegradable substrates; this 
thin layer has to maintain its ability to induce FN fibrillogenesis, without altering 
the degradation profile of the underlying material.  The inclusion of thin layers 
of PEA, produced by plasma polymerisation and spin-coating has been shown to 
provide additional functionality to glass and poly caprolactone (Llopis-
Hernandez, Cantini et al. 2015, Llopis-Hernandez, Cantini et al. 2016, Cheng, 
Alba-Perez et al. 2019). In turn, this thin polymer layer, as small as a couple of 
nanometers, can be subsequently metabolized (Kreyling, Abdelmonem et al. 
2015, Muellner, Dodds et al. 2015, Schulz, Gojzewski et al. 2018). Techniques 
currently utilised to produce these thin layers of PEA include plasma and spin 
coating (Llopis-Hernandez, Cantini et al. 2016, Cheng, Alba-Perez et al. 2019). 
These processed have been shown to retain the functionality of PEA, however 
they can result in modified polymer chain chemistry or ineffective translation to 
3D systems (Cantini, Gonzalez-Garcia et al. 2012). Plasma polymerisation has 
been utilised in coating bone chips pre-implantation in vivo, these PEA coated 
bone chips were observed to enhance osteogenic regeneration in critical bone 
defect models through enhanced presentation of ultra-low doses of BMP-2 
(Cheng, Alba-Perez et al. 2019). While plasma has been utilised to coat the 
internal architecture of 3D scaffolds, this coating has been shown to be 
heterogeneous (Barry, Silva et al. 2005, Canal, Khurana et al. 2016). Additionally 
plasma coating does not produce PEA chemically bound to the coated surface 
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and therefore “peeling” may occur. Therefore further advances in developing 
treatments for the inclusion of homogenous thin layers of PEA within 3D scaffolds 
is required.    
1.8. Surface modification of polymer substrates 
 
Polymers are vastly useful as biomaterials, primarily because of their 
versatility and potential to be modified to produce substrates with specific 
properties, attuned to the desired application. Therefore, there have been vast 
amounts of research into methodologies to tune polymer characteristics for 
specific biomedical uses. In particular, surface modification strategies 
predominantly focus on the addition of a functional layer to the surface of the 
polymer, modulating the interface where the majority of the interactions with the 
biological milieu occur. These approaches aim at optimising the biological 
performance of the polymer, tuning its surface to control its interfacial 
properties. Surface modification strategies include plasma treatment, including 
plasma polymerisation (Chu, Chen et al. 2002, Chen and Su 2011, Jacobs, Declercq 
et al. 2013, Cheng, Alba-Perez et al. 2019), addition of topographical features 
(Dalby, Gadegaard et al. 2007, Costa Martinez, Rodriguez Hernandez et al. 2008), 
or inclusion of functional chemical groups or polymer brushes (Xu, Yang et al. 
2011, Gonzalez-Garcia, Moratal et al. 2012, Khetan, Guvendiren et al. 2013, Yu, 
Johnson et al. 2014).  The aim of these modifications is to add a certain biological 
functionality to the polymer; such as immobilisation of GFs, addition of non-
fouling properties or improving biocompatibility (Zhu, Gao et al. 2004, Siegwart, 
Oh et al. 2012, Nemani, Annavarapu et al. 2018), while generally maintaining its 
bulk properties.  
 
1.8.1. Surface Initiated-Atomic Transfer Radical Polymerisation 
(SI-ATRP) 
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While many surface modification techniques have been developed over the 
years, surface-initiated atomic transfer radical polymerisation (SI-ATRP) has 
emerged as a widely used methodology for controlled alteration of surface 
properties for biomedical applications (Xu, Yang et al. 2011). In SI-ATRP, the 
surface intended to be altered is initially functionalised or primed and an 
initiator molecule is then immobilised. This initiator is activated in the presence 
of the intended monomer for a specified time (Matyjaszewski, Dong et al. 2007, 
Matyjaszewski 2012), and the monomer is therefore polymerised in place of the 
anchored initiator and bound to the surface (Datta, Bhowmick et al. 2008) 
(Figure 1.11). The polymerisation can be supplemented with other catalysts: for 
example an activators regenerated by electron transfer (ARGET) protocol utilises 
non-radical forming reducing agents to facilitate the activation and substitution 
of the initiator; in this way the reaction kinetics are lowered and less catalytic 
activator is required (Simakova, Averick et al. 2012). 
 
Compared to other surface modification polymerisation techniques SI-ATRP 
is tolerant of slight impurities (Matyjaszewski, Dong et al. 2007), such as oxygen 
in the system, and does not require the same extreme experimental conditions 
required for ionic and ring opening metathesis polymerisation (Datta, Bhowmick 
et al. 2008). Due to the versatility and variability of SI-ATRP it can be carried 
out in many different solvents in different conditions, which make it a widely 
utilised surface modification methodology in biomedical research (Datta, 
Bhowmick et al. 2008, Xu, Yang et al. 2011, Siegwart, Oh et al. 2012, Simakova, 
Averick et al. 2012). The specificity of the reaction also allows for refined control 
of molecular weight and functionality of polymers produced from SI-ATRP on 
many different surfaces, including proteins, inorganic materials and organic 
surfaces (Siegwart, Oh et al. 2012). 
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Figure 1.11. General mechanism by which atomic transfer radical 
polymerisation occurs. The base polymer (X) is bound to a functional initiator 
molecule (R), this complex is generally referred to as the “initiator”. The 
initiator can have one or several reactive side chains, providing high degrees of 
attenuation in designing ATRP processes. This “initiator” reacts with the ligand 
to be bound in a complex with a strong transition metal catalyst (Mtn) in the 
lower oxidation state, transferring the atom or group from the initiator to create 
a free radical (R) and an oxidized transition metal halide complex (X-
Mtn+1/Ligand). The radical propagates polymerisation of the introduced monomer 
(M), further reacting with the oxidized transition metal halide complex 
rejuvenating the catalyst. This process can repeat itself and is reversible, 
requiring the control of the temperature and atmospheric conditions as 
introduction of air or other free radicals will stop the reaction. Adapted with 
permission from Krzysztof Matyjaszewski and Jianhui XiaAtom (2001) Transfer 
Radical Polymerization. Chem. Rev. 2001, 101, 9, 2921-2990. Copyright 2001 
American Chemical Society. 
 
 
The SI-ATRP reaction allows for the incorporation of functional polymer 
chains onto surfaces without significantly altering the chemical characteristics 
of the host material. Moreover, the mechanical characteristics of the substrate 
can be maintained, which is incredibly useful in biomedical applications (Xu, 
Yang et al. 2011). This technique allows for the incorporation of functional 
polymer chains onto surfaces in a robust, efficient, cost-effective and 
controllable manner (Simakova, Averick et al. 2012). Due to the accessibility and 
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versatility of SI-ATRP it has being utilised in many aspects of biomedical 
research, including drug delivery methodologies (altering or encapsulating drugs) 
and surface functionalisation for improved cellular interactions (Khandare and 
Minko 2006, Datta, Bhowmick et al. 2008, Xu, Yang et al. 2011). 
 
1.9. Objectives 
 
The aim of the research outlined in this doctoral dissertation is to develop an 
implantable and degradable polymeric scaffold with optimised protein and cellular 
interactions for application in tissue engineering. The system will consist of a 
biodegradable rigid backbone (PLLA) and of biologically active brushes (PEA) able 
to induce the organisation of the ECM component, fibronectin (FN) into 
physiological-like fibrils (Figure 1.12). 
 
 
Figure 1.12. Surface modification of PLLA with PEA brushes to induce material-
driven assembly of fibronectin into nanonetworks. (A) PLLA modified via SI-ATRP 
to present PEA brushes (bPEA) on its surface; PEA drives the assembly of FN into 
physiological-like nanonetworks that facilitate cell adhesion and differentiation. (B) 
Sketch of FN outlining main matrix assembly and cell binding domains, and 
representation of the nanofibrils formed upon adsorption on PEA, which expose 
integrin binding domains and therefore facilitate the formation of focal adhesions 
by cells. Taken from Sprott et al, 2019.  
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To this end, we will first develop a SI-ATRP based methodology to produce PEA 
brushes on PLLA surfaces: 
1. We aim to optimise each step in this SI-ATRP process to achieve minimal 
alterations to any physical properties of PLLA so as to preserve its 
favourable characteristics (mechanical strength, degradability), whilst 
introducing nanometric PEA brushes on the substrate (Chapter 2).  
2.  We will characterise the interfacial properties of the synthetized polymer 
brushes, with attention to the retention of their ability to support the 
formation of biologically active FN assembly into nanonetworks, and we 
will test the ability of our surface modification to enhance cell adhesion 
and support cell differentiation using a model cell line (Chapter 3). 
3.  We will compare alternative SI-ATRP protocols and their biological 
interactions (Chapter 4).  
4. Then, we will further characterise the ability of our system to recruit and 
successfully present growth factors to mesenchymal stem cells. We will 
show the translation potential of the surface modification strategy 
developed in this thesis by applying it to a 3D scaffold designed for bone 
tissue engineering applications (Chapter 5).  
5. In the final chapter, we will present an overall discussion of our results and 
future perspectives for the materials and methodologies developed in this 
thesis (Chapter 6). 
 
 
 
 
 
 
 
 
 
 
 
2- Synthesis via ARGET SI-ATRP and physico-
chemical characterisation of PLLA-bPEA 
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2.1  Introduction 
 
Poly L-lactic acid (PLLA) is a well-established and widely used polymer in 
tissue engineering applications; however, it does not possess an inherent 
biological activity. In this chapter, we propose a methodology to introduce 
functional poly (ethyl acrylate) (PEA) brushes on its surface. The chosen 
methodology for surface modification is an atomic transfer radical polymerisation 
technique. This system has been used for many years, but the polymerisation of 
acrylate brushes onto PLLA has not been documented. Therefore, we aim to 
develop a novel protocol for this procedure. Initially, production of these brushes 
onto PLLA samples was performed on 2D films. Each step of the activator 
regenerative electron transfer (ARGET) surface-initiated atomic transfer radical 
polymerisation (SI-ATRP) (Figure 2.1) was optimised so as to ensure efficient 
functionalisation of the surface while maintaining the favourable characteristics 
of the bulk substrate.  
 
 
Figure 2.1. SI-ATRP process.  Characterisation of the key steps of SI-ATRP on 
PLLA and the surface chemical reactive groups produced from each step. 
Adapted from (Sprott, Gallego-Ferrer et al. 2019). 
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2.2  Materials and methods 
 
2.2.1 Materials: Poly (L-Lactide) films (thickness 50 µm) were purchased from 
Goodfellow (Huntingdon, UK). 1,6-hexanediamine (98%), 2-propanol (≥99.5%), 2-
bromoisobutyryl bromide (BIBB, 98%), anhydrous pyridine (Py, 99.8%), anhydrous 
hexane (95%), copper(I) bromide (CuBr,99.999 %), Tris(2-pyridylmethyl)amine 
(TPMA, 98%), ethyl acrylate (EA, 99.5%), methanol ( 99.99%), ascorbic acid (AsAc) 
were purchased from Sigma Aldrich, Dorset, UK. Glass reaction vessels were 
custom-made. Spin-coated PEA controls (PEA) were prepared on 12 mm glass 
coverslips from 4% solutions in toluene of bulk PEA, obtained via polymerisation 
of EA using 1% benzoin (Sigma, St. Louis, MO) as a photonitiator, spun at 3000 rpm 
with acceleration of 3000 rpm s-1 and vacuum dried at 60oC for 2 hours to remove 
excess toluene.  
 
2.2.2 Preparation of PLLA-bPEA films: The developed SI-ATRP system takes 
place in three steps: priming (aminolysis), initiator immobilisation (bromination) 
and polymerisation (Figure 2.1.); these processes take place sequentially and 
separately within different reaction vessels (Figure 2.2.). PLLA films were cut into 
13.8 mm circles, with an area of 1.9 cm2. The aminolysis protocol was carried out 
according to the method described in (Zhu, Gao et al. 2004). Briefly, PLLA films 
were immersed in 1, 6-hexanediamine and 2-propanol at 40ºC for 10 minutes. 
Samples were then washed in deionised water at RT for 24 hours with constant 
agitation to remove excess 1, 6-hexanediamine and then vacuum dried at room 
temperature to a constant weight.  
 
For initiator immobilisation, aminolysed PLLA films were placed on shelves 
within a 3-necked sealed reaction vessel, which was then degassed with oxygen-
free nitrogen gas. 3.5 mL BIBB and 70 mL anhydrous hexane were degassed within 
a side-arm and added to the reaction vessel to fully cover the samples. 1.4 mL 
pyridine was then dropped slowly into the reaction vessel as the reagents were 
stirred vigorously with a magnetic stirrer. The overall ratio of the reagents was 
hexane: BIBB: pyridine (20:1:0.4). The reaction was maintained at 0 ºC with an ice 
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bath for 2 hours and then subsequently kept at room temperature (24°C) for 22 
hours. A nitrogen flow was maintained throughout the entire 24 hour protocol. 
The initiator immobilised PLLA samples were then removed from the reaction 
vessel and washed with 2:1 deionised water: methanol solution in a soxhlet 
apparatus for ≥72 hours and then vacuum dried to constant weight. Polymerisation 
of initiator immobilised PLLA samples was carried out within a separate reaction 
vessel in a nitrogen atmosphere at room temperature. 1.95 mg CuBr and 12.8 mg 
TPMA powder were added to the bottom of the reaction vessel containing the PLLA 
samples. 16.65 g of ethyl acrylate and 16mL of methanol were then placed in a 
side arm of the reaction apparatus and the whole vessel was purged with nitrogen. 
Once all samples were immersed in this solution and thoroughly mixed through, 
123.28 mg ascorbic acid dissolved in 16 mL methanol was introduced dropwise 
(over 1 to 4 hours). The final ratio of the reactants was EA: CuBr: TPMA: AsAc 
(96:0.005:1:0.4). The polymerisation was stopped by flooding the vessel with 
oxygen and the samples (PLLA-bPEA) were then washed in 2:1 deionised water: 
methanol solution within a soxhlet apparatus for ≥72 hours and vacuum dried to 
constant weight. For the measurement of grafting yield samples were weighed 
before and after SI-ATRP treatment using an Ohaus Pioneer balance; grafting yield 
was calculated as (WPLLA-bPEA-WPLLA)/A, where A is the film area (30 samples of ~1 
cm2).  
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Figure 2.2. Experimental set-up. The reaction vessels are on the left and in the 
centre, connected to condenser and dropper side arm; on the right is a soxhlet 
set-up for washing of the samples post reaction.  Each reaction vessel consists of 
either a 3 or 4-necked lid and vessel, sealed with a Teflon O-ring and vacuum 
grease. Each neck is further connected to a condenser to retain all reagents within 
the vessel, a dropper arm with controllable drip rate regulated by a rotating 
stopper or an airtight rubber stopper with a needle pumping 0-grade nitrogen into 
the system(not shown) (nitrogen outlet was monitored via a bubbling apparatus 
downstream from the condenser). Each reaction vessel was placed within a glass 
water bath (not shown) on a magnetic stirrer enabled bench heater, so as to allow 
for control over general temperature and agitation of the reagents during 
reaction. Within each glass reaction vessel were perches for glass shelves used to 
maintain samples within the centre of the reaction and separate them from the 
magnetic stirrer. A basic soxhlet apparatus was set up, with a boiling vessel for 
solvents and glass boiling beads and a collection soxhlet tube with a Teflon sieve 
to ensure samples were not dropped into boiling solvents. A water system was set 
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up connecting flow between the condensers of all three apparatus so as to 
condensate reaction vapours. 
 
2.2.3. Atomic force microscopy: Atomic Force Microscopy was used to quantify 
surface roughness and visualise topology in dry conditions. Height and lock-in 
phase images were taken in AC mode using a Nanowizard 3 Bioscience AFM (JPK, 
Berlin Germany). Scans were made using cantilevers with a resonance frequency 
of 75 kHz and a force constant of 3 N m-1 (MPP-21120 from Bruker, Billerica, MA). 
Surface area scans (n=3) of 5x5 μm (0.5Hz) were used to analyse surface roughness 
of each sample from any given condition. The Rrms was calculated using the JPK 
DP software after image levelling to remove variations or tilts in the background. 
Scans of 2x2 μm (0.7Hz), 1x1 μm (0.8Hz) and 0.5x0.5 μm (1Hz) were used to 
identify features and qualitatively assess surface topology.  
Force spectroscopy curves were obtained, after calibration of cantilever 
sensitivity and spring constant, using ~30 Nm-1 cantilevers with a 20 µm diameter 
spherical silica tip. The cantilever was approached to the surface with a constant 
speed of 2.0 µm s-1, at room temperature in water or ambient conditions, and the 
Young’s modulus was calculated using a Hertz model (JPK DP software), with an 
indentation depth of 30 nm.  
 
2.2.4 Dynamic mechanical analysis: Dynamic mechanical analysis (DMA) was 
performed on a DMA 8000 (Perking-Elmer) apparatus at a frequency of 1Hz in 
tension mode, the temperature range was -150 to 100oC at a rate of 1oC min-1. 
Young’s modulus was determined at 36-38oC on sample of 10 mm x ~6 mm x 0.05 
mm. 
 
2.2.5 Water contact angle: Water contact angle measurements were undertaken 
on PLLA and functionalised samples. Static contact angles (SCA) were measured 
by dropping 3 μL of deionised water onto the samples (Figure 2.3). Advancing 
(ACA) and receding (RCA) contact angles were measured by the addition or 
removal of water to the droplet until an increase or decrease in the length of the 
baseline was observed. Contact angle hysteresis was calculated from the 
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difference between ACA and RCA. Analysis was conducted using a Theta optical 
tensiometer (Biolin Scientific, Stockholm, Sweden). 
 
Figure 2.3. WCA images. Showing 3 µl water drop on PLLA, PEA and PLLA-bPEA 
surfaces.  
 
2.2.6. Ninhydrin assay: A ninhydrin colorimetric method was utilised to quantify 
the amount of available amine groups bonded onto the surface of the aminolysed 
PLLA samples. Samples were immersed in 1 ml of ninhydrin solution, prepared by 
mixing 40 ml of 0.35M hydrinatin dihydrate and 4.49M ninhydrin in ethylene glycol 
with 10 ml of 0.04M lithium acetate buffer at pH 5.2. The samples were then 
heated to 90°C for 20 minutes and subsequently diluted with 9 ml of 1:1 2-
propanol: deionised water solution. The vials containing the samples were 
vigorously vortexed to include any chromatic sediments, elutes were pipetted into 
a 96 well plate and absorbance was read at 566 nm using Tecan NanoQuant Infinite 
M200 Pro plate reader (Männedorf, Switzerland). A calibration curve was obtained 
using solutions containing glycine of known concentrations. 
 
2.2.7. Enzymatic degradation: Individual samples were dried to constant weight 
under vacuum for a minimum of 2 days, samples were then submerged in 0.2 mg 
mL-1 proteinase K enzyme (Sigma, St. Louis, MO) in Tris-HCL buffer (pH 8.6) with 
0.2 mg mL-1 sodium azide (Sigma, St. Louis, MO). Incubated samples were kept at 
37oC with agitation. The degradation solution was replaced every 24 hours to 
maintain enzymatic activity. Samples were dried under vacuum to constant weight 
before final weight was established.  
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2.2.8. X-ray photoelectron spectroscopy: X-ray Photoelectron Spectroscopy 
(XPS) was used to identify the surface chemical composition of samples. All X-ray 
photoelectron spectra were obtained at the National EPSRC Users’ Service (NEXUS) 
at Newcastle University (found at: http://www.ncl.ac.uk/nexus/). Each sample 
was analysed at three points with a maximum beam size (400 μm x 800 μm) with 
a K-alpha XPS apparatus (Thermo Scientific) equipped with a monochromatic Al-
K-alpha source for Carbon, Oxygen, Nitrogen, Bromine and overview spectra. X-
ray energy was 1486.68 eV at a voltage of 12 kV, current of 3 mA and power of 36 
W. Analysis of the XPS results was conducted with CasaXPS version 2.3.16 (Casa 
Software Ltd) with adjustments for transmission and escape depth included in the 
VAMAS block provided by NEXUS. 
 
2.2.9 Statistical analysis: Pre-processing and normalization of data are stated 
in the individual methods sections. Analysis of statistical differences was 
conducted using student T-test (Graphpad) for two sample comparison and One-
way ANOVA for different groups using a Turkey HSD post hoc test to compare 
different groups. Differences were considered significant *p < 0.05, **p < 0.01, ***p 
< 0.001, ****p < 0.0001. All data presented are mean values, error bars are 
standard deviation and n numbers are noted in the figure captions. 
 
 
2.3 Results 
 
2.3.1 Surface characterisation 
 
Surface modification of PLLA films was conducted via an optimized ARGET 
SI-ATRP process. This system consists of three separate steps, each allowing for 
further controlled optimization and customization of desired products. Briefly, 
surfaces are functionalized during initial aminolysis procedures; this primes the 
PLLA for immobilisation of bromine based initiators. Upon bromination of these 
surfaces ethyl acrylate chains can be polymerised at these initiation points 
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producing PEA brushes onto the surface of the PLLA. Due to the high degree of 
variability in these steps, optimization at each stage can lead to dramatically 
altered properties of the PLLA-bPEA samples, ranging from PEA brush density 
to PLLA bulk mechanical stiffness.  Therefore we initially aimed to optimize 
each step in the SI-ATRP system so as to maintain substrate properties such as 
surface roughness and stiffness, while maximizing the surface 
functionalization. As the first step of SI-ATRP, aminolysis represents a vital 
process in surface modification, determining the homogeneity and density of 
priming sites for initiation and subsequently polymer brushes. However, as this 
reaction chemically breaks polymer backbones to incorporate functional amine 
groups, it has been shown that longer durations and temperatures of aminolysis 
are degradative to PLLA films (Zhu, Gao et al. 2004). Therefore it is vital to 
optimize this step to maintain the originally desirable mechanical properties of 
PLLA. Aminolysis of PLLA samples, performed with 0.06 mg mL-1 1,6-
hexanediamine at 40 °C, showed that increasing time while decreasing the 
hydrophobicity of the surfaces (Figure 2.4B) produced samples with a 
significantly increased RMS roughness (Figure 2.4A). The decrease of contact 
angle is representative of the inclusion of hydrophilic amine groups onto the 
surface, as observed via ninhydrin assay (Figure 2.4C). The available amine 
groups on the surface were observed to increase relative to time and 
temperature of aminolysis, however the dramatic chemical alterations to PLLA 
films aminolysed at 50°C resulted in structurally inviable films, which would 
crumble upon handling. Samples produced at 40°C for either 10 or 20 minutes 
were observed to have similar available surface amine densities and increased 
surface hydrophilicity relative to 5 minute aminolysed samples. However, 10 
minute samples were not observed to have significantly rougher surfaces than 
pristine PLLA, therefore in order to maintain physical characteristics, 10 
minutes of aminolysis with 0.06 mg mL-1 1, 6-hexanediamine at 40 °C was 
concluded to be the optimum protocol for initial functionalization. With this 
methodology, a surface density of –NH2 functional groups (~1.6 x 10-7 mol cm-2) 
was calculated via ninhydrin assay. 
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Figure 2.4. Aminolysis of PLLA. (A)  Surface root mean squared roughness 
measurements of PLLA samples aminolysed for 5, 10 and 20 minutes with 0.06 mg 
mL-1 1, 6-hexanediamine at 40 °C.  The PLLA samples were washed with deionised 
water. A minimum of 12 measurements were taken from 5x5 µm2 AFM scans of 
each sample. (B) Static water contact angle characterisation of PLLA films 
aminolysed for either 5, 10 or 20 minutes. (C) NH2 density on PLLA surfaces 
aminolysed for 5, 10 and 20 minutes with 0.06 mg mL-1 1, 6-hexanediamine at 50 
°C compared to PLLA aminolysed at 40 °C. Graphs show mean values and standard 
deviation.  *p < 0.05. 
 
 Characterisation of samples treated further through the SI-ATRP procedure, 
with subsequent 24 hours of initiator immobilisation and 4 hours of polymerisation, 
showed that topological and chemical alterations had been implemented (Figure 
2.5). Surface roughness was measured to increase progressively through each step 
after aminolysis (Figure 2.45A). While untreated PLLA and PLLA-NH2 had similarly 
smooth surfaces (RRMS ~ 10.9 nm), initiator immobilisation was observed to 
increase this to ~ 19.5 nm and polymerisation to ~ 26.0 nm. Static contact angle 
was observed to recover to similar levels of hydrophobicity as PLLA post 
bromination (~90°) (Figure 2.5B), potentially due to the loss of amine groups and 
addition of initiator. PLLA-bPEA samples were measured to have similar 
hydrophobic surfaces to bulk PLLA and PEA, however dynamic contact angle 
measurements suggest distinctly altered surface chemistries on PLLA-bPEA 
compared to pristine PLLA. Receding contact angle was measured to drop on PLLA-
bPEA samples to levels resembling PEA (Figure 2.5C), resulting in these samples 
presenting surfaces of similar chemical mobility to bulk PEA (Figure 2.5D).   
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Figure 2.5. Surface characterisation (A) Surface root mean squared roughness 
measurements of PLLA samples through the entire SI-ATRP process. A minimum of 
12 measurements were taken from 5x5 µm2 AFM scans of each sample (B) Static 
water contact angle characterisation of PLLA, aminolysed PLLA, initiator 
immobilised PLLA, polymerised PLLA-bPEA and spin-coated PEA controls. (C) 
Advancing (Adv) and Receding (Rec) contact angles of spin-coated PLLA, PLLA-Br, 
PLLA-bPEA and PEA. (D) Water contact angle hysteresis of pristine PLLA, PLLA-
bPEA and spin-coated PEA samples. Graphs show mean values and standard 
deviation.  **p < 0.01, ***p < 0.001, ****p < 0.0001. 
 
Having shown that surface modification had successfully altered the 
chemical composition of the sample surface, it was important to ensure the 
maintenance of bulk PLLA properties. Enzymatic degradation was investigated 
using proteinase K; SI-ATRP treated samples were observed to maintain similar 
percentage weight loss to untreated PLLA after 72 and 96 hours. This highlights 
that the surface modification does not impact on the bulk hydrolytic degradation 
and is able to maintain the degradative property of PLLA. Sample stiffness was 
51 
 
measured by a variety of methodologies in either ambient or liquid conditions; 
these characterisations were performed to ensure that SI-ATRP did not impact the 
mechanical properties in either of these conditions. Generally mechanical 
properties were measured to be maintained within the sample MPa range on all 
PLLA-bPEA samples respectively to their PLLA controls: the Young’s modulus as 
measured by DMA (Figure 2.6D) was observed to be 141 MPa (PLLA) and 63 MPa 
(PLLA-bPEA). However as this procedure is performed on whole samples this value 
may be influenced by fissures or macroscale imperfections of the films. 
Nanoindentation was performed on the samples, both in air and liquid (Figure 2.6 
B and C), to establish the Young’s modulus of the polymer without the influence 
of macroscopic factors. Nanoindentation performed in ambient conditions 
presented higher Young’s modulus values for PLLA (690 MPa) and PLLA-bPEA (240 
MPa), whereas in liquid they were observed to be similar to those measured by 
DMA (159 MPa and 91 MPa respectively). This suggests that nanoindentation in air 
conditions does not account for liquid diffusion and swelling of the polymer, as 
found in liquid conditions. In any case from these Young’s modulus data and 
enzymatic degradation we can observe that SI-ATRP does not critically impact on 
the mechanical properties of the bulk PLLA films.  
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Figure 2.6. Bulk characterisation (A) Percentage weight loss of PLLA and PLLA-
bPEA samples after 72 and 96 hours of degradation with 0.2 mg mL-1 proteinase K 
at 37oC. (B) Elastic modulus of PLLA and PLLA-bPEA measured via nanoindentation 
in air using AFM. Inset shows AFM nanoindentation technique. (C) Nanoindentation 
in liquid. (D) Elastic modulus of PLLA and PLLA-bPEA at 37 oC measured from 
dynamic mechanical analysis (DMA) using a DMA 8000 (Perking-Elmer) apparatus 
at a frequency of 1Hz in tension mode; the temperature range was -150 to 100oC 
at a rate of 1oC min-1. Young’s modulus was determined at 37oC on sample of 10 
mm x ~6 mm x 0.05 mm. Graphs show mean values and standard deviation. Graphs 
show mean values and standard deviation.   
   
2.3.2 Surface chemical composition 
 
X-ray photoelectron spectroscopy was performed to characterise the 
surface chemical composition of the top <10nm of the samples to confirm 
functionalization through each step of the SI-ATRP. Carbon (C1s), oxygen (O1s), 
nitrogen (N1s) and bromine (Br3D) scans were collected from PLLA, PLLA-NH2, 
PLLA-Br, PLLA-bPEA and spin-coated PEA (Figure 2.7 A-E). Each carbon and oxygen 
spectra have been fitted with peaks corresponding to binding conformations of 
the relevant atoms within these samples; the spectra of the intermediate 
aminolysis and initiator elements show the presence of these elements on the 
surface of the samples (Figure 2.7 B and C). These scans confirm the incorporation 
of nitrogen peaks after aminolysis (Figure 2.7 B) and subsequent immobilisation of 
the bromine based initiator, BIBB (Figure 2.7 C). Bromine to carbon ratios were 
found to be 3.4 x 10-3 ± 1.0 x 10-3, which indicates a sufficient surface density of 
initiator to allow for continuous brush coverage after polymerisation (Xu, Yang et 
al. 2011). It can also be noted that both these elements are removed post 
polymerisation on PLLA-bPEA (Figure 2.7 D), suggesting that these intermediates 
are removed or masked by the PEA brushes formed on the surface. Observation of 
the carbon spectra confirm the maintenance of PLLA carbon spectra compositions 
(Figure 2.7 A), a distinct 3 peak composition (1:1:2) relating to the carbon 
backbone bonding, carboxyl and ester groups, on PLLA, PLLA-NH2 and PLLA-Br. 
This maintenance highlights the specificity of both the aminolysis and initiator 
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immobilisation reaction, as they are able to incorporate nitrogen and bromine 
during functionalisation while not significantly altering the chemistry of the bulk 
PLLA backbone. This is also confirmed by observing the oxygen binding 
conformation on these samples. PLLA-bPEA is observed to have a significantly 
altered carbon and oxygen spectra comparatively to bulk PLLA (Figure 2.7 D); 
these spectra possess binding domains similar to control and theoretical PEA 
(Figure 2.7 E). In fact, PLLA-bPEA surfaces was calculated as having similar carbon 
binding domain ratios as spin-coated PEA, suggesting that PEA has been 
successfully polymerised onto these samples.  
 
54 
 
 
 
Figure 2.7. C 1s, O1s, N1s and Br3d core-level spectra of all SI-ATRP steps, 
taken by XPS analysis. (A) Shows the initial untreated PLLA series of spectra. (B)  
Shows the aminolysed sample, a peak can be observed in the nitrogen spectra 
showing the presence of nitrogen. (C) Shows the spectra of PLLA-Br samples. 
Peaks can be observed in both the bromine and nitrogen spectra indicating the 
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presence of these elements on the surface of this sample. (D) Shows the spectra 
of PLLA-bPEA polymerised for 4 hours. (E) Shows the spectra of PEA spin-coated 
onto glass coverslips. (F) Percentage of different binding environments for carbon 
and oxygen.  
 
Further XPS characterisation confirms the presence of PEA on the surface 
of PLLA-bPEA. Comparing the PLLA, PLLA-bPEA and PEA spectra (Figure 2.8 A) 
illuminates how significant the similarities between PLLA-bPEA and PEA spectra 
are. While PLLA possesses three similar carbon binding peaks (1:1:2 carboxyl group 
(COO): ester bond (CO): carbon to carbon peaks (CC)), both PLLA-bPEA and PEA 
possess 4 distinct chemical binding domains; these almost identical spectra 
possess a tertiary carbon to carbon binding peak not present in PLLA. The presence 
of this PEA sidechain peak on PLLA-bPEA, as well as the distinctive binding ratios 
of the other carbon peaks, confirm the successful polymerisation of PEA brushes 
onto the surface of PLLA. The oxygen peaks found on PLLA-bPEA signify that the 
underlying PLLA backbone remains and that this coverage of PEA is not 100% over 
the top 10nm. This was further confirmed by analysing the changes in surface 
chemical composition during polymerisation (Figure 2.8 B). Peak fitting PLLA-bPEA 
spectra produced at two time points of polymerisation (2 or 4 hours) with control 
PLLA and PEA spectra allows for the estimation of the amount of each polymer on 
each surface. These results show increased estimated PLLA ratios on 2 hour PLLA-
bPEA and conversely a higher concentration of PEA than PLLA on 4 hour PLLA-
bPEA. In fact, it was calculated that increased time of polymerisation directly 
increased the PEA percentage, 40% at 2 hours and 60% at 4 hours (Figure 2.8 C). 
Therefore from these XPS scans we are able to confirm the successful 
polymerisation of PEA brushes onto the PLLA surface and we have identified that 
increased time of polymerisation directly regulates the density of acrylate brushes 
on these samples.  
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Figure 2.8. Chemical composition of the surface. (A) C 1s and O1s core-level 
spectra of PLLA, PLLA-bPEA (after 4 hours of polymerisation) and spin-coated PEA 
taken by XPS analysis. Each fitted peak represents a binding conformation of 
carbon atoms on the top 10 nm of the sample surface. From left to right the carbon 
peaks represent carboxyl group (COO), ester bond (CO) and carbon to carbon 
peaks (CC), PEA and PLLA-bPEA possess two C-C peaks which represent the 
polymer backbone carbons with and without sidechains. From left to right the 
oxygen peaks correspond to the ester bond and carboxyl group within the 
polymers. Peaks are numerically labelled corresponding to representative 
chemical structure insets. (B) C 1s core-level showing quantification of polymer 
line-shape elements for PLLA-bPEA after a 2 hour or 4 hour polymerisation, using 
the spectra obtained from control PLLA and PEA as components during line fitting. 
The bright red line corresponds to the experimental spectra for each sample. The 
line shapes are as follows: black line shows the PLLA carbon spectra, the grey line 
represents the PEA spectra, brown is the combined spectra of PLLA, PEA. (C) The 
calculated percentage of each polymer component (PEA or PLLA) in PLLA-bPEA 
samples acquired from polymer component peak fitting analysis software.  
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2.4 Discussion  
 
 A developing field in biomedical engineering research is the improvement 
of established biomaterials through methodologies of surface modification (Roach, 
Eglin et al. 2007, Khan, Tanaka et al. 2015, Khan and Tanaka 2017). These 
investigations aim to provide additional functionality to the surface through a 
variety of techniques (Zhu, Gao et al. 2004, Dalby, Gadegaard et al. 2014); 
however a significant challenge in this task is the maintenance of desirable bulk 
characteristics of the modified biomaterial.  Here we present the development 
and optimisation of a tuneable, scalable and potentially translatable surface 
modification technique for the addition of advanced functionality to PLLA via the 
addition of PEA brushes. The inclusion of these PEA brushes via SI-ATRP was 
developed to provide optimal functionalization while maintaining desirable PLLA 
properties. This will ideally provide a new platform for mimicry of in vivo cellular 
microenvironments for regenerative medicine applications.  
 
  The SI-ATRP protocol described here was designed to grow PEA brushes 
onto PLLA. The general SI-ATRP system is well documented and allows for 
production of a highly tuneable procedure, able to control a variety of properties, 
including initiator density, surface roughness and architecture (Liu and Roy 2005, 
Liu and Su 2005, Khabibullin, Mastan et al. 2016). This specific reaction was 
optimized via the addition of an activator regeneration electron transfer 
mechanism during polymerisation which provided reduction of time, temperature 
and concentration of reagents used, improving the efficiency of the produced 
reaction (Zoppe, Ataman et al. 2017). By utilising tris(2-pyridylmethyl)amine, a 
neutral tripodal nitrogen-based ligand, able to form complexes with both copper 
and bromine allowed for the stabilization, regeneration and increased reduction 
potential of the copper (I) oxidation state (Kaur, Ribelli et al. 2015). By optimizing 
the steps of SI-ATRP and the characteristics of the produced PLLA samples, we 
were able to obtain PLLA-bPEA samples of defined characteristics designed for 
regenerative medicine purposes.  
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Surface modification was characterised through several methodologies, to 
determine significant alterations to the bulk PLLA film. Initially it was noted that 
surface topology was significantly altered with elongated time of aminolysis 
(Figure 2.4A); however this step was optimized to minimize this variation. The 
optimization of aminolysis provided a well-defined, high concentration of amine 
groups on the surface to continue the SI-ATRP procedure (Figure 2.4). Initiator 
immobilisation was observed to drastically increase RMS surface roughness (Figure 
2A), as the incorporation of bromine initiator was calculated as the primary SI-
ATRP step to introduce surface roughening on PLLA. This was suspected to be a 
by-product of this exothermic reaction proceeding at undefined temperatures, 
potentially stressing the base polymer and resulting in degradation. While it has 
been shown that nanotopographical features are able to modulate cellular 
interactions (Dalby, Gadegaard et al. 2014, Mpoyi, Cantini et al. 2016), here we 
attempted to minimize unnecessary variations to bulk PLLA surfaces, hence the 
optimization of aminolysis time. While the surface roughness does significantly 
increase post initiator immobilisation, the inherent properties of this reaction 
produce a certain degree of heat to function therefore it would be detrimental to 
the overall efficacy of SI-ATRP to further optimize initiator immobilisation to 
reduce roughening. RMS roughness was observed to increase on PLLA-bPEA 
samples, as a results of the formation of PEA polymer brushes on the surface (Zhu, 
Zhang et al. 2002). While roughness was optimized, it may still present an issue in 
further characterisation of surface interactions via AFM and therefore for further 
protein characterisation (Chapter 3) spin-coated PLLA-bPEA samples were 
produced with initially lower RMS roughness than purchased PLLA films.  
 
As designed and expected, PLLA surface chemistry was observed to vary 
significantly through the SI-ATRP process. Chemical priming of the surfaces, by 
aminolysis, incorporated hydrophilic amine groups into the PLLA backbone, 
reducing the hydrophobicity of these samples (Figure 2.4 B and C). Immobilisation 
of bromine based initiators was observed to remove this additional hydrophilicity, 
increasing the WCA, which was subsequently maintained upon polymerisation of 
hydrophobic PEA brushes (Figure 2.5B). The inclusion of PEA onto PLLA films was 
observed to increase the surfaces WCA hysteresis, indicating enhanced molecular 
mobility as result of the inclusion of polymer brushes and surface roughness (Zhu, 
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Gao et al. 2004, Liu, Du et al. 2007). These chemical modifications were further 
confirmed via chemical analyses utilising XPS. Analysis of each intermediate PLLA 
sample highlighted the efficacy of the 3 steps of SI-ATRP; clear nitrogen and 
bromine peaks were identified on aminolysed and initiator immobilised samples, 
respectively (Figure 2.7 B and C). The introduction of these elements showing 
successful surface modification and the subsequent utilisation and removal of 
these peaks on PLLA-bPEA are further proof of the efficacy of the polymerisation 
procedure (Figure 2.7 D).  In fact, by calculating the amine density and 
bromination of the surfaces, in accordance with other studies demonstrating the 
tuneability of ATRP reactions for optimised brush length and density (Xiao and 
Wirth 2002, Ohno and Matyjaszewski 2006, Kang, Crockett et al. 2014), it is 
possible to further characterise the homogeneity of PLLA-bPEA surfaces. In 
accordance to these studies we can note that the PLLA-bPEA samples presented 
here possess a sufficient surface density of amine groups (~1.6 x 107 mol cm-2) and 
subsequently of bromine-based initiator groups ((Br)/(C) of ~3.4 x 10-3) to achieve 
continuous brush coverage (Xu, Yang et al. 2011). 
 
Further XPS analysis of PLLA-bPEA surfaces show that PEA brushes formed 
through SI-ATRP, on the top 10 nm of the polymer, possess carbon binding spectra 
that closely resemble those of bulk PEA, polymerised via photoinitiated radical 
polymerisation (Figure 2.8 A). PLLA-bPEA surfaces present carbon binding 
conformations that, when peak-fitted, not only possess the same ratios of binding 
domains as PEA (1:1:3) as opposed to PLLA (1:1:2), but possess an additional peak 
corresponding to PEA sidechains. The inclusion of this sidechain and the spectra 
shape of PLLA-bPEA show that PEA is successfully polymerised onto the surface of 
PLLA samples during SI-ATRP. Additionally, the production of full PEA chains with 
no loss of individual binding environments upon polymerisation, which is indicative 
of fragmentation of the polymer chain (Yasuda and Yasuda 2000), suggests an 
improved surface modification from other established methodologies, such as 
plasma polymerisation (Chu, Chen et al. 2002, Cantini, Rico et al. 2012, Cheng, 
Alba-Perez et al. 2019). However, while the EA molecules are not fragmented 
during polymerisation, PLLA-bPEA samples do not possess identical spectra to PEA. 
Slight variations in the carbon spectra, lower densities of the tertiary carbon 
binding peak and altered oxygen spectra indeed correspond to the underlying PLLA 
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film, indicating that PEA brush thickness  is <10 nm.  This was observed to 
correlate directly to the duration of the polymerisation, as a longer time was 
shown to increase surface percentages of PEA relative to PLLA on the surface. 
Therefore here we have shown the successful incorporation of chemical elements 
via each step of SI-ATRP and the characterisation of a time-dependent production 
of grafted PEA chains onto PLLA films.  
 
Investigation of the bulk mechanical properties and degradation rates were 
investigated and no significant variations from untreated PLLA were encountered, 
suggesting that PLLA treated with SI-ATRP is still a viable structurally supportive 
polymer. Degradation rates and Young’s modulus were maintained within the 
same range between PLLA and PLLA-bPEA (Figure 2.6). Young’s modulus was 
measured locally, via AFM nanoindentation, and macroscopically, via dynamic 
mechanical analysis, in either air or liquid conditions. While differences were 
noted between methodologies, accounting for macroscopic fractures potentially 
incorporated during aminolysis and swelling of the polymer (Zhu, Gao et al. 2004), 
the general behaviour confirmed no excessive variation of the Young’s modulus 
before and after SI-ATRP. The retention of similar PLLA degradation rates imply 
that PLLA-bPEA samples, like the untreated biomaterial, are able to act as a 
supportive structural scaffold in vivo, gradually reintroducing physical function to 
cells during regeneration in a tuneable manner (Ulery, Nair et al. 2011). These 
properties are ideal for in situ bone regenerative purposes: retention of Young’s’ 
modulus and of the degradation rate, allowing to provide adequate structural 
support for a controllable time (Armentano, Dottori et al. 2010, Saito, Liao et al. 
2013, Wang, Wang et al. 2016). Therefore, the SI-ATRP system outlined here is 
able to provide a highly specific surface modification which do not significantly 
alter the bulk characteristics of the structural PLLA backbone.   
 
 While PLLA is often modified in aid of improving cellular interactions and 
biological activity these modification techniques have been shown to impact on 
the mechanical properties of the bulk PLLA. Processes such as etching (Kramer, 
Kunkemoeller et al. 2014), chemical modification (Zhu, Gao et al. 2004), blending 
(Xiao, Wang et al. 2011) and UV treatment (Janorkar, Metters et al. 2007), have 
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been utilised to improve cellular interactions on PLLA. However, several of these 
processing techniques drastically alter the mechanical properties, such as poor 
mechanical strength and altered degradation rates. Processing techniques to 
improve the mechanical properties such as co-polymerisation with poly (glycolic 
acid), while improving the co-polymer strength present their own issue, such as 
stress shielding and decreased cellular proliferation (Athanasiou, Niederauer et 
al. 1996), and therefore require further processing (Gentile, Chiono et al. 2014). 
Therefore techniques such as the plasma treatment, which has been shown not to 
affect bulk structural mechanics (Xiao, Wang et al. 2011) and SI-ATRP as described 
within this thesis, present methodologies for modifying biological activity of PLLA 
while retaining bulk physical properties. These systems allow for the inclusion of 
thin polymer layers or brushes onto the surface of biodegradable polymers, 
without altering the mechanical properties. In this and previous studies, PEA has 
been incorporated onto the surface of biodegradable polymers, such as PCL 
(Cheng, Alba-Perez et al. 2019). The plasma polymerisation of PEA onto the 
surface of PCL was shown to improve protein interactions, driving FN 
fibrillogenesis, and facilities enhanced cellular adhesion and osteogenic 
differentiation (Cheng, Alba-Perez et al. 2019). However, a main disadvantage of 
plasma-based surface modification of PLLA is surface rearrangement of the bulk 
polymer chains caused by thermally activated macromolecular motion, potentially 
impacting on the degradation rate (Xiao, Wang et al. 2011). Additionally, PEA 
polymerised onto these surfaces were altered, via plasma fragmentation (Cantini, 
Rico et al. 2012), resulting in chemically modified PEA surfaces. Our system of SI-
ATRP has been shown to successfully modify PLLA with nanoscale, chemically 
unmodified PEA brushes, without impacting on the bulk mechanical properties as 
would be found utilising other modification techniques.  
 
2.5 Conclusion  
 
This chapter has outlined the development of a novel SI-ATRP process, able 
to produce defined and controlled modifications of the surface of an established 
biomaterial, PLLA. While this system introduces functional PEA brushes onto the 
surface of PLLA, it does so while maintaining the bulk characteristics of the 
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backbone polymer, such as controlled degradability and mechanical strength. 
Hence, this SI-ATRP surface modification methodology provides a tuneable and 
scalable technique to enhance the interfacial interactions of established 
biomaterials.  
 
 
 
 
 
 
 
 
 
 
 
 
3. Fibronectin organisation and cell response 
on PLLA-bPEA  
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3.1. Introduction 
 
To establish the efficacy of the engineered PLLA-bPEA surfaces, the 
interaction of the PEA brushes with proteins, namely fibronectin (FN), and their 
ability to influence cellular interactions was investigated. The ability of PEA to 
drive fibrillogenesis of fibronectin, leading to the assembly of elongated fibrils 
and eventually nanonetworks, allows the exposure of cryptic cellular binding 
domains that favour cellular interactions (Schwarzbauer and Sechler 1999, 
Salmeron-Sanchez, Rico et al. 2011, Cantini, Gonzalez-Garcia et al. 2012, Llopis-
Hernandez, Rico et al. 2013).  Therefore, having confirmed the production of PEA 
brushes onto PLLA films via surface initiated atomic transfer radical 
polymerisation, we proceeded to investigate the ability of the produced polymer 
microenvironments to drive FN fibrillogenesis. Furthermore, the ability of the 
produced surfaces to facilitate cellular adhesion and differentiation upon coating 
with FN was investigated. Indeed, while the ability of FN nanonetworks formed on 
PEA surfaces to favourably expose binding domains (Vanterpool, Cantini et al. 
2014) has been previously demonstrated, here we aim to determine whether PLLA-
bPEA surfaces retain this ability of bulk PEA and the corresponding cellular 
behaviour. In particular, C2C12 murine mouse myoblast cells were utilised as a 
cell model as they have been shown to favourably bind to FN nanonetworks on PEA 
and possess the potential to differentiate through distinct lineages according to 
defined stimuli; more specifically, they have the ability to form myotubes in vitro 
(Salmeron-Sanchez, Rico et al. 2011, Bathawab, Bennett et al. 2016). Cellular 
adhesion, characterised by the formation and maturation of focal adhesion 
complexes, and contractile-dependent differentiation were utilised to determine 
the functionality of the PEA brushes and their ability to drive enhanced cellular 
interactions on PLLA. Ultimately, in this chapter we aim to provide a direct 
characterisation of the efficacy of SI-ATRP in producing enhanced biocompatible 
materials for regenerative medicine applications.   
3.2 Materials and methods 
3.2.1. Materials: Poly (L-Lactide) films (thickness 50 µm) were purchased from 
Goodfellow (Huntingdon, UK), PLLA granules (Cargill Dow) provided by prof. Gloria 
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Gallego Ferrer (CBIT, UPV). 1,6-hexanediamine (98%), 2-propanol (≥99.5%), 2-
bromoisobutyryl bromide (BIBB, 98%), anhydrous pyridine (Py, 99.8%), anhydrous 
hexane (95%), copper(I) bromide (CuBr,99.999 %), Tris(2-pyridylmethyl)amine 
(TPMA, 98%), ethyl acrylate (EA, 99.5%), methanol ( 99.99%), ascorbic acid (AsAc) 
were purchased from Sigma Aldrich, Dorset, UK. Glass reaction vessels were 
custom-made. Spin-coated PEA controls (PEA) were prepared on 12 mm glass 
coverslips from 4% solutions in toluene of bulk PEA, obtained via polymerisation 
of EA using 1% benzoin (Sigma, St. Louis, MO) as a photonitiator, spun at 3000 rpm 
with acceleration of 3000 rpm s-1 and vacuum dried at 60oC for 2 hours to remove 
excess toluene.  
3.2.2. Spin-coating: Spin-coated PLLA samples (scPLLA) were prepared by first 
treating 12mm glass cover slips with hexamethyldisilazane (HMDS) and then a 2% 
PLLA solution in chloroform was spun at 2000 rpm with an acceleration of 3000 
rpm s-1. ScPLLA samples were then aminolysed as previously described and washed 
with milliQ water for 6 hours and subsequently air dried. Initiator immobilisation 
was performed for 6 hours without agitation, samples were then washed with 
gentle pipetting of water and methanol 2:1 mix and air dried. Polymerisation was 
performed as before with the exemption of soxhlet washing, instead spin-coated 
samples were washed carefully by hand. ScPLLA and scPLLA-bPEA were used to 
observe FN conformation via AFM (Figure 3.3 A). 
3.2.3. Protein adsorption: Fibronectin (R&D Systems) solutions of 20 μg mL-1 in 
Dulbecco's phosphate buffered saline (DPBS) were adsorbed onto samples for 1 
hour for all applications unless otherwise stated. Samples were rinsed with DPBS 
before use. 
3.2.4. FITC-FN labelling: FN was labelled using the DyLight™ 488 NHS Ester 
(ThermoFisher), following manufacturer instructions. Briefly, 1 mg fibronectin 
powder (Sigma-Aldrich) was dissolved in 0.05 M sodium borate at pH 8.5 (Thermo 
Scientific). DyLight™ 488 NHS Ester was dissolved in 10 mg mL-1 DMF. The protein 
to be labelled was incubated with labelling ester at room temperature within a 
dialysis membrane chamber for 4 hours with 3 dialysis buffer replacements.    
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3.2.5 Atomic force microscopy: Atomic Force Microscopy was used to quantify 
surface roughness and visualise topology before and after FN coating in all 
conditions on dried samples in air. FN-coated samples were rinsed with water after 
FN adsorption and gently dried with a nitrogen flow. For AFM imaging of FN in 
liquid, sample were not dried, but rather washed with DPBS and MilliQ water 
before being fixed with 4% formaldehyde at room temperature for 20 minutes. 
Height and lock-in phase images were taken in AC mode using a Nanowizard 3 
Bioscience AFM (JPK, Berlin Germany). Scans were made using cantilevers with a 
resonance frequency of 75 kHz and a force constant of 3 N m-1 (MPP-21120 from 
Bruker, Billerica, MA). Fractal dimension analysis was carried out on the 1x1 μm2 
images of FN-coated samples using the ImageJ Fractal box count analysis tool, 
using box sizes of 2, 3, 4, 6, 8, 12, 16, 32, and 64 pixels. 
3.2.6. Water contact angle: Water contact angle measurements were 
undertaken on PLLA and functionalised samples. Static contact angles (SCA) were 
measured by dropping 3 μL of deionised water onto the samples. Advancing (ACA) 
and receding (RCA) contact angles were measured by the addition or removal of 
water to the droplet until an increase or decrease in the length of the baseline 
was observed. Contact angle hysteresis was calculated from the difference 
between ACA and RCA. Analysis was conducted using a Theta optical tensiometer 
(Biolin Scientific, Stockholm, Sweden). 
3.2.7. Micro-bicinchoninic acid protein quantification: The density of adsorbed 
protein was determined by measuring the amount of non-adsorbed FN. A standard 
curve was created via serial dilutions of a FN stock of known concentration. 
Samples were coated for 1 hour and the remaining FN solution was transferred to 
96-well plates, where the bicinchoninic acid working reagent was added (Thermo 
Fisher Scientific, Waltham, MA). The plate was then agitated and incubated at 
37°C for 2 hours. The absorbance was read at 562 nm with a Tecan NanoQuant 
Infinite M200 Pro plate reader (Männedorf, Switzerland). 
3.2.8. In-Cell Western: Binding domain availability on samples was examined 
using in-cell western (ICW). Fibronectin coated samples were blocked with 
Odyssey blocking buffer (LICOR) and incubated with primary antibody, HFN7.1 
(DSHB, Iowa City, IA) or mAb1937 (Millipore) in blocking buffer for 1 hour. Samples 
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were then washed 5 times with agitation in 0.1% v/v Tween20/PBS. IRDye® 800CW 
antibodies were then prepared in blocking buffer and samples were incubated for 
1 hour. After washing as before and drying, measurements were made at 800 nm 
using an Odyssey® system. 
3.2.9 C2C12 culture: Mouse C2C12 myoblasts were thawed and re-suspended in 
Dulbecco's modified Eagle's medium (DMEM, high glucose, without pyruvate) with 
1% v/v penicillin/streptomycin and 20% v/v foetal bovine serum (FBS). Cells were 
incubated in 37°C, 5% CO2, and harvested by trypsinisation at 70% confluency. 
For adhesion experiments, samples were sterilized under a UV lamp for 40 
minutes on each side, as the samples are opaque, and coated with 20 μg mL-1 FN; 
negative controls were coated with PBS for 1 hour. Samples were then washed 
with PBS and seeded with 5000 cells cm-2 for 4 hours and then fixed with 4% 
formaldehyde for 30 minutes at 4°C. The cells were then permeabilised with 0.1% 
triton X-100, washed and finally blocked (PBS/BSA1%) for 30 minutes at room 
temperature. Samples were first incubated with anti-vinculin primary antibody 
(1:400), hVIN-1 (Sigma-Aldrich), in blocking buffer for 1 hour at room temperature 
and subsequently washed with washing buffer, PBS/Tween 20 0.5%. Cy3-
conjugated secondary antibodies (Jackson ImmunoResearch) and BODIPY FL 
Phallacidin (Thermo Fisher Scientific) were then added for 1 hour at RT. The 
samples were then washed and mounted with mounting medium containing DAPI 
(Vector Laboratories, Inc.) and visualised with a fluorescence microscope (Zeiss 
AxioObserver Z1). Images were merged using ImageJ to localise nuclei and actin. 
Focal adhesions were analysed using the vinculin stain images; the procedure is 
described in Horzum et al. Images were analysed with threshold area of 0.5 µm2 
and 0-0.99 circularity. 
For differentiation assays, samples were UV sterilised; collagen controls 
were obtained by coating sterile coverslips with 1 mg mL-1 ColI (Stem Cell 
Technologies, Cambridge, UK) and subsequently all samples were coated with 20 
μg mL-1 FN for 1 hour. Cells were then seeded on the samples at 20,000 cells cm-2 
for 3 hours in DMEM +1%P/S. This was then replaced with differentiation media 
after 3 hours and again after 2 days (DMEM +1%P/S +1%ITS-X, Life Technologies). 
10μM Blebbistatin was used as contractility inhibitor and added after 3 hours of 
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culture. After 4 days of culture the cells were washed and fixed with 20:2:1 EtOH 
70%/formaldehyde 37% acetic acid for 10 minutes at 4°C. Cells were then washed 
with PBS and blocked with 5% goat serum in PBS. Cells were then incubated with 
MF20-b antibody (Developmental Studies Hybridoma Bank, University of Iowa, 
USA) for 1 hour and washed, blocked and stained with a Cy3-conjugated antibody 
for 1 hour at 37°C. Samples were then mounted with mounting medium containing 
DAPI and imaged. ImageJ was used to capture and merge the images. Cell density 
and cell differentiation were calculated using CellC image analysis software 
(http://www.cs.tut.fi/sgn/csb/cellc/, Selinummi et al., 2005). 
3.2.10. Statistical analysis: Pre-processing and normalization of data are stated 
in the individual methods sections. Analysis of statistical differences was 
conducted using student T-test (Graphpad) for two sample comparison and One-
way ANOVA for different groups using a Turkey HSD post hoc test to compare 
different groups. Differences were considered significant *p < 0.05, **p < 0.01, ***p 
< 0.001, ****p < 0.0001. All data presented are mean values, error bars are 
standard deviation and n numbers are noted in the figure captions. 
 
3.3 Results 
 
3.3.1. Surface characterisation  
To determine the functionality of the PEA produced via SI-ATRP surface 
characteristics were investigated post treatment with 20 μg mL-1 fibronectin. PLLA 
and PLLA-bPEA surfaces were observed to have lower RMS surface roughness after 
FN treatment (Figure 3.1 A), due to the protein covering the surface and 
diminishing the measured roughness of the samples. Static water contact of FN-
treated samples was measured to be maintained within the same range on all 
samples as before FN treatment (~90°) (Figure 3.1B), showing no distinct variation 
of hydrophobicity due to protein adsorption. However, dynamic water contact 
angle analysis presented an overall decrease of receding contact angle resulting 
in a similar surface hysteresis on all surfaces (Figures 3.1C and D). This suggests 
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that treatment with this concentration of FN is able to fully cover the surface of 
all the samples, which present a FN mediated surface mobility regardless of the 
surface type.  
 
Figure 3.1. Comparison of FN treated surfaces (A) Surface root mean squared 
roughness measurements of PLLA and PLLA-bPEA samples with and without 
fibronectin coating. (B) Static water contact angle characterisation of spin-coated 
PEA controls, PLLA and polymerised PLLA-bPEA after FN adsorption. (C) Advancing 
(Adv) and Receding (Rec) contact angles of FN treated PLLA, PLLA-bPEA and PEA. 
(D) Water contact angle hysteresis of FN coated PLLA, PLLA-bPEA and spin-coated 
PEA samples. Graphs show mean values and standard deviation. *p < 0.05, ***p < 
0.001, ****p < 0.0001. 
3.3.2. FN assembly 
 
 To investigate FN organisation on the surfaces, fluorescently tagged FN was 
produced and adsorbed onto the samples. Homogeneous layers of fluorescent FN 
70 
 
were observed on PLLA surfaces, whereas PEA and PLLA-bPEA surfaces were 
observed to trigger the organisation of protein into fibrils interconnecting into 
network structures. Of these networks two different conformations can be noted; 
larger networks (Figure 3.2A), predominantly found on higher concentrations of 
FN, and smaller networks observed on lower concentrations (Figure 3.2B). The 
presence of FN networks on PLLA-bPEA suggests that PEA brushes on these surfaces 
are as functional as bulk PEA and able to drive fibrillogenesis. However, we have 
previously observed that SI-ATRP increases the surface roughness of PLLA and this 
underlying topology may contribute to the perceived microscopic conformation of 
FN on these surfaces.  
 
Figure 3.2. Adsorption of FITC-labelled FN. Samples of PLLA, PLLA-bPEA and PEA 
coated with (A) 20 μg mL-1 or (B) 2 μg mL-1. Samples were coated with fibronectin-
FITC in DPBS for 1 hour at room temperature, washed with DPBS and visualized 
under a fluorescent microscope after mounting. FN was labelled using the 
DyLight™ 488 NHS Ester (ThermoFisher), following manufacturer instructions. 
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Fibronectin networks can be observed throughout the samples with the exception 
of PLLA. Scale bar is 20μm. 
Hence, to further confirm the presence of FN networks on the surface of 
SI-ATRP-treated PLLA samples atomic force microscopy was utilised, so as to 
visualise surfaces at the nanoscale and investigate more accurately the 
organisation and structure of the adsorbed FN molecules. Since we have previously 
noted increasing surface roughness on PLLA-bPEA samples (Figure 2.4 A), this 
roughness was speculated to prevent the ability to properly visualise the FN fibrils 
and nanonetworks via AFM. Indeed, the roughness in the same order of magnitude 
as the protein features to be visualised, both ~40 nm (Gugutkov, Gonzalez-Garcia 
et al. 2009), therefore FN features would be harder to distinguish via height scans. 
On flatter regions of PLLA-bPEA films small areas that resembled dense FN 
nanonetworks were observed in both height and phase scans, however these 
features could not be definitively distinguished due to surrounding surface 
roughness. The presence of these potential FN fibrils suggested that high RMS 
roughness was masking FN features on the PLLA-bPEA films. Therefore, spin-
coated PLLA was instead treated with SI-ATRP. Spin-coated PLLA samples were 
initially smoother and, post polymerisation, these PLLA-bPEA samples possessed 
significantly lower RMS roughness than the films (5.77 nm ± 1.2 nm vs. 25.71 nm 
± 8.16 nm). Therefore for all subsequent AFM imaging scPLLA and scPLLA-bPEA 
samples were used. AFM imaging confirmed that PLLA-bPEA surfaces were able to 
trigger FN assembly upon adsorption, similarly to PEA. FN fibrillogenesis, indicated 
by the presence of FN nanonetworks, was observed on PLLA-bPEA and PEA, 
whereas no such structures were present on PLLA, where FN remained in a flat 
monolayer (Figure 3.3 A). Nanonetworks formed on PLLA-bPEA were observed to 
be thicker and less interconnected, as confirmed by the decreased fractal 
dimension comparatively to FN on PEA.  Fractal analysis of the AFM scans, used as 
a measure of connectivity of the protein network, showed that, while both PLLA-
bPEA and PEA presented FN nanonetworks which possessed fractal properties, 
there were slightly lower levels of interconnection of on the PEA brushes 
compared to bulk PEA (Figure 3.3 B).  The presence of FN nanonetworks on PLLA-
bPEA proves that the PEA brushes retain the bio-functionality of bulk PEA to 
regulate FN secondary structure, through the same material driven fibrillogenesis 
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mechanism; however, due to the conformation and surface presentation of PEA in 
brush form, these nanonetworks possess altered characteristics.  
 
Figure 3.3. AFM Imaging of adsorbed FN on samples. (A) Height images from 
tapping mode AFM of spin-coated PLLA (scPLLA), scPLLA-bPEA and PEA coated 
with 20 and 0 μg mL-1 FN for 1 hour at room temperature. Scale bar is 200 nm. 
Please note that the colour scale is different for every image, as indicated, to 
allow clear visualisation of the surface features. (B) Fractal analysis of FN 
nanonetworks found on scPLLA-bPEA and PEA. 
Further characterisation of the FN fibres produced on PEA brushes 
confirmed that these features as well as generally being thicker are also taller 
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than nanonetworks on PEA (Figure 3.4). Indeed, FN fibrils on PEA brushes 
presented increased average height and peak-to-valley roughness (Figure 3.4B 
and C).  
 
Figure 3.4. AFM analysis of FN Fibril conformation and thickness.  (A) FN 
networks on PEA and PLLA-bPEA height scans as visualised via AFM, and 
corresponding cross-section which highlights the height of a FN fibril. (B) 
Average fibril height. (C) Peak-to-Valley Roughness. Graphs show mean values 
and standard deviation, n>3.  ****p < 0.0001. 
AFM imaging was predominantly performed in ambient conditions in air: 
samples were coated with FN, washed and dried gently with a nitrogen flow. 
However, FN fibrillogenesis was observed in both air and liquid on PEA; in the 
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latter case, samples were not dried but rather maintained in a liquid environment. 
FN nanofibrils were identified in liquid, highlighting that the protein-surface 
interactions occurring on these samples and the subsequent formation of protein 
nanonetworks are not a product of drying artefacts (Figure 3.5). Indeed, 
comparison of AFM performed in wet and dry conditions did show that improved 
definition of the FN nanonetworks could be obtained when imaging in dry 
conditions, due to improved tip-sample stability which allows a more accurate and 
easier scanning.  
 
Figure 3.5. AFM phase images in liquid and dry conditions of spin-coated PEA 
coated with increasing concentration of fibronectin of 5, 10 and 20 μg mL-1 for 1 
hour. FN nanofibrils are formed at the lower FN concentration as visible in liquid. 
After gentle drying, a similar fibrillary morphology is maintained and tip-sample 
stability is enhanced allowing easier scanning. This is confirmed at 10 µg mL-1, 
whilst the increased protein density at 20 µg mL-1 makes distinguishing these 
structures in liquid more difficult due to higher surface coverage. Please note that 
the colour scale is different for every image, as indicated, to allow clear 
visualisation of the surface features.  
 
3.3.3.   Binding domain availability  
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 Upon confirmation via AFM of the structural re-organisation of FN into 
nanonetworks at the molecular level on PLLA-bPEA, the biological functionality of 
these fibrils was investigated. The ability of PLLA-bPEA to adsorb and present FN 
in favourable orientations, therefore enhancing the availability of selected 
binding domains as found on PEA, was used to assess the potential of SI-ATRP for 
further cellular assays. It was observed that the total amount of FN absorbed on 
PLLA, PLLA-bPEA or PEA was similar, indicating no significant difference in protein 
surface density due to the formation of the nanonetwork (Figure 3.6A). This 
correlates with previous characterisation of material-driven fibrillogenesis, which, 
utilizing non-network forming acrylates and bulk poly (ethyl acrylate), showed 
similar densities of adsorbed FN independently of the protein structure 
(Vanterpool, Cantini et al. 2014). Regarding availability of integrin binding 
domains on adsorbed FN, this was measured using both the antibody HFN 7.1, 
which recognises to the RGD cell binding domain (Takahashi, Leiss et al. 2007, 
Vanterpool, Cantini et al. 2014), and the antibody mAb1937, which binds close to 
the PHSRN synergy domain (Garcia, Vega et al. 1999, Grigoriou, Cantini et al. 
2017) (Figure 3.6D). While there was no significant upregulation of RGD 
presentation of FN adsorbed onto PLLA-bPEA or PEA (Figure 3.6B), the PHSRN 
synergy domain availability was significantly higher on both compared to FN on 
PLLA (Figure 3.6C). This indicated increased exposure of the cryptic PHSRN domain 
on PLLA-bPEA, as found on PEA, which is a hallmark of the conformational change 
occurring during FN fibrillogenesis (Pankov and Yamada 2002, Gee, Yueksel et al. 
2013, Vanterpool, Cantini et al. 2014).  
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Figure 3.6. Fibronectin conformation. (A) Surface density of adsorbed FN on 
PLLA, PLLA-bPEA and PEA. (B) Quantification of the availability of the integrin 
binding domain on FNIII10, as measured by HFN7.1 binding via ICW. (C) 
Quantification of the availability of the synergy binding domain on FNIII9, as 
measured by mAb1937 binding via ICW. (D) 3D cartoon of FN integrin binding 
region (FNIII9-10); the binding sequences (PHSRN synergy binding domain, 
recognised by mAb1937, and RGD binding domain, recognised by HFN7.1) are 
highlighted by red arrows. Adapted from PBD ID: 1FNF (Leahy, Aukhil et al.). 
Graphs show mean values and standard deviation, n≥3.  **p < 0.01, ***p < 0.001. 
 
3.3.4. Cell adhesion 
Having established that the fibrillar organisation of FN on PLLA-bPEA leads 
to enhanced exposure of adhesion-related binding domains, cellular assays using 
C2C12 cells were performed to further characterise this added functionality of SI-
ATRP-treated PLLA. By conducting an adhesion assay and staining for actin and 
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vinculin, we aimed to investigate the PLLA-bPEA samples cellular interactions in 
comparison to untreated PLLA and spin-coated PEA (Figure 3.7A). Cells adhere to 
PLLA-bPEA samples with and without fibronectin coating, but they were observed 
to adhere and spread better on FN treated PLLA-bPEA surfaces. PLLA-bPEA 
samples generally had high density of healthy viable cells spread across a wide 
area of the sample surface. The PLLA-bPEA samples showed cellular adhesion and 
morphology similar to bulk PEA controls and within these cells well-defined stress 
fibres, indicated by the actin staining, were observed compared to PLLA. Average 
cell area was observed to be maintained between all surface conditions (Figure 
3.7B), while circularity was significantly reduced on PEA presenting samples. This 
shows that while the cells cultured on PLLA-bPEA maintain the same size as on 
PLLA, they are able to adhere and spread more favourably as on PEA. This is due 
to the presence of FN nanonetworks and exposure of the PHRSN synergy domain.  
 
Figure 3.7. Adhesion of C2C12 cells. (A) Representative images of C2C12 cells 
adhering on FN-coated PLLA, PLLA-bPEA and PEA after 4 hours of culture. Samples 
were stained for actin (green), vinculin (red) and DAPI (blue). Scale bar is 100 μm. 
(B) Cell size. (C) Cell circularity. Graphs show mean values and standard 
deviation, n≥15. **p < 0.01, ***p < 0.001. 
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Cellular adhesion was further evaluated by investigating the focal adhesion 
(FAs) complexes formed on these surfaces. Number, size and distribution of focal 
adhesions formed were analysed by vinculin staining and analysis of images of 
single cells (Figure 3.8A). Single cells were observed to have a more obviously 
increased abundance of defined stress fibres on PLLA-bPEA and PEA surfaces 
compared to untreated PLLA. Cells seeded on both PLLA-bPEA and PEA were noted 
to possess large areas of densely packed focal adhesions at their periphery, while 
these areas were not noted on PLLA samples (Figure 3.8A).  From thresholded 
vinculin images, larger concentrations of mature focal adhesions were confirmed 
to localise on the outer extremities of the cells on PLLA-bPEA and PEA surfaces 
(Figure 2B).   
 
Figure 3.8. Focal adhesions of C2C12 cells. (A) Representative images of focal 
adhesions formed by C2C12 cells on FN-coated PLLA, PLLA-bPEA and PEA after 4 
hours of culture. Samples were stained for actin (green), vinculin (red) and DAPI 
(blue). (B)  Show thresholded binary images of the vinculin staining. Scale bar is 
50 μm.  
Analysis of thresholded FA images confirmed that the total number and size 
of FAs increased from PLLA through PLLA-bPEA to PEA (Figure 3.9 A and B); this 
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corresponds to variations in FN fractal analysis observed on these surfaces (Figure 
3.9B). These FAs were measured to be larger on PEA presenting surfaces (20% and 
35% of focal adhesions are longer than 2 µm on PLLA-bPEA and PEA, respectively), 
while on PLLA smaller FA plaques were mostly formed (95% <2 µm). These results 
show that SI-ATRP treatment is able to profess enhanced cellular adhesions onto 
PLLA surface via the incorporation of PEA brushes onto the surface, facilitating 
increasing focal adhesion complex formation and maturation.   
 
 
Figure 3.9. Adhesion of C2C12 cells, quantification. (A) Number of focal 
adhesions per cell. (B) Average focal adhesion size. (C) Frequency distribution of 
FA size. Graphs show mean values and standard deviation, n≥15. *p < 0.05, **p < 
0.01, ***p < 0.001, ****p < 0.0001. 
3.3.5. Myogenic differentiation 
Further to adhesion, the differentiation of C2C12 cells towards the 
myogenic lineage was evaluated by staining for sarcomeric myosin after 4 days in 
differentiation medium (Figure 3.10). Cells were observed to differentiate 
predominantly on PLLA-bPEA and PEA, as observed from increased myotube 
density on these samples. Indeed, PEA and PLLA-bPEA presented high degrees of 
differentiation (~70%), while on PLLA low percentages of differentiated cells were 
present (~25%) (Figure 3.11B). On the other hand, cell density was calculated to 
be maintained independently of sample type (Figure 3.11A). Therefore, due to the 
similarities between surfaces, cell density is not responsible for the increased 
cellular differentiation on PLLA-bPEA samples. To further characterise whether 
the mechanism of differentiation observed on PLLA-bPEA was due to the inclusion 
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of PEA brushes, blebbistatin was utilised to inhibit cellular contractility. 
Blebbistatin is a myosin II inhibitor (Kovacs, Toth et al. 2004), which has been 
shown to inhibit cellular differentiation on PEA (Bathawab, Bennett et al. 2016). 
While cell density was not impacted (Figure 3.11A), the inclusion of blebbistatin 
significantly reduced the degree of differentiation on both PLLA-bPEA and PEA 
(Figure 3.11B). On the PEA presenting surfaces the degree of differentiation 
dropped to 25%, similar to that of PLLA. There was no difference in the number 
of differentiated cells on PLLA samples with blebbistatin treatment, however 
cellular morphology was observed to vary significantly on all surfaces with 
contractility inhibition.  These results suggest that enhanced myogenic 
differentiation is facilitated by PEA brushes produced via SI-ATRP on PLLA-bPEA 
and that this supplementary characteristic is myosin II-dependent, as on PEA. 
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Figure 3.10. Cell differentiation. Sarcomeric myosin (red) and nuclei (blue) of 
C2C12 cells after 4 days of differentiation on FN-coated (A) PLLA, (B) PLLA-bPEA 
and (C) PEA. Blebbistatin (Blebb) 10 μM, was added in the media of Blebb+ samples 
as a contractility inhibitor. Scale bar is 100 μm. 
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Figure 3.11. Cell differentiation analysis. (A) Cell density. (B) Degree of 
myogenic differentiation measured as percentage of sarcomeric-myosin positive 
cells. Blebbistatin (Blebb) was used as a contractility inhibitor. Graphs show mean 
values and standard deviation, n≥4. ***p < 0.001, ****p < 0.0001. 
 
3.4. Discussion  
In this chapter, having confirmed the production of PEA brushes on PLLA-
bPEA in Chapter 1, we characterised fibronectin and cellular interactions on these 
surfaces, in order to evaluate the biological functionality of produced polymer 
brushes. Indeed, PEA is known to induce the assembly of FN into nanonetworks, 
through material-driven fibrillogenesis (Salmeron-Sanchez, Rico et al. 2011, 
Cantini, González-García et al. 2012); the change in the protein structure upon 
adsorption has been shown to induce the formation of fibrils and subsequent 
nanonetworks, which favourably present integrin binding domains for enhanced 
cellular interactions. Therefore, the aim of this project being to provide additional 
functionality to PLLA, we aimed to assess the improved availability of these 
binding domains, predominantly the cryptic PHSRN synergy domain, which has 
been shown to improve the binding of α5β1 integrins to the RGD domain of FN.  
First, the functionality of the PEA brushes was investigated through their 
ability to drive changes in protein structure and fibril formation. FN coating was 
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observed to decrease the measured roughness and mask the differences in 
hydrophobicity and chemical mobility between samples (Figure 3.1). It can be 
suggested that FN provided a uniform coverage of all surfaces, regardless of 
changes in its conformation or organisation. This changes were instead detected 
microscopically via fluorescently tagged FN and at the molecular level via AFM. 
Microscopically FN networks were observed on PLLA-bPEA, similarly to those found 
on PEA. Fibronectin was observed to form fibril networks on both high and low 
concentrations of FN (Figure 3.2). While this suggested the biofunctionality of PEA 
brushes to drive fibrillogenesis, at this scale the RMS roughness introduced through 
the SI-ATRP process may also affect FN orientation and conformation on these 
surfaces.   
In order to discard the effect of the nanotopography, FN molecules were 
examined at the nanoscale utilising AFM on smoother samples; this would further 
confirm changes in protein structure associated with the presence of PEA brushes 
on the surfaces. Indeed, on PLLA-bPEA FN was observed to form nanonetworks, 
similar to those found on bulk PEA (Figure 3.3); however on untreated PLLA this 
FN architecture was not present. FN was observed to remain in globular cluster 
conformation on pristine PLLA, due to the lack of chemical sidechains on the 
unmodified polymer backbone. The presence of nanonetworks on PLLA-bPEA 
shows the retention of the biological functionality of the PEA brushes produced 
via SI-ATRP. In fact, they provide the ability for modified PLLA surfaces to drive 
surface-initiated fibrillogenesis. However, FN fibrils formed on PLLA-bPEA samples 
were altered compared to those formed on bulk spin-coated PEA (Figure 3.4). 
These fibrils were measured as thicker and less interconnected than those found 
on PEA, producing wider nanonetworks with a slightly lower fractal dimension 
(Figure 3.3 B) (Pelta, Berry et al. 2000).  
The larger fibrils on PLLA-bPEA can be attributed to the size of the FN 
protein and to the inherent nature of the polymer brushes. While FN is presented 
as few nanometres in thickness and with two ~40 nm stretched arms when in non-
globular fibril conformation (e.g. as found on PEA), initial interactions with the 
surfaces is performed by globular FN, which is sized to ~30 nm (Pelta, Berry et al. 
2000, Gugutkov, Gonzalez-Garcia et al. 2009).  While the protein size does not 
affect its interaction with a homogenous microscopic layer of polymer (e.g. when 
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FN is adsorbed onto spin-coated PEA), this large protein initially interacts with 
PEA brushes that are estimated to be only few nanometres high when it is adsorbed 
onto PLLA-bPEA surfaces. These interactions are likely to cause local disruption of 
these small polymer brushes, inhibiting further FN interactions in the local vicinity 
of pre-adsorbed FN and therefore favouring FN-FN binding instead. This with FN 
would impact on the interconnectivity of the nanonetworks and is suspected to 
aid in the development of thicker fibrils compared to bulk PEA surface. Surface 
roughness of the treated polymer may also contribute to these differences, as 
nano-roughness has been previously shown to affect the protein adsorption and 
subsequent fibrillogenesis (Rico 2014).  
It should also be noted that AFM was performed in both air and liquid conditions 
to investigate the potential that FN material-driven fibrillogenesis was an artefact 
of rapid osmotic variations on the surface during drying (Figure 3.5). Similar FN 
nanonetworks were observed on fixed FN-treated PEA samples in both conditions 
regardless of environmental conditions (Figure 3.5B); however, images obtained 
in liquid suffered from diminished tip-surface stability which impacted image 
quality. Here we have presented FN fibrillogenesis on spin-coated PEA in liquid as 
these surfaces presented improved tip surface stability compared to scPLLA-bPEA, 
resulting in clearer visualisation of FN nanonetworks. This could be due to slight 
increases in scPLLA roughness caused by SI-ATRP contributing to poor image 
quality as found in AFM visualisation in liquid conditions. Our results confirmed 
that FN nanonetworks observed on PEA samples were not a drying artefact, but 
rather they were induced by protein interactions with this polymer.   
The conformational change of FN on PLLA-bPEA shows that PEA brushes have a 
biological functionality similar to bulk PEA. To further characterise the availability 
of binding domains in the FN nanonetworks assembled on the PEA brushes was 
investigated. As fibronectin mediates a wide range of cellular interactions with 
the ECM in vivo, the conformation and presentation of integrin binding domains 
on this protein are vital for the development of this, or any, tissue engineering-
orientated systems (Schwarzbauer and Sechler 1999, Pankov and Yamada 2002, 
Martino, Tortelli et al. 2011). It has been shown that fibrillogenesis drives the 
presentation of different, cryptic integrin binding domains (Keselowsky, Collard 
et al. 2003, Keselowsky, Collard et al. 2004, Keselowsky, Collard et al. 2005, Costa 
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Martinez, Rodriguez Hernandez et al. 2008, Vanterpool, Cantini et al. 2014, 
Bathawab, Bennett et al. 2016, Grigoriou, Cantini et al. 2017); these published 
systems have utilised surface mobility and varying surface chemistries, such as 
side-chain length of acrylates or monolayers presenting defined chemistries, to 
expose these binding motifs, which were otherwise inaccessible on globular FN 
(Garcia, Vega et al. 1999, Salmeron-Sanchez, Rico et al. 2011). This subsequently 
facilitated enhanced cellular behaviours such as adhesion and differentiation 
(Garcia, Vega et al. 1999, Keselowsky, Collard et al. 2004). Here, we found that 
PLLA-bPEA surfaces present enhanced integrin binding domain availability, 
through increased exposure of the PHSRN synergy domain of FN (Redick, Settles 
et al. 2000, Vanterpool, Cantini et al. 2014), similarly to PEA (Figure 3.6C). This 
correlates with the observation of nanonetworks on these surfaces, as 
fibrillogenesis and therefore stretching of the FN molecule would present this 
cryptic binding domains; on the other hand on PLLA, where PHSRN availability was 
observed to be low, globular FN would not preferentially present this binding 
domain (Ballester-Beltran, Moratal et al. 2014). Availability of the RGD domain 
was instead observed to be similar on all surface conditions (Figure 3.6 B) due to 
the universal presentation of this domain on both fibril and globular FN, in line 
with the surface density of adsorbed FN, which was shown to be independent of 
nanonetwork formation (Figure 3.6 A) (Redick, Settles et al. 2000, Vanterpool, 
Cantini et al. 2014). This definitively shows the presence and functionality of PEA 
brushes produced via SI-ATRP on PLLA, and suggests potential enhanced cellular 
interactions favourable for tissue engineering applications of this surface 
modification. PEA driven FN fibrillogenesis has been utilised in similar systems via 
spin-coating and plasma polymerisation (Cantini, Rico et al. 2012, Llopis-
Hernandez, Cantini et al. 2016), including onto the surface of biomaterials (Cheng, 
Alba-Perez et al. 2019). These approaches to incorporating thin layers of PEA onto 
the surface have shown similar enhancement of FN binding domain availabilities 
and formation of nanonetworks. However, spin-coating is a planar surface coating 
methodology and is therefore not a feasible technique for thin layer production in 
3D scaffolds or other more complex systems. Plasma polymerisation is able to 
diffuse through complex 3D structures, this however has been shown to 
heterogeneously coat the surface, to produce PEA coating (Barry, Silva et al. 2005, 
Barry, Howard et al. 2006). However, FN nanonetworks observed on plasma 
polymerised PEA on glass coverslips are much more densely packed than scPEA or 
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scPLLA-bPEA (Cheng, Alba-Perez et al. 2019), resembling more FN nanonetworks 
on PLLA-bPEA films.  These layer of PEA produced by spin-coating or plasma 
polymerisation are also not chemically bound to the surface and therefore can 
peel, unlike PEA brushes produced via SI-ATRP which are grafted from the PLLA 
and covalent bound to the surface (Matyjaszewski, Dong et al. 2007).    
Indeed, cell adhesion was observed to improve on PLLA samples treated with 
SI-ATRP. Cells cultured on PLLA-bPEA spread better and showed lower circularity, 
resulting in improved morphologies comparatively to PLLA (Figure 3.7). 
Furthermore, PLLA-bPEA surfaces were observed to facilitate larger numbers of 
focal adhesions than PLLA, and of these FAs a higher concentration were longer 
mature focal adhesion plaques as found on PEA (Figures 8 and 9). These findings 
are in line with previous characterisations of cellular interactions on PEA 
(Vanterpool, Cantini et al. 2014), which highlighted enhanced adhesion of cells on 
these surfaces. This confirms that the PEA brushes formed via SI-ATRP are able to 
drive FN fibrillogenesis and subsequently present binding domains associated with 
cellular adhesion via the same mechanism as bulk PEA.  Variations in number and 
size of focal adhesions between PLLA-bPEA and PEA may correspond to the 
diminished fractal dimension and interconnection of the FN nanonetworks formed 
on the brushes.  In any case, the added functionality induced enhanced cellular 
adhesion to modified PLLA, highlighting the viability of SI-ATRP as a surface 
modification technique. 
Additionally, PLLA-bPEA surfaces were observed to induce myogenic 
differentiation to similar degrees as control bulk PEA (Figure 3.10 and 3.11). While 
PLLA surfaces alone were ineffective in driving differentiation of C2C12 cells, both 
PLLA-bPEA and PEA surfaces presented high concentrations of differentiated cells 
after 4 days of incubation (Figure 11A). This highlights that PLLA-bPEA surfaces 
are able to facilitate more complex cellular functions than enhanced adhesion 
(Zhu, Gao et al. 2004). While higher cellular densities have been shown to 
contribute to increased degrees of myogenic differentiations (Tanaka, Sato et al. 
2011), here we observed similar cellular densities in all sample conditions while 
increased differentiation percentages were present only on PLLA-bPEA and PEA. 
Therefore the increased myotube formation is due to the presence of functional 
FN nanonetworks on these samples. Moreover, C2C12 differentiation on FN 
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nanonetworks on PEA has been found to be contractility-dependent (Salmeron-
Sanchez, Rico et al. 2011, Bathawab, Bennett et al. 2016), and here we aimed to 
further confirm if differentiation on PLLA-bPEA occurred via the same mechanism 
as on bulk PEA. Introduction of blebbistatin, a myosin II contractility inhibitor 
(Kovacs, Toth et al. 2004, Allingham, Smith et al. 2005), significantly decreased 
the degree of differentiated cells on PLLA-bPEA and PEA, whilst no decrease was 
observed on PLLA. This confirmed the contractility dependence of differentiation 
on PLLA-bPEA and PEA, showing that the FN nanonetworks formed on both of these 
surfaces activate actin-myosin contractility and drive cell fate (Cai, Rossier et al. 
2010). This further shows the similarities to bulk PEA and the functionality of the 
SI-ATRP-produced PEA brushes, validating the potential of SI-ATRP as an avenue 
for tissue engineering applications. 
3.5 Conclusion 
In this chapter we have assessed the biological functionality of PEA brushes 
produced from SI-ATRP, primarily their ability to drive fibrillogenesis presenting 
previously inaccessible binding domains on FN to enhance cellular interactions. 
This retention of the functionality of PEA, similar to that of the conventionally 
produced bulk polymer, confirms the previous identification of chemical 
similarities between these two production mechanisms (Chapter 2). Therefore 
confirmation of nanonetwork formation and synergy domain presentation suggest 
PLLA-bPEA surfaces will favourably allow for cellular adhesion, as found for bulk 
PEA (Vanterpool, Cantini et al. 2014, Llopis-Hernandez, Cantini et al. 2016). This 
was confirmed via characterisation of PLLA-bPEA cellular interactions; 
highlighting supplementary cellular adhesion and differentiation capabilities of SI-
ATRP treated PLLA. These results show that PLLA-bPEA is able to facilitate 
enhanced cellular adhesions and differentiation allowing for the potential use of 
stem cells and further development of this system for use in tissue regeneration.  
 
 
 
 
 
 
 
 
 
 
 
4- Streamlining of SI-ATRP system 
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4.1. Introduction 
In the previous chapters we have outlined the optimization of a 3-step SI-ATRP 
methodology. During this process a variant SI-ATRP system, which incorporates 
priming and initiator immobilisation in one step, was developed in tandem. While 
the previously described system of immobilising the SI-ATRP initiator on the PLLA 
surfaces involved 2-pots, first the functionalisation (aminolysis) and then the 
initiator immobilisation (bromination), this optimized system aims at preparing 
the PLLA surfaces for polymerisation within the same reaction vessel, therefore 
being a “1-pot SI-ATRP” system. The process was developed to produce PLLA-bPEA 
samples efficiently in a shorter time scale, avoiding the necessity to aminolyse 
and wash the samples before bromination. These optimization steps were 
undertaken based on several surface modification protocols (Charvet and Novak 
2004, Min, Gao et al. 2009, Morsi, Pakzad et al. 2011, Espeel and Du Prez 2015), 
which outline 1-pot bromination in the presence of functionalization. Through this 
variant SI-ATRP protocol it was speculated that time of PLLA-bPEA production 
could be reduced alongside improved maintenance of bulk polymer 
characteristics, so as to allow for enhanced upscaling of the procedure while 
maintaining control of products specifications. However, it was also essential to 
ensure that the modified material was as functional as the one obtained with the 
previously outlined 2-pot production. Therefore, 1-pot SI-ATRP samples were 
produced and characterised alongside 2-pot surfaces; in this chapter, we compare 
the materials resulting from 1-pot and 2-pot PLLA-bPEA samples. While the 
aminolysis in the 2-pot procedure is a defined controlled reaction modulated by 
concentration of 1, 6 hexanediamine, temperature and time of reaction, 1-pot 
samples are functionalised via surface interactions with the pyridine present in 
the immobilisation vessel which produce complexes with α-bromoisobutyryl 
bromide. This manner of pyridine-based functionalisation or pyridinolysis, has 
been previously described in ATRP reactions (Kickelbick, Paik et al. 1999, Xia, 
Zhang et al. 2000, Tsarevsky and Matyjaszewski 2005, Braunecker and 
Matyjaszewski 2006, Tang and Matyjaszewski 2006, Iacono and Heise 2015, Kassel, 
Gerke et al. 2018); however, due to simultaneous inclusion of pyridine sidechains 
and immobilisation of initiator occurring in 1-pot reactions, it is not as controlled 
or definable as a separate aminolysis. Within the 2-pot reaction this pyridine based 
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functionalisation is suspected to be inhibited by the presence and coverage of 
amine groups. By characterising this pyridine based procedure, defining the 
alterations to the chemical and mechanical properties of the films and comparing 
them to 2-pot surfaces, we aim to optimize it to allow for fast and efficient PEA 
brush formation that may allow for easier translation into industrial or clinical 
applications. 
 
4.2.  Materials and methods 
4.2.1. Materials: Poly (L-Lactide) films (thickness 50 µm) were purchased from 
Goodfellow (Huntingdon, UK). 1,6-hexanediamine (98%), 2-propanol (≥99.5%), 2-
bromoisobutyryl bromide (BIBB, 98%), anhydrous pyridine (Py, 99.8%), anhydrous 
hexane (95%), copper(I) bromide (CuBr,99.999 %), Tris(2-pyridylmethyl)amine 
(TPMA, 98%), ethyl acrylate (EA, 99.5%), methanol ( 99.99%), ascorbic acid (AsAc) 
were purchased from Sigma Aldrich, Dorset, UK. Glass reaction vessels were 
custom-made.  
4.2.2. Preparation of PLLA-bPEA films: The developed SI-ATRP system takes 
place in two or three steps: priming (aminolysis), initiator immobilisation 
(bromination) and polymerisation. These processes take place sequentially and 
separately within different reaction vessels for the formation of 2-pot PLLA-bPEA. 
For 1-pot PLLA-bPEA, samples are functionalised within the initiator 
immobilisation reaction vessel by available nitrogen sources during bromination 
(soluble pyridine), with reagent ratios hexane: BIBB: pyridine (20:1:0.4) and 
subsequently immobilised. They are then polymerised within a separate reaction 
vessel alongside the 2-pot samples. PLLA films were cut into 13.8 mm circles, with 
an area of 1.9 cm2.  
4.2.3. Atomic force microscopy: Atomic Force Microscopy was used to quantify 
surface roughness in all conditions on dried samples in air. Height and lock-in 
phase images were taken in AC mode using a Nanowizard 3 Bioscience AFM (JPK, 
Berlin Germany). Scans were made using cantilevers with a resonance frequency 
of 75 kHz and a force constant of 3 N m-1 (MPP-21120 from Bruker, Billerica, MA). 
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Surface area scans (n=3) of 5x5 μm (0.5Hz) were used to analyse surface roughness 
of each sample from any given condition. The Rrms was calculated using the JPK 
DP software after image levelling to remove variations or tilts in the background.  
4.2.4. Water contact angle: Water contact angle measurements were 
undertaken on PLLA and functionalised samples. Static contact angles (SCA) were 
measured by dropping 3 μL of deionised water onto the samples. Analysis was 
conducted using a Theta optical tensiometer (Biolin Scientific, Stockholm, 
Sweden). 
4.2.5. Enzymatic degradation: Individual samples were dried to constant weight 
under vacuum for a minimum of 2 days, samples were then submerged in 0.2 mg 
mL-1 proteinase K enzyme (Sigma, St. Louis, MO) in Tris-HCL buffer (pH 8.6) with 
0.2 mg mL-1 sodium azide (Sigma, St. Louis, MO). Incubated samples were kept at 
37oC with agitation. The degradation solution was replaced every 24 hours to 
maintain enzymatic activity. Samples were dried under vacuum to constant weight 
before final weight was established.  
4.2.6. Dynamic mechanical analysis: Dynamic mechanical analysis (DMA) was 
performed on a DMA 8000 (Perking-Elmer) apparatus at a frequency of 1Hz in 
tension mode, the temperature range was -150 to 100oC at a rate of 1oC min-1. 
Young’s modulus was determined at 36-38oC on sample of 10 mm x ~6 mm x 0.05 
mm.   
4.2.7. Differential scanning calorimetry: Differential scanning calorimetry 
(DSC) was performed using a PerkinElmer 8000 apparatus. Samples were weighed 
to ~4mg and encapsulated within DSC pans before being cooled from 30°C to -
80 °C and isothermally stabilized for 5 minutes. Samples were then heated to 
200 °C at a rate of 20 °C min−1 (first heating) and subsequently cooled to -80 °C, 
this process was then repeated for the second heating. Temperature changes were 
at a rate of 20 °C min-1, nitrogen gas rate was maintained at 20 ml2 min-1. 
Crystallinity percentages were obtained using the equation: 
𝐶𝑟𝑦𝑠𝑡𝑎𝑙𝑙𝑖𝑛𝑖𝑡𝑦 (%) =
ΔHm − ΔHc
93.1
𝑥100 
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Where ΔHm is the enthalpy of melting, ΔHc corresponds to the enthalpy of 
crystallisation and 93.1 the theoretical melting enthalpy of 100% crystalline PLLA 
(Ribeiro, Sencadas et al. 2011). All measurements are presented as the average 
of 3 replicates.  
4.2.8. Thermogravimetric analysis: Thermogravimetric analysis was performed 
with TGA/DSC 2 STAR System (Mettler Toledo) thermobalance, at 10 °C min−1 from 
30 to 800 °C in a nitrogen atmosphere of 50 mL min−1. Samples were weighed to 
4mg and encapsulated in metal casings before cooling from ambient temperature 
to 800 °C from ambient temperatures. Thermogram data processing and analysis 
was performed using the Mettler Toledo software. 
4.2.9. Fourier-transform infrared spectroscopy: Attenuated total reflection 
(ATR) FT-IR was performed to characterise the bulk chemical composition of PLLA 
modified through SI-ATRP, comparatively to PLLA and PEA controls. Scans in the 
range of 4000- 600 cm-1 were acquired using a Bruker ATR device, correcting for 
atmospheric contamination by taking a blank scan in air conditions.  
4.2.10. Dielectric relaxation spectroscopy: The molecular dynamics of the 
samples were determined by means of a Novocontrol Broadband Dielectric 
Spectrometer (Hundsagen, Germany) consisting of an Alpha analyzer to 
carry out measurements from 510-2 to 3106 Hz. This allows measurement 
of the complex dielectric permittivity,      * i        , where     
and     are the storage and loss part of the dielectric permittivity. The 
temperature was controlled by a Novocontrol Quatro cryosystem with a 
precision of ±0.1 K during each sweep in frequency. The isothermal 
measurements were performed from -120 °C to 70 °C (step of 5 ºC) in an 
inert N2 atmosphere to avoid moisture uptake. Molded disc shaped samples 
of about 0.05 mm in thickness, with diameter of 10 mm, were mounted in 
the dielectric cell between two parallel gold-plated electrodes. The 
thickness of each sample was measured with a micrometer screw. The 
experimental uncertainty was less than 5% in all cases. DRS was performed 
by Prof. M Sanchis, Universitat Politècnica de València. 
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4.2.11. X-ray photoelectron spectroscopy: X-ray Photoelectron Spectroscopy 
was used to identify the surface chemical composition of samples. All X-ray 
photoelectron spectra were obtained at the National EPSRC Users’ Service (NEXUS) 
at Newcastle University (found at: http://www.ncl.ac.uk/nexus/). Each sample 
was analysed at three points with a maximum beam size (400 μm x 800 μm) with 
a K-alpha XPS apparatus (Thermo Scientific) equipped with a monochromatic Al-
K-alpha source for Carbon, Oxygen, Nitrogen, Bromine and overview spectra. X-
ray energy was 1486.68 eV at a voltage of 12 kV, current of 3 mA and power of 36 
W. Analysis of the XPS results was conducted with CasaXPS version 2.3.16 (Casa 
Software Ltd) with adjustments for transmission and escape depth included in the 
VAMAS block provided by NEXUS. 
4.2.12. Cytotoxicity assay:  a lactose dehydrogenase assay (LDH) kit (Roche; 
catalogue number 11644793001) was utilised to determine the cytotoxicity of 
polymer samples with hMSCs cells (p4, Promocell). Cells were seeded at 5x103 
cells cm-1 in a 96 well plate and polymer samples were cultured within 24 well 
plates for 24 hours without serum in antibiotic containing culture medium. 
Polymer samples were incubated with and without 2% triton X-100 within media. 
Cell media was replaced with media incubated with and without polymer and cells 
were incubated for 24 hours. The cell-free culture supernatant was collected and 
assayed for LDH release as directed by the kit provider. The increased 
concentration of enzyme activity in the supernatant represented cell 
permeabilization and membrane damage, and was analysed by the colour change 
of reagents, measured at 492nm and compared to reference media without 
polymer with and without 2% triton X100.  
4.2.13. Cell adhesion: Mouse C2C12 myoblasts were thawed and re-suspended in 
Dulbecco's modified Eagle's medium (DMEM, high glucose, without pyruvate) with 
1% v/v penicillin/streptomycin and 20% v/v foetal bovine serum (FBS). Cells were 
incubated in 37°C, 5% CO2, and harvested by trypsinisation at 70% confluency. 
For adhesion experiments, samples were sterilized under a UV lamp for 40 minutes 
on each side, as the samples are opaque, and coated with 10 μg mL-1 FN; negative 
controls were coated with PBS for 1 hour. Samples were then washed with PBS 
and seeded with 5000 cells cm-2 for 4 hours and then fixed with 3.7% formaldehyde 
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for 30 minutes at 4°C. The cells were then permeabilised with 0.1% triton X-100, 
washed and finally blocked (PBS/BSA1%) for 30 minutes at room temperature. 
Samples were first incubated with anti-vinculin primary antibody (1:400), hVIN-1 
(Sigma-Aldrich), in blocking buffer for 1 hour at room temperature and 
subsequently washed with washing buffer, PBS/Tween 20 0.5%. Cy3-conjugated 
secondary antibodies (Jackson ImmunoResearch) and BODIPI FL Phallacidin 
(Thermo Fisher Scientific) were then added for 1 hour at RT. The samples were 
then washed and mounted with mounting medium containing DAPI (Vector 
Laboratories, Inc.) and visualised with a fluorescence microscope (Zeiss 
AxioObserver.Z1). Images were merged using ImageJ to localise nuclei and actin. 
Focal adhesions were analysed using the vinculin stain images; the procedure is 
described in Horzum et al (Horzum, Ozdil et al.) Images were analysed with 
threshold area of 0.5 µm2 and 0-0.99 circularity. 
4.2.14. Statistical analysis: Pre-processing and normalization of data are stated 
in the individual methods sections. Analysis of statistical differences was 
conducted using student T-test (Graphpad) for two sample comparison and One-
way ANOVA for different groups using a Turkey HSD post hoc test to compare 
different groups. Differences were considered significant *p < 0.05, **p < 0.01, ***p 
< 0.001, ****p < 0.0001. All data presented are mean values, error bars are 
standard deviation and n numbers are noted in the figure captions. 
 
4.3. Results 
4.3.1.  Surface characterisation and mechanical properties of 
1- and 2-pot PLLA-bPEA 
To characterize differences between products of SI-ATRP through a 1- or 2-
pot immobilization mechanism, surface characterization was conducted. AFM 
showed a significant increase in RMS roughness post initiator immobilization of 
PLLA samples independent of pot mechanism (Figure 4.1A). Both 1- and 2-pot 
PLLA-bPEA samples have similarly increased roughness post polymerization, 
showing that the pot mechanism by which SI-ATRP is performed does not impact 
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on the topography of the samples. In contrast, 1-pot PLLA-bPEA surfaces were 
measured to have a much higher hydrophobicity than any other condition (Figure 
4.1B). The increased WCA of 1-pot PLLA-bPEA may be a result of altered surface 
chemistry from the pyridinolysis immobilization mechanism. Therefore, while 
there are no significant topographical alterations, pyridinolysis produces distinctly 
altered PLLA-bPEA surface chemistries compared to aminolysis-based SI-ATRP. 
Bulk properties were analyzed initially via dynamic mechanical analysis and 
enzymatic degradation. Enzymatic degradation of PLLA films showed that 1-pot 
PLLA-bPEA degraded at a slower rate than 2-pot samples and pristine PLLA (Figure 
4.1C). This suggests that pyridinolysis produces a physical or hydrostatic barrier 
to PLLA degradation. The Young’s modulus was maintained within the same mega 
pascal range independent of pot mechanism, however 1-pot samples were 
observed to possess higher stiffness values than 2-pot samples and pristine PLLA. 
This could indicate that the inclusion of pyridine-BIBB initiators causes a 
supplementary stiffening of PLLA. These results indicate that while 1-pot initiator 
immobilisation does not detrimentally impact on the bulk characteristics or 
surface topography of PLLA-bPEA, the altered mechanism of initiator 
immobilisation does result in increased surface hydrophobicity and decreased 
degradation at the shorter time point post treatment. 
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Figure 4.1. Surface and bulk properties. (A) Surface root mean squared 
roughness measurements of PLLA samples through the entire SI-ATRP process. A 
minimum of 20 measurements were taken from 5x5 µm2 AFM scans of each sample. 
(B) Static water contact angle characterisation of spin-coated PEA controls, PLLA 
and PLLA-bPEA produced by either a 1-pot or 2-pot bromination. (C) Elastic 
modulus of PLLA and 1- or 2-pot PLLA-bPEA at 36-38 oC measured from dynamic 
mechanical analysis (DMA) using a DMA 8000 (Perking-Elmer) apparatus at a 
frequency of 1Hz in tension mode; the temperature range was -150 to 100oC at a 
rate of 1oC min-1. Young’s modulus was determined at 37oC on samples of 10 mm 
x ~6 mm x 0.05 mm. (D) Percentage weight loss of PLLA and PLLA-bPEA samples 
after 72 hours of degradation with 0.2 mg mL-1 proteinase K at 37oC. Graphs show 
mean values and standard deviation.  *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 
0.0001. 
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4.3.2.  Thermal analyses of 1- and 2-pot PLLA-bPEA 
Further bulk characterisation was performed to investigate the thermal 
properties of 1-pot samples, in order to determine whether these immobilisation 
variants resulted in alterations in polymer crystallinity or resistance to thermal 
degradation. The DSC scans (Figure 4.2A) show the first and second heating of the 
samples in each condition. The first heating scans highlight the crystalline state 
of the polymers after each step of the SI-ATRP (Figure 4.2A). Both SI-ATRP systems 
drive crystallisation of the amorphous PLLA to around 40% post initiator 
immobilisation and 50% crystallinity in PLLA-bPEA (Figure 4.2B). These increases 
in crystallinity may be a product of heating or exposure to solvents, such as 
methanol during the associated reactions.  The second heating scans alone 
indicate no distinct differences between 1-pot and 2-pot PLLA-bPEA, suggesting 
that these samples have similar heat of thermal transition and ability to crystallize 
(~20% crystallinity) (Figure 4.2B). While the first heating takes into account the 
thermal history of the analysed polymer sample, the second heating scan 
represents the reorganisation of polymer chains by successive melting and re-
crystallization (Tamano-Machiavello, Costa et al. 2015), effectively erasing the 
thermal history of the polymer and resulting in an investigation into the bulk 
thermal capacitance. DSC scans and calculated crystallinity of both PLLA-bPEA 
conditions during the second heating indicate minor variations from the inherent 
crystallinity potential of pristine PLLA. These data suggest that the crystallization 
and chemical reactions occurring through SI-ATRP, as observed from first heating 
scans, do not drastically affect the availability of nucleation sites for PLLA 
crystallization (Figures 4.2A and B). All scans show glass transition and melting 
temperatures within the same range as bulk PLLA, ~60°C and ~160°C respectively, 
showing that neither 1-pot nor 2-pot SI-ATRP impact on these bulk characteristics. 
However, the inclusion of additional melting peaks at ~150°C, exclusively found 
in first heating scans of PLLA-Br and the second heating scan of 2-pot PLLA-Br, 
highlight the inclusion of the initiator. The addition of BIBB on these surfaces 
providing an additional melting peak in these spectra. Second heating scans of 1-
pot PLLA-Br may resemble that of PLLA due to smaller concentration or chemical 
composition of the pyridine linked initiator providing diminished changes in 
thermal properties. Cooling was performed at the relatively high rate of -20 °C 
per minute, which may have inhibited re-crystallization at this step however 
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allowed for examination of crystallization properties upon second heating. 
Generally, these DSC analyses show no distinct differences in thermal properties 
between PLLA-bPEA pot conditions, but do indicate altered heating properties of 
intermediates.  
 
Figure 4.2. Thermal capacitance of SI-ATRP modified samples. (A) DSC heating 
thermographs of PLLA films treated through the SI-ATRP protocol. First heating 
examines the crystallinity of PLLA after each stage of treatment. Second heating 
investigates the heat capacity of each intermediate PLLA condition post 
treatment. (B) Crystallinity values of each step of 1-pot SI-ATRP compared to 2-
pot conditions, showing both first and second heating. Calculated by measuring 
the change in enthalpy of heating minus crystallisation over 100% crystalline PLLA. 
All conditions are significantly different by at least *p < 0.05 unless otherwise 
stated.  
Thermal stability of SI-ATRP-treated PLLA samples was further 
characterised via thermogravimetric analysis (TGA) (Figure 4.3). PEA thermal 
degradation was observed to occur at a higher temperature than PLLA, shown by 
the point of highest rate of weight change, at ~400°C and ~360°C respectively. 
Both PLLA-bPEA pot conditions maintained similar thermal stability to PLLA, 
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confirming that neither surface modification methodology significantly alters the 
bulk thermal stability of the PLLA films.  
  
 
Figure 4.3.  Thermogravimetric analysis. Show the percentage weight dependant 
on temperature and (B) first derivative, highlighting the temperature at which the 
highest weight change occurs of PLLA, PEA, 1-pot PLLA-bPEA and 2-pot PLLA-
bPEA. 
4.3.3 Physico-chemical characterisation  
FT-IR, DRS and XPS were utilised to investigate the presence of nanoscale 
PEA brushes. While the relatively small concentration and similar chemical 
composition of PEA comparatively to the bulk PLLA make identifying the products 
of SI-ATRP difficult, some markers were identified via FT-IR (Figure 4.4A). The 
addition of a peak on both PLLA-bPEA and PLLA-Br samples at 920 cm-1  (Figure 
4.4A and B), corresponding to a 1,2,4-trisubstituted carbon bonding, indicates the 
immobilized BIBB backbone maintained as an initiation point by the PEA brushes 
that are subsequently formed. Elongation of the peaks at 1350 and 750 cm-1 on 2-
pot PLLA-bPEA, showing the presence of alcohol groups and carbon-hydrogen 
respectively, represent the accumulation of these groups due to the inclusion of 
PEA onto the surface of PLLA. This suggests that aminolysis is a more efficient 
functionalisation methodology, as it produces larger densities of PEA brushes onto 
the surface and therefore larger concentrations of these chemical groups.   
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By comparing the chemical composition of 1- and 2-pot products we can 
note differences in the initiator immobilisation mechanisms. Generally, the PLLA-
Br samples have very similar FT-IR spectra, possessing peaks at 800 cm-1 and 1000 
cm-1, which are products of immobilisation of the initiator and are subsequently 
removed with 2-pot polymerisation. These peaks are found to be maintained on 
1-pot PLLA-bPEA conditions (Figure 4.4B), suggesting retention of immobilised 
initiator post polymerisation. In fact, all 1-pot samples are observed to possess 
elongation of the peak found at ~1250 cm-1, which may be due to the addition of 
nitro compound (N-O stretching) caused by the pyridinolysis of PLLA.  
Generally, we are able to observe the conservation of characteristic 
chemical stretching of immobilisation products on 1-pot SI-ATRP-treated samples. 
This suggests that while immobilisation does occur on these surfaces, pyridinolysis 
produces a less favourable surface initiator for EA polymerisation compared to 
aminolysis.   
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Figure 4.4. Surface chemical characterisation. (A) FT-IR analysis of PLLA, 4 hour 
polymerised 1- and 2-pot PLLA-bPEA and PEA. Highlighted areas at 750 cm-1, 920 
cm-1, 1000 cm-1 and 1350 cm-1. (B) Comparison of 4 hour polymerised, 12 hour 
brominated and pristine PLLA FT-IR scans of either 1-pot (left) or 2-pot (right). 
Highlighted areas at ~800 cm-1, 1000 cm-1 and 1250 cm-1. 
Further chemical characterisation of the SI-ATRP products using dielectric 
relaxation spectroscopy (DRS) reveals the presence of a β-relaxation peak on 
PLLA-bPEA and PEA samples (Ribelles, Duenas et al. 1989) (Figure 4.5 A). This peak 
found on PEA at -60°C is observed to be shifted, potentially due to the surrounding 
PLLA bonds, to -120°C on PLLA-bPEA samples (Kyritsis, Ribelles et al. 2004).  The 
presence of PEA beta relaxation suggest that brushes have been formed on the 
surface of PLLA, corresponding to this additional chemical characteristic (Williams 
1966). Moreover, this β-relaxation peak is more pronounced on 2-pot PLLA-bPEA 
samples, suggesting a higher abundance of PEA chains compared to 1-pot surfaces.  
Analysis of surface chemical composition via XPS showed significant 
differences between bromination strategies, as shown by XPS of 1- and 2-pot PLLA-
Br samples (Figure 4.5B). Both surface functionalisation methodologies introduce 
elemental nitrogen and bromine onto the surface, showing successful aminolysis 
and bromination. C1s carbon spectra reveal that while 2-pot PLLA-Br samples 
maintain a PLLA-like spectra, 1-pot conditions have a dramatically altered carbon 
binding conformation, possessing predominantly carbon-carbon bonding and a 
significant loss of the carboxyl and ester bonding environments within the top 10 
nm of the surface. The carbon-carbon peak is also shifted -0.8 eV from standard 
PLLA on 1-pot PLLA-Br suggesting these carbon are further bound in a stronger 
chemical bond, potentially in C=C sp2 hybrid as found within pyridine. A distinct 
loss of ester group oxygen bonding peak, suggesting a loss or masking of this PLLA 
binding domain.  
Peak fitting PLLA-bPEA spectra utilising control PLLA and PEA spectra 
models show that while 2-pot conditions can be modelled as composites of both 
polymers, surfaces of 1-pot samples are distinctly chemically altered from PLLA 
(Figure 4.5 C and D). Additional sp2 carbon peaks on both 1-pot conditions, as 
observed post initiator immobilisation suggest a considerable and maintained 
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chemical alteration to the PLLA surface. This peak shift could be attributed to the 
inclusion of carbons bound in an aromatic cyclic ring, occurring with inclusion of 
pyridine through pyridinolysis. The carbon-carbon bonds formed from 1-pot 
immobilisation (Figure 4.5B) and retained on 1-pot PLLA-bPEA conditions (Figures 
6C and D dark blue peak), represent a less favourable chemical surface 
modification, potentially masking the presence of PEA brushes on these surfaces. 
These sp2 hybrid or tertiary bound carbon molecules are abundant on all 1-pot 
PLLA-bPEA samples and a smaller amount can be speculated to be present on 2 
hour 2-pot PLLA-bPEA (Figure 4.5C), but via polymerisation for 4 hours on 2-pot 
conditions these intermediates are either fully utilised or removed. This would 
suggest that the 1-pot mechanism produces an inefficient immobilisation of 
functional initiator on the surface of PLLA and that a lesser degree of pyridinolysis 
may occur on 2-pot samples. However, 4 hour 2-pot PLLA-bPEA highlights that an 
extended polymerisation time is able to fully quench the surface bound 
functionalization, producing PEA on the surface.  Polymerisation exceeding 4 
hours was observed to significantly decrease the structural integrity of the 
produced films for both functionalisation methodologies (data not shown). 
Therefore, increasing time of polymerisation is not a suitable methodology for 
attempted quenching of the initiators formed through the 1-pot mechanism.  
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Figure 4.5. Bonding conformation of elements (A) Dielectric relaxation 
spectrometry analysis of PLLA, PEA, 4 hour 2-pot PLLA-bPEA and 4 hour 1-pot 
PLLA-bPEA. Highlighted red square shows β relaxation peak on PLLA-bPEA and PEA 
but not found on PLLA. (B) XPS spectra of PLLA, 1-pot PLLA-Br and 2-pot PLLA-Br. 
Carbon, Bromine, nitrogen and oxygen spectra reveal the presence and binding 
conformation each element. (C and D) C 1s core-level showing quantification of 
polymer line-shape elements for PLLA-bPEA after a (C) 2 hour and (D) 4 hours 
polymerisation, using the spectra obtained from control PLLA and PEA as 
components during line fitting. The bright red line corresponds to the 
experimental spectra for each sample. The line shapes are as follows: teal line 
shows the PLLA carbon spectra, the pink line represents the PEA spectra, brown 
is the combined spectra of fitted peaks.  The blue line shape labelled C-C 
corresponds to potential fragmentation found on 1-pot samples. All binding 
energies and CPS axes are uniform between graphs to allow comparison of peaks.  
 
4.3.4. Cytotoxicity and cell adhesion 
A cytotoxicity assay based on LDH release (Figure 4.6), measuring the 
cellular stress resulting from interaction with media incubated with the samples, 
showed that all substrates, from SI-ATRP of either mechanism, are non-cytotoxic 
to cells.  To further assess the cell response on substrates modified with differing 
SI-ATRP pot conditions, the adhesion of C2C12 cells on 10 µg mL-1 FN-coated 
samples for 4 hours was investigated. Cells seeded onto PLLA and 1-pot samples 
were observed to have limited spreading and cluster together, whereas on 2-pot 
surfaces better spreading was seen (Figure 4.7). Cell area and circularity 
characteristics were maintained from PLLA on 1-pot PLLA-bPEA; conversely, on 2-
pot samples cells were widely spread as on PEA (Figure 4.8 A and B). The number 
of focal adhesions were observed to increase on 2-pot samples relatively to PLLA 
and spin-coated PEA, while cells behaved on 1-pot samples as on PLLA (Figure 
4.8C). This indicates that 1-pot pyridinolysis based functionalisation does not 
produce adequate coverage with PEA brushes to facilitate similar levels of cellular 
adhesion as shown by 2-pot SI-ATRP.  
104 
 
C
y
to
x
ic
it
y
 (
%
)
P L L A 1 -p o t
P L L A
-B r
2 -p o t
P L L A
-B r
1 -p o t
P L L A
-bP E A
2 -p o t
P L L A
-bP E A
M e d ia 2 %
T r ito n
-2 5
0
2 5
5 0
7 5
1 0 0
1 2 5
1 5 0
 
Figure 4.6. Cytotoxicity. Cytotoxicity of media incubated with each sample to  
cells, normalized to 2% triton x100 and media toxicities. Graphs show mean values 
and standard deviation, n=3. 
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Figure 4.7. Adhesion of C2C12 cells.  Representative images of adhering C2C12 
cells on FN-coated PLLA, PLLA-bPEA and PEA after 4 hours of culture. Samples 
were stained for actin (green), vinculin (red) and DAPI (blue). Scale bar is 100 μm. 
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Figure 4.8. Cellular adhesion. Characterisation of representative images of 
C2C12 cells seeded onto 10 µg mL-1 coated surfaces for 4 hours. (A) Average cell 
size. (B) Average cell circularity. (C) Number of focal adhesions. (D) Graphs show 
mean values and standard deviation, n≥15. *p < 0.05, **p < 0.01, ***p < 0.001, ****p 
< 0.0001. 
 
4.4. Discussion 
 Here we have presented the characterisation of the attempted production 
of an optimized SI-ATRP methodology with a 1-pot bromination, streamlined to 
avoid aminolysis and instead utilizing an in situ pyridinolysis procedure for initial 
surface functionalization and subsequent initiator immobilization within the same 
reaction vessel. We have compared this 1-pot mechanism to the 2-pot bromination 
(aminolysis followed by initiator immobilisation in two separate reaction vessels) 
to assess its efficacy in the formation of functional PEA brush formation and in the 
retention of favourable PLLA characteristics.  
  Characterisation of the modified surfaces showed that while 1-pot 
bromination did not impact on the RMS roughness of the PLLA-bPEA samples 
(Figure 4.1A), it did significantly increase their hydrophobicity (Figure 4.1B). This 
already suggests a distinct surface chemical composition compared to the 
previously established PLLA-bPEA samples obtained following a 2-pot bromination. 
This was further confirmed via XPS characterisation (Figure 4.5), which showed a 
high abundance of sp2 hybrid carbon bonding on 1-pot surfaces, corresponding to 
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the cyclic pyridine binding to the surface. This suggest that pyridine is directly 
bound instead of the amine groups in this 1-pot mechanism and that adequate 
amine densities on the 2-pot samples has an inhibitory impact on ATRP 
pyridinolysis. While these 1-pot surfaces possessed bromine and nitrogen peaks 
post immobilisation (Figure 4.5B), similarly to 2-pot samples, it was not clear 
whether PEA had successfully been polymerised onto 1-pot surfaces (Figure 4.5 C 
and D). This may be due to masking of the PEA spectra from excess initiator or 
could indicate a less abundant immobilisation providing lower surface 
presentation of polymerisation sites.  Evaluation of the bulk film chemistry, via 
FT-IR (Figure 4.4), highlighted similar addition of chemical groups on both 1-pot 
and 2-pot PLLA-Br, however did suggest retention of these initiator immobilised 
groups on 1-pot PLLA-bPEA (Figure 4.4B). Therefore, it could be suggested that 
while 1-pot initiator immobilisation is functional, it does not present sufficiently 
activated initiator to facilitate polymerisation of EA to the same extent as amine-
based SI-ATRP. This may occur due to the presentation of N-terminal ligands in 
pyridinolysis based ATRP, it has been shown that ligand activity depends on linking 
units (C4 << C3 < C2), topology (cyclic ~ linear < branched) and nature (aryl amine 
< aryl imine < alkyl imine < alkyl amine ~ pyridine) (Tang and Matyjaszewski 2006). 
Therefore, it can be speculated that diminished PEA brush production may result 
from poor presentation of the potentially highly linked cyclic pyridine ligands 
produced via pyridinolysis, in interactions with the copper (Cu) based SI-ATRP 
developed (Braunecker and Matyjaszewski 2007). In this case additional 
immobilisation reactions on the immobilised pyridine, increasing the linking units 
while retaining the cyclic structure would inhibit the inherent activity of pyridine 
based ligands. Dielectric relaxation spectroscopy for both PLLA-bPEA surfaces 
confirmed the presence of supplementary relaxation peaks on treated PLLA 
(Figure 4.5A); this could indicate the inclusion of PEA onto 1-pot PLLA-bPEA at a 
lower concentration that on 2-pot surfaces. However, further characterisation of 
these DRS measurements must be carried out to confirm that this added relaxation 
is exclusively conferred by PEA brushes rather than potentially retained pyridine 
sidechains bound to the surface (Potolinca, Buruiana et al. 2017). Hence, from 
chemical analysis of 1-pot SI-ATRP we are able to speculate that while PEA brushes 
may be formed, they are not evident in either the XPS or FT-IR spectra, which 
suggests the retention of initiator immobilised onto the surface of PLLA (Figure 
4.9).  
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Figure 4.9. Proposed 1-pot SI-ATRP system. A general mechanism of controlled 
2-pot functionalisation of PLLA and subsequently successful PEA brush 
polymerisation. Pyridine based functionalisation of surfaces and subsequent 
immobilisation of initiator (BIBB) is suspected to occur uncontrolled within the 
reaction vessel inhibiting the reactivity of the initiator. This results in retention 
of 1-pot initiator post polymerisation and inefficient PEA brush formation.   
   Mechanical properties of 1-pot samples also show variability compared to 
2-pot samples in certain aspects. While stiffness is maintained within the same 
mega pascal range as pristine PLLA and 2-pot PLLA-bPEA, there is a distinct 
increase in the Young’s modulus (Figure 4.1C). This is suspected to be a result of 
the different chemical composition of the material surface, which provides 
additional mechanical stiffness to the PLLA. This changed surface chemistry may 
also explain the diminished degradation rate (Figure 4.1D). The hydrophobic 
chemical composition of the 1-pot PLLA-bPEA surfaces may present a barrier for 
proteinase K to diffuse through to degrade the bulk PLLA film. To further 
investigate this, extended times of degradation would need to be considered, as 
this characteristic was not observed at 96 hours of degradation. Thermal analyses 
showed that PLLA-bPEA produced from both methodologies retain the same glass 
transition and melting temperatures (Figure 4.2) and possess similar thermal 
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stability (Figure 4.3). On the other hand, 1-pot PLLA-Br possessed similar 
crystallinity potential to bulk PLLA and not the increased potential measured in 
2-pot PLLA-Br samples (Figure 4.2 B, second heating). This suggests again that the 
1-pot pyridinolysis methodology does not immobilize initiator in the same form or 
density as 2-pot SI-ATRP, as was also observed via XPS (Figure 4.5B). This may 
suggest that bromine immobilised via the 2-pot mechanism is able to act as a 
nucleation point not presented by 1-pot brominated samples. Additionally 
increased crystallinity of 1-pot PLLA-bPEA samples compared to pristine PLLA, 
produced from SI-ATRP (Figure 4.2 B, first heating), without the degradative 
impact of separate 1,6-hexanediamine aminolysis-based functionalisation may 
result in these samples increased bulk stiffness and decreased degradation rate.  
Collectively, these data show that while 1-pot SI-ATRP does not significantly alter 
the thermal properties of produced PLLA-bPEA, the use of pyridinolysis for surface 
functionalisation does influence the early degradation rate and Young’s modulus 
of PLLA-bPEA, and the thermal properties of the produced intermediates.    
Cell behaviour also confirmed a low yield of functional PEA brush formation 
on 1-pot PLLA-bPEA. Indeed, albeit non-cytotoxic as the 2-pot system (Figure 4.6), 
the 1-pot samples do not promote the well-spread, focal adhesion forming 
phenotype that the cells adopt when seeded on 2-pot PLLA-bPEA or PEA (Figure 
4.7). Instead, these cells interact on 1-pot samples as they do on PLLA. This 
suggests an insufficient surface presentation of PEA brushes able to drive 
fibrillogenesis and facilitate enhanced cellular interactions on 1-pot samples 
(Figure 4.8). Therefore, these results indicate that the 1-pot PLLA-bPEA is not an 
appropriate system for the modification of PLLA and should not be further utilised 
for tissue regenerative purposes. Cells were observed to be much more rounded 
and possessed less apparent actin filaments on PLLA treated with 10 µg mL-1 FN 
(Figures 4.7 and 4.8) compared to identical surfaces treated with 20 µg mL-1  FN 
(Figure 3.7). Additionally PLLA-bPEA was observed to facilitate increased numbers 
of FA comparatively to PEA at lower FN concentrations (Figures 3.9 and 4.8). 
Potentially the thicker FN nanonetworks (Figure 3.3 and 3.4) formed on these 
surfaces require less protein to facilitate improved cellular adhesion than PEA.  
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 4.5. Conclusion 
 The alternative methodology, based on pyridinolysis, presented in this 
chapter to try and streamline the SI-ATRP procedure, was observed to confer to 
the modified samples slightly increased stiffness and resistance to short-term 
degradation, while maintaining thermal capacitance and stability. However, it did 
not provide sufficient densities of chemically functional initiation sites for 
polymerisation of ethyl acrylate. This short-coming of the 1-pot system is a critical 
issue in its development for tissue engineering applications. While potential 
optimization of this system and continued characterisation of the produced 
samples could be conducted to address this issue, these are not required since we 
have confirmed that 2-pot SI-ATRP is instead functional.   
 
 
 
 
 
 
 
 
 
 
 
5. Growth factor presentation on PLLA-bPEA 
and translation from 2D to 3D scaffolds 
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5.1. Introduction 
In order to assess the translation potential of the SI-ATRP system developed 
and optimised in Chapters 2 to 3, we aim here to apply the developed methodology 
to three-dimensional scaffolds composed of medical grade PLLA and relevant for 
future clinical use in regenerative medicine, particularly for bone regeneration. 
The final objective is to produce fully biocompatible and implantable 3D PLLA 
scaffolds on which the FN nanonetworks induced by the grafted PEA brushes would 
be able to interact with the cells, ideally mesenchymal stem cells of the host, 
enhancing their differentiation through further synergistic interaction with locally 
adsorbed growth factors. To achieve this aim, a 3D printing methodology was used 
to manufacture medical grade PLLA scaffolds with controlled architecture and key 
SI-ATRP-mediated characteristic variations to the polymer properties were 
investigated so as to ensure appropriate translation of the system from 2D films 
to 3D scaffolds. In order to exploit the ability of surface-initiated FN nanonetworks 
to sequester and locally present clinically relevant growth factors, we also aimed 
to further characterise our system, ensuring that FN-coated PLLA-bPEA retain the 
enhanced availability of the Heparin II binding domain of FN, in a similar way as 
the improved exposure of the PHSRN motif was retained. Indeed, this domain, 
when exposed, is able to bind and favourably present a wide range of growth 
factors, including BMP-2. This solid-phase presentation of BMP-2 via FN 
nanonetworks has been previously hypothesised and shown to synergistically 
improve osteogenic differentiation of MSCs in vitro and in vivo (Martino and 
Hubbell 2010, Martino, Tortelli et al. 2011, Cantini, Gonzalez-Garcia et al. 2012, 
Llopis-Hernandez, Cantini et al. 2016, Salmerón-Sánchez and Dalby 2016). To 
implement these characterisations several methodologies utilised with the 2D 
films were repeated to compare the properties of 3D scaffolds to their 2D 
counterparts. The Hep II growth factor binding domain availability was 
investigated along with the abundance and localisation of BMP-2 molecules on the 
PLLA-bPEA surfaces. Finally, MSCs were cultured on 2D and 3D PLLA-bPEA samples, 
with the aim to establish the potential for the developed SI-ATRP methodology to 
induce controlled differentiation in the cell type that would be used in vivo.  
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5.2. Material and methods 
 
5.2.1. Preparation of 3D PLLA-bPEA scaffold: Circular scaffolds were designed 
(BioCAD software, Regen HU) with 90° perpendicular fibres between layers 
allowing for ~0.05 mm2 pore size, to ensure sufficient diffusion of cells and 
solutions to the centre of the scaffold. Scaffolds were designed with a diameter 
of 10 mm and 1 mm height, made up of 8 individual crossing layers. Medical grade 
PL18 PLLA (Corbion PURAC) pellets were purchased for the production of the 
scaffold. Printing was performed in a RegenHU 3D Discovery bioprinter within a 
custom-built enclosure with an air temperature of 27°C and 35% relative humidity. 
First, PLLA pellets were melted at 210°C for >2 hours, extrusion was performed 
with a speed of 12 rpm, needle gauge of 0.33 mm, needle temperature of 200°C 
and 2 bar extrusion pressure to produce a fibre thickness of  0.15 mm and a line 
space of 0.16 mm.  
 Produced 3D PLLA scaffolds were SI-ATRP treated as previously described, 
with the exclusion of magnetic stirring during bromination and polymerisation and 
extension of all washing steps to a minimum of 144 hours and extensive vacuum 
drying for > 20 hours at room temperature to remove excess washing solutions.   
5.2.2. Atomic force microscopy: Atomic Force Microscopy was used to visualise 
topology before and after FN coating in all conditions on samples in air conditions. 
FN-coated samples were rinsed with water after FN adsorption and gently dried 
with a nitrogen flow, for imaging in air. Height and lock-in phase images were 
taken in AC mode using a Nanowizard 3 Bioscience AFM (JPK, Berlin Germany). 
Scans were made using cantilevers with a resonance frequency of 75 kHz and a 
force constant of 3 N m-1 (MPP-21120 from Bruker, Billerica, MA).  
Force spectroscopy curves were obtained, after calibration of cantilever 
sensitivity and spring constant, using ~30 Nm-1 cantilevers with a 20 µm diameter 
spherical silica tip. The cantilever was approached to the surface with a constant 
speed of 2.0 µm s-1, at room temperature in ambient conditions, and the Young’s 
modulus was calculated using a Hertz model to an indentation depth of 15 nm (JPK 
DP software).  
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5.2.3. Ninhydrin assay: A ninhydrin colorimetric method was utilised to quantify 
the amount of available amine groups bonded onto the surface of the aminolysed 
PLLA samples (PLLA-NH2). Samples were immersed in 1 ml of ninhydrin solution, 
prepared by mixing 40 ml of 0.35M hydrinatin dihydrate and 4.49M ninhydrin in 
ethylene glycol with 10 ml of 0.04M lithium acetate buffer at pH 5.2. The samples 
were then heated to 90°C for 20 minutes and subsequently diluted with 9ml 1:1 
2-propanol: deionised water solution. The 2-propanol solution stabilised the blue 
compound created from the reaction between ninhydrin and amine groups on the 
PLLA samples. The vials were then vigorously vortexed to include any chromatic 
sediments and elutes were pipetted into a 96 well plate were the absorbance at 
566 nm was read using Tecan NanoQuant Infinite M200 Pro plate reader 
(Männedorf, Switzerland).  
5.2.4. Average area of pores within scaffolds:  Variations in scaffold pore 
architecture were analysed by imaging the individual scaffolds after each step of 
SI-ATRP (including the related washing protocol and vacuum drying). Samples were 
imaged using a Carl Zeiss™ Stemi 2000-C Stereo Microscope (Zeiss) and images 
were analysed utilizing ImageJ to determine the cross-sectional pore area.  
5.2.5. Enzymatic degradation: Individual samples were dried to constant weight 
under vacuum for a minimum of 2 days, samples were then submerged in 0.2 mg 
mL-1 proteinase K enzyme (Sigma, St. Louis, MO) in Tris-HCL buffer (pH 8.6) with 
0.2 mg mL-1 sodium azide (Sigma, St. Louis, MO). Incubated samples were kept at 
37oC with agitation. The degradation solution was replaced every 24 hours to 
maintain enzymatic activity. Samples were dried under vacuum to constant weight 
before final weight was established.  
5.2.6. X-ray photoelectron spectroscopy: X-ray Photoelectron Spectroscopy was 
used to identify the surface chemical composition of samples. All X-ray 
photoelectron spectra were obtained at the HarwellXPS, Cardiff University and 
University College London (found at: http://www.harwellxps.uk/). Each sample 
was analysed at three points with a maximum beam size with a Kratos SUPRA XPS 
fitted with a monochromatic Al kα X-ray source (1486.69 eV) (High tension: 15 kV, 
emission current 15 mA) and an electron flood gun charge neutraliser, for Carbon, 
Oxygen, Nitrogen, Bromine and overview spectra. Samples were affixed to stage 
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using carbon tape to attach samples to a microscope slide to ensure full electrical 
isolation from the system. Samples entered the analysis chamber at a pressure 
below 1 x 10-8 Torr. Survey scans were recorded at a pass energy of 160 eV. High 
resolution spectra were recorded using a pass energy of 20 eV.  Analysis of the XPS 
results was conducted with CasaXPS version 2.3.16 (Casa Software Ltd) with 
adjustments for transmission and escape depth included in the VAMAS block 
provided by Harwell. 
5.2.5 Growth factor adsorption: Prior to growth factor adsorption, fibronectin 
(R&D Systems) solutions of 20 μg mL-1 in Dulbecco's phosphate buffered saline 
(DPBS) were adsorbed onto samples for 1 hour for all applications unless otherwise 
stated. Samples were then rinsed with DPBS, blocked with heat inactivated BSA 
(Roche) for half an hour, rinsed again with DPBS and finally coated with a solution 
of BMP-2 (R&D Systems, 355-BM) in DPBS for 1 hour. The concentration of the BMP-
2 solution was 100 ng ml-1 unless otherwise stated. After growth factor adsorption, 
samples were rinsed with DPBS before use. 
5.2.7. In-Cell Western: Binding domain availability on samples was examined 
using in-cell western (ICW). Fibronectin coated and BMP-2 treated samples were 
blocked with Odyssey blocking buffer (LICOR) and incubated with primary 
antibody, anti-Heparin II domain (Santa Cruz Biotechnologies, sc-18827) or anti-
BMP-2 (R&D Systems, MAB3551) in blocking buffer for 1 hour. Samples were then 
washed 5 times with agitation in 0.1% v/v Tween20/PBS. IRDye® 800CW antibodies 
were then prepared in blocking buffer and samples were incubated for 1 hour. 
After washing as before and drying, measurements were made at 800 nm using an 
Odyssey® system. 
5.2.8. ImmunoGold staining of BMP-2:  Samples were coated with FN at 20 μg 
ml-1 for 10 min, washed twice with PBS and then coated with BMP-2 (R&D Systems, 
355-BM/CF) for 1 hour. Samples were then fixed (4% formaldehyde/PBS) for 30 
min and washed with filtered MilliQ water. Samples were first treated with an 
anti–rabbit BMP-2/BMP-4 primary antibody (Santa Cruz Biotechnology, sc-9003, 
1:50) for 1 hour. Samples were then washed (0.5% v/v Tween 20/PBS) repeatedly 
with agitation before addition of secondary antibody containing 15-nm gold 
particle–conjugated anti-rabbit immunoglobulin (Aurion, 815.011, 1:20) for 1 
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hour. Samples were then washed as before, re-fixed and washed with filtered 
MilliQ water before being dried with a N2 flow. Samples were finally was visualised 
via AFM in AC mode using a Nanowizard 3 Bioscience AFM to localise the adsorbed 
BMP-2 (JPK, Berlin Germany). 
5.2.9. MSC culture: human bone-marrow derived mesenchymal stem cells 
(Promocell) were cultured in Dulbecco's modified Eagle's medium (DMEM, high 
glucose, without pyruvate, Sigma-Aldrich, D5671) with 10% foetal bovine serum 
(FBS, ThermoFisher, 10 500-064), 1% v/v penicillin/streptomycin (Sigma-Aldrich, 
P0781), 1  ×  nonessential  amino  acids  (ThermoFisher, 11  140-035),  and  an  
antibiotic  mix  consisting  of  sodium  pyruvate  (Sigma-Aldrich, S8638),  L-
glutamate  (Sigma-Aldrich, G7513),  and  0.5%  Fungizone  (ThermoFisher, 15 290-
018). Cells were incubated in 37°C, 5% CO2, and harvested by trypsinisation at 
passage 2-3, all cultures were performed in triplicate. Cells were starved of serum 
(media with 1% FBS) overnight before experimentation. 
For MSC cultures, samples were UV sterilised and subsequently all samples were 
coated with 20 μg mL-1 FN for 1 hour, samples were blocked with heat inactivated 
BSA (Roche) for half an hour and then coated with 100 ng mL-1 BMP-2 (R&D 
Systems, 355-BM) for an hour. FN controls were covered in PBS-/- during BMP-2 
coating. Cells were then seeded on the samples at 2 x104 cells cm-2 on 2D surfaces 
and at 1.5 x 106 cells ml-1 within 3D scaffolds for 3 hours in DMEM + 1% P/S + 0.5% 
fungizone. This was then replaced with media containing 1% serum after 3 hours; 
25 ng mL-1 BMP-2 supplements were used to drive osteogenic differentiation and 
added with every subsequent media change, which took place every 2-3 days. 
After 27 days of culture the cells were washed and then fixed with 4% 
formaldehyde for 30 minutes at 4°C. The cells were then permeabilised with 0.1% 
triton X-100, washed and finally blocked (PBS/BSA1%) for 30 minutes at room 
temperature. Samples were first incubated with anti-OCN primary antibody (Santa 
Cruz Biotechnology, sc-73464, 1:50), in blocking buffer for 1 hour at room 
temperature and subsequently washed with washing buffer, PBS/Tween 20 0.5%. 
Cy3-conjugated secondary antibodies (Vector Laboratories) and BODIPI FL 
Phallacidin (Thermo Fisher Scientific) were then added for 1 hour at RT. The 
samples were then washed and mounted with mounting medium containing DAPI 
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(Vector Laboratories, Inc.) and visualised with a fluorescence microscope (Zeiss 
AxioObserver.Z1). Images were merged using ImageJ to localise nuclei and actin. 
5.2.10. Calcium assay: Matrix mineralization was determined by a direct assay 
of total calcium produced by the seeded MSCs after 27 days. Concentration of 
calcium was analysed by complexing o-cresolphthalein complexone (Sigma-
Aldrich, Fluka Analytical), 8-Hydroxyquinoline (Sigma-Aldrich) and alkaline buffer 
reagent (Sigma-Aldrich). A standard calibration curve was established to detect 
dilutions of 0−1600 μg/mL CaCl2·6H2O (Sigma-Aldrich). Measurements of calcium 
were performed according to the following protocol: 500 μL of 1 M HCl was added 
per well to lyse the cells for 24 hours at 37°C. Samples were then collected, and 
the o-cresolphthalein complexone solution was applied to obtain the calcium 
absorbance values which were then converted according to the CaCl2·6H2O 
standard curve. The solutions were pipetted into a 96 well plate were the 
absorbance at 566 nm was read using Tecan NanoQuant Infinite M200 Pro plate 
reader (Männedorf, Switzerland). 
5.2.11. Statistical analysis: Pre-processing and normalization of data are stated 
in the individual methods sections. Analysis of statistical differences was 
conducted using student T-test (Graphpad) for two sample comparison and One-
way ANOVA for different groups using a Turkey HSD post hoc test to compare 
different groups. Differences were considered significant *p < 0.05, **p < 0.01, ***p 
< 0.001, ****p < 0.0001. All data presented are mean values, error bars are 
standard deviation. 
 
 
5.3. Results 
 
5.3.1. Characterisation of 3D medical grade PLLA-bPEA Scaffolds.  
Medical Grade (MG) PLLA was utilised to facilitate future translatability of the 
scaffolds; however, this required establishing the characteristics of this PLLA post 
SI-ATRP treatment. Therefore, several techniques previously used to characterise 
the 2D PLLA-bPEA surfaces (Chapters 2 and 4) were utilised to ensure the 
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successful formation of functional PEA brushes while retaining favourable 
mechanical properties of the bulk PLLA after SI-ATRP treatment.  
Scaffolds were designed in accordance with modern literature, utilising 
established fibre thickness, pore size and geometry currently utilised for bone 
regenerative PLLA scaffolds (Patricio, Gloria et al. 2013, Serra, Mateos-Timoneda 
et al. 2013, Gregor, Filova et al. 2017, Ravi, Shiakolas et al. 2017, Przekora 2019). 
While alternative fibre geometries, such as 45/135° have been utilised in these 
studies the fibre geometry has not been shown to significantly impact on long term 
cellular density, as would be required for osteogenic regeneration (Gregor, Filova 
et al. 2017). Therefore, an established polymer architecture of 0/90° (Figure 5.1) 
interconnected fibres with ~150 nm fibre thickness was designed, to allow for 
sufficient cell invasion and media diffusion while producing standard mechanical 
integrity of the bulk scaffold (Ravi, Shiakolas et al. 2017). PLLA pellets were 
melted at 210°C and upon melting immediately extruded at 200°C, so as to 
minimize damage to the polymer. The pellets were not allowed to cool within the 
extruder, as re-heating and further printing was observed to produce brittle 
discoloured scaffolds, therefore all printing was performed immediately after 
polymer melting. These factors have previously been shown to impact on the 
thermal stability of PLLA, as increased temperature and time of thermal 
processing cause increased thermal degradation rates (Taubner and Shishoo 2001, 
Sodergard and Stolt 2002, Jamshidian, Tehrany et al. 2010). To maintain the 
desired fibre thickness and porosity the extruder was maintained at 12 revolutions 
per minute and a gas pressure of 2000 psi was utilised for printing. These 
parameters produced consistently uniform scaffolds, with defined fibre thickness 
and pore size. 
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Figure 5.1. 3D printer and printing. (A) 3D printer printing scaffolds. Polymer 
melting chamber and extruder (orange) attached to mechanised arm controlling 
printing onto glass cover slips held by vacuum on gantry. (B) Glass slides were 
placed on printer gantry and polymer printed in a continuous line into layers. Red 
arrow representing printing direction. (C) Multiple layers of 90° rotated fibres 
created a lattice structured scaffold.  
While the same principle concept of SI-ATRP was to be maintained when 
translating to 3D scaffolds it was imperative to ensure certain key steps and 
characteristics were retained when altering the bulk MG PLLA used. Therefore, 
firstly upon producing 3D MG PLLA scaffolds were aminolysed, as previously 
implemented in 2D, this produced healthy concentrations of amines introduced to 
the scaffolds. Aminolysis is such an important step as it provides the foundations 
for an abundant and uniform coverage of initiation steps and therefore produced 
polymer brushes on the surface. A high concentration of available surface amine 
groups was observed on 3D PLLA-NH2 surfaces (Figure 5.2A). This concentration of 
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amine groups was higher than on untreated 3D PLLA and all 2D samples; producing 
a 5 fold increase in amine density compared to 2D PLLA-NH2. Both 2D and 3D PLLA 
was observed to possess similar surface amine availability without treatment. The 
high concentration of amines indicates a successful aminolysis of the 3D scaffolds, 
which facilitates further SI-ATRP treatment.  As we have previously noted, SI-ATRP 
produces physical alterations on 2D surfaces, in particular increased surface 
roughening; this was not observed in 3D scaffolds (Figure 5.2 B) as 3D printing was 
observed to produce inherently rougher untreated PLLA (2D ~10.9 nm; 3D ~46.5 
nm) which did not significantly increase upon SI-ATRP treatment (PLLA-bPEA, 2D 
~26.0 nm ; 3D ~40.9 nm). This increased surface roughness was speculated to be 
caused by machining and extrusion during printing, producing a rougher PLLA fibre 
which masks the surface roughening caused by SI-ATRP, as observed in 2D (Figure 
2.4 A). Additionally, with regards to 3D scaffolds we aimed to ensure the retention 
of pore size so as to enable sufficient cell invasion and media diffusion into the 
centre of the scaffold. Therefore to characterise this property samples were 
treated with each step of SI-ATRP and subsequently washed and extensively 
vacuum dried before imaging (Figure 5.2C). The average area of pores within 
scaffolds was observed to vary significantly due to one process, increasing due to 
aminolysis and then reverting post bromination. Therefore we are able to identify 
that in 3D using medical grade PLLA, aminolysis produces the most significant 
surface alteration, as opposed to 2D in which initiator immobilisation is 
responsible for a significant increase in surface RMS. The Young’s modulus of 
individual scaffold fibres, measured via nanoindentation in air with AFM (Figure 
5.2D) was observed to be within the same range as 2D controls measured in the 
same conditions, maintaining for untreated PLLA and for PLLA-bPEA values of ~200 
MPa and ~100 MPa, respectively. Degradation with proteinase K (Figure 5.2E) 
showed similar relationships between PLLA and PLLA-bPEA samples but with 
slightly decreased total degradation percentage with respect to 2D PLLA samples. 
This was unexpected as 3D scaffolds present much higher surface areas, this 
variation between 2D and 3D could be due to altered processing of the bulk 
untreated PLLA before SI-ATRP treatment or variation in the bulk molecular 
weights of untreated bulk PLLAs purchased from different companies. 
Crystallization of 3D scaffolds during printing and subsequently due to SI-ATRP 
treatment may decrease the abundance of amorphous regions of polymer to be 
enzymatically degraded by proteinase K. Overall these results show that core 
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surface and bulk properties are retained when SI-ATRP is performed on 3D 
scaffolds, similarly to what occurred on 2D films    
 
 
Figure 5.2. Physical characterisation of 3D scaffolds. (A) NH2 density on 2D and 
3D PLLA surfaces aminolysed for 10 minutes with 0.06 mg mL-1 1, 6-hexanediamine 
at 40 °C normalized by surface area. (B) RMS roughness values of fibres from 
centre of PLLA and PLLA-bPEA scaffolds.   (C) Average area of pores of SI-ATRP 
treated medical grade PLLA 3D scaffolds after each respective procedural step 
and extensive vacuum drying to remove excess liquids and potential polymer 
122 
 
swelling. Images show whole PLLA scaffold (scale bar 2mm) and examples of 
scaffold pores  for each step of SI-ATRP. (D) Elastic modulus of 3D PLLA and PLLA-
bPEA fibres measured via nanoindentation using AFM in air. (E) Percentage weight 
loss of 3D PLLA and PLLA-bPEA scaffolds after 72 and 96 hours of degradation with 
0.2 mg mL-1 proteinase K at 37oC. Graphs show mean values and standard 
deviation.  *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. 
 As with 2D surfaces, X-ray photoelectron spectroscopy was utilised to 
characterise the surface chemical composition of the top 10nm of the scaffold 
surface and the composition of fibres within cut cross-sections in the middle of 
the scaffolds (Figure 5.3). In the front facing, outer surface area carbon spectra 
of all samples were identical to those found in 2D, highlighting no differences 
between MG 3D scaffolds and 2D samples. As with 2D, PLLA-bPEA samples were 
observed to possess spectra corresponding to a mix of PLLA and PEA, confirming 
that PEA brushes were produced on the surface of the scaffolds. Carbon scans 
taken of the centre of the scaffolds were observed to have the same spectra as 
those on the surface, confirming that SI-ATRP is able to fully permeate the scaffold 
producing PEA brushes on the surface of internal PLLA fibres of the scaffold. In 
addition, the presence of nitrogen and bromine was observed throughout the SI-
ATRP process; primarily, the addition of bromine post initiator immobilisation on 
both the outer surface and the internal fibres shows sufficient diffusion of SI-ATRP 
reagents during treatment. However, it was noted that background nitrogen peaks 
were present on untreated PLLA and retained post polymerisation on PLLA-bPEA. 
The presence of dual nitrogen peaks on PLLA-Br could result from this background 
nitrogen being retained and/or interacting with the aminolysis reagents, 1, 6-
hexanediamine, or pyridine during immobilisation. The inclusion of a secondary 
nitrogen binding environment may result in further binding of bromine during 
initiator immobilisation producing the two observed Br3D peaks; however this does 
not produce non-functional initiator as all bromine peaks are removed post 
polymerisation. While this underlying nitrogen may result from the stock MG PLLA, 
the inclusion of a secondary peak and the presence of defined nitrogen peaks in 
PLLA-Br, potential due to retention of unused aminolysis sites, indicate that 
aminolysis is also able to fully diffuse through the entire scaffold and does not 
only occur on the surface of the scaffold. These XPS results are able to show the 
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successful production of PEA brushes on the surface and within the 3D PLLA 
scaffolds.  
  
 
 
Figure 5.3. C 1s, O1s, N1s and Br3d core-level spectra. Showing the front face 
and segmented centre of the scaffold of PLLA, PLLA-Br and PLLA-bPEA. In all XPS 
spectra the red curve represents the experimental data. Each section shows the 
carbon spectra (C1s), simply peak fitted as C-C bonding (pink and blue), C-O-C 
bonding (blue) and O-C=O group (red). Nitrogen (N1s) and Bromine (Br3D) spectra 
have been peak fitted where appropriate and indicate the presence of the 
respective element on the top 10nm of the surface.  All carbon spectra range from 
124 
 
281-291 eV, nitrogen from 392 – 410 eV and Bromine from 179- 196 eV, counts per 
second vary between samples and conditions. Each spectra is representative of 3 
replicate scans from each sample, represented below in each corresponding 
cartoon of scaffolds. Front scans represents scanning the external surface of the 
scaffold, while side scans are taken from the centre of cut scaffolds, as indicated 
by the red circle.  3D scaffold representative images created in Tinkercad, 
Autodesk 123D software. 
 
To further confirm the presence and functionality of the PEA brushes produced 
on the surface of the fibres of the PLLA-bPEA scaffolds AFM was performed to 
visualise FN organisation after adsorption. Fibres from the centre of the scaffolds 
were removed and surface topology was visualised via AFM; afterwards, these 
surfaces were then coated with FN. The AFM images (Figure 5.4) show rough PLLA 
surfaces, with areas of varying phase, most likely due to machining marks 
produced during extrusion in the printing process. When treated with FN no 
nanonetworks are observed on PLLA surfaces, however on PLLA-bPEA areas of 
interconnected nanonetworks can be observed, showing that PEA brushes are able 
to trigger fibrillogenesis in 3D MG PLLA-bPEA scaffolds.    
Figure 5.4. AFM of 3D printed fibres before and after FN coating.  Height and 
phase images from tapping mode AFM of struts from 3D (A) PLLA and (B) PLLA-
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bPEA before and after coating with 20 μg mL-1 FN for 1 hour at room 
temperature in dry conditions. Fibres were taken from centre of scaffold, see 
sketch Figure 5.2. Scale bar is 100 nm.  
 
5.3.2. Growth factor binding to PLLA-bPEA 
The ability of PEA brushes produced from SI-ATRP to drive FN fibrillogenesis 
has been shown to favourably expose cryptic binding domains associated with 
nanonetwork formation and cellular adhesion. While enhanced cellular adhesion 
is desirable, for regenerative medicine applications it is also important to actively 
drive cellular differentiation. This can be achieved by efficient binding and 
presentation of specific growth factors, such as BMP-2 for osteogenic 
differentiation.  In order to assess the ability of the FN nanonetworks formed on 
PLLA-bPEA to sequester BMP-2, polymer films and 2D spin-coated SI-ATRP treated 
PLLA surfaces were investigated using ICW, AFM and immunogold antibody staining 
to determine the availability of the GF binding domain on FN, the binding of BMP-
2, and the location of the bound GF. The availability of the growth factor binding 
domain (Hep II) of FN on PEA and PLLA-bPEA was observed to be higher than on 
PLLA (Figure 5.5A), indicating that this cryptic FN region is favourably exposed 
when FN is in fibrillar conformation (Martino, Tortelli et al. 2011, Llopis-
Hernandez, Cantini et al. 2016). The relative concentration of BMP-2 on PLLA-
bPEA samples was also higher than on both PLLA and PEA (Figure 5.5B), which was 
unexpected as we have previously shown that the total amount of adsorbed BMP-
2 is not impacted by the formation of a FN nanonetwork (Llopis-Hernandez, 
Cantini et al. 2016). This suggests that the nanonetworks formed via PEA brushes, 
having shown to be composed by thicker and less interconnected fibrils than on 
PEA are potentially able to bind higher amounts of BMP-2. To further investigate 
BMP-2 binding on PLLA-bPEA, samples were treated with FN and BMP-2 before 
being fixed and immunostained with 15 nm immunogold nanoparticles targeting 
BMP-2 molecules (Figure 5.5 E and D). The co-localisation of BMP-2 to the FN 
nanonetworks was analysed via AFM. On scPLLA-bPEA samples, BMP-2 could be 
observed to clump onto the FN fibrils, while these large features were not 
observed on stained PLLA-bPEA samples without BMP-2. The BMP-2-immunogold 
complexes are much more pronounced than FN nanonetworks and show altered 
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phase profiles than FN fibres. This shows that FN fibrils formed via adsorption of 
the protein on PLLA-bPEA samples are able to favourably present the growth 
factor binding domain, similarly to those found on PEA, but are also able to bind 
a higher concentration of BMP-2 molecules, which co-localise with the FN 
nanonetworks.  
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Figure 5.5.  Growth factor binding on 2D scPLLA-bPEA surfaces. (C) Sketch of 
fibrillar FN highlighting growth factor binding domain and 3D cartoon of FN GF 
binding region (FNIII12-14); the binding sequence of Heparin II domain, recognised 
by HepII is highlighted by red arrows. Adapted from PBD ID: 1FNF (Leahy, Aukhil 
et al. 1996). (A) Quantification of the availability of the growth factor binding 
domain on FNIII12-14, as measured by HepII binding via ICW. Performed on spin-
coated PEA, PLLA films and PLLA-bPEA films. (B) Relative surface density of 
adsorbed BMP-2 on FN treated PLLA, PLLA-bPEA and PEA measured via ICW. 
Performed on spin-coated PEA, PLLA films and PLLA-bPEA films. (C) Sketch of 
fibrillar FN highlighting growth factor binding domain and 3D cartoon of FN GF 
binding region (FNIII12-14); the binding sequence of Heparin II domain, recognised 
by HepII is highlighted by red arrows. Adapted from PBD ID: 1FNF (Leahy, Aukhil 
et al. 1996). (D) Sketch of spin-coated PLLA-bPEA surfaces, treated with 20 μg mL-
1 FN and 100 ng mL-1 BMP-2 and subsequently immunostained for BMP-2 with 
Immunogold nanoparticles. These nanoparticles protrude from the surface 
highlighting the localisation of BMP-2. (E) Height and Phase AFM images of 20 µg 
mL-1 FN treated PLLA-bPEA samples with and without BMP-2 adsorption. 3D images 
show the areas of increased height caused by the presence of BMP-2-bound gold 
particles of 15 nm diameter. AFM height and phase relative scales have been 
modified to be within the same range so as to allow for visual comparison. Scale 
bars are 200 nm and 1 µm. Performed on spin-coated PLLA and PLLA-bPEA.  Graphs 
show mean values and standard deviation.  ***p < 0.001, ****p < 0.0001. 
 
 
5.3.3. MSC differentiation  
 Having identified that PLLA-bPEA is able to favourably induce exposure of 
GF binding domains, bind BMP-2 and that 3D MG scaffolds are not cytotoxic to 
cells (Figure 5.6), both 2D and 3D samples were utilised in MSC differentiation 
assays, to ascertain whether SI-ATRP-treated samples were able to facilitate 
controlled osteogenic differentiation via the presentation of BMP-2. Due to the 
opacity and mechanical properties of PLLA and PLLA-bPEA scaffolds, 
immunostaining was not performed on 3D scaffolds, as neither confocal imaging 
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nor histological sectioning were available as potential methodologies to visualise 
cells within the scaffolds. Therefore, immunostaining of actin (green), osteocalcin 
(OCN) (red) and nuclei (blue) were performed on 2D surfaces (Figure 5.7 and 5.8). 
MSC cells were observed to spread on all surfaces, although the actin cytoskeleton 
was more developed on PEA containing surfaces, suggesting that as with myoblast 
cells the FN nanonetworks are able to improve cellular interactions. BMP-2 treated 
surfaces were noted to possess increased deposition of osteocalcin, a signalling 
protein indicating mature osteoblast differentiation and bone matrix production 
(Aubin 2001). Clusters of OCN can be noted in both PEA and PLLA-bPEA samples 
coated with BMP-2 (Figure 5.7); these are clearer at higher magnification (Figure 
5.8). These results show that PLLA-bPEA surfaces coated with FN and subsequently 
with BMP-2 are able to drive osteogenic differentiation of MSCs similarly to bulk 
PEA. ` 
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Figure 5.6. Cytotoxicity. Cytotoxicity of media incubated with each 3D sample 
to MSC cells, normalized to 2% triton x100 and media toxicities. Graphs show mean 
values and standard deviation, n=3. 
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Figure 5.7. Osteogenic differentiation of hMSCs on 2D surfaces.  Representative 
images of MSCs on FN or FN and BMP-2 coated PLLA and PLLA-bPEA after 27 days 
of culture. Samples were stained for actin (green), osteocalcin (red) and DAPI 
(blue). Scale bar is 100 µm. 
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Figure 5.8. Secretion of osteocalcin by hMSCs on 2D surfaces.  Representative 
images of MSCs on FN and BMP-2 coated PLLA and PLLA-bPEA after 27 days of 
culture. Samples were stained for actin (green), osteocalcin (red) and DAPI (blue).  
 
To characterise osteogenic differentiation in 3D scaffolds a calcium assay 
was performed to analyse the mineralization potential of the differentiated MSCs. 
No significant amounts of calcium phosphates were observed on 2D surfaces, or in 
3D PLLA-bPEA scaffolds without GFs (Figure 5.9). The concentration of calcium 
phosphates was observed to significantly increase when cells were incubated 
within 3D PLLA-bPEA scaffolds pre-treated with BMP-2. This increased 
mineralization in 3D can be correlated to FN nanonetwork-mediated BMP-2 
presentation, as PLLA coated with FN and BMP-2 does not show this increase. This 
suggests that 3D PLLA-bPEA scaffolds are able to outperform their 2D counterparts 
by presenting increased surface area of produced brushes to individual cells.  
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Figure 5.9. Mineralisation by MSCs on 2D and 3D biomaterials.  Deposition 
of calcium phosphates by MSCs cultured on (A) 2D surfaces and (B) 3D 
scaffolds after 27 days with and without initial BMP-2 (BMP-2-/+) coating of 
100 ng mL-1 and subsequent supplements of 25 ng mL-1 with each media 
change. Cells were removed via freeze-thawing and matrix calcium 
phosphate was solubilized via overnight incubation in 1M HCL. Calcium 
phosphate concentrations are quantified via comparison to a standard 
curve.  Graphs show mean values and standard deviation.  *p < 0.05, ***p < 
0.001. 
 
5.4.  Discussion  
In this chapter, we have translated our ARGET SI-ATRP from a 2D model 
system to 3D medical grade scaffolds able to support the growth and 
differentiation of MSCs, with the objective of establishing the potential of this 
methodology for regenerative medicine applications.  
Initially, the design and production of 3D PLLA-bPEA scaffolds was 
optimized to maintain key surface properties such as initial amine group 
functionalisation and pore size. The developed printing programme produced 
consistently uniform medical grade PLLA scaffolds with a defined pore size that 
maintained their mechanical strength as compared to PLLA films. Application of 
the established SI-ATRP process, firstly utilising aminolysis, showed successful 
incorporation of amine groups allowing for a significantly higher density of 
available amine comparatively to 2D surfaces. The bulk surface modification was 
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investigated so as to maintain a similar pore size post treatment allowing for 
effective cellular invasion and media diffusion into the centre of scaffold.  The 
retention of interconnectivity and porosity, signified by the average area of pores 
are vital for ensuring that the produced polymer architecture of the scaffold is 
able to facilitate cellular proliferation, migration, nutrient transfer and in vivo 
tissue colonization, which have been shown to be ideal for tissue engineering 
purposes (Polo-Corrales, Latorre-Esteves et al. 2014, Velasco, Narvaez-Tovar et 
al. 2015, Gregor, Filova et al. 2017).  
The mechanical properties were examined by AFM nanoindentation and 
enzymatic degradation, these showed comparably similar results to 2D PLLA and 
PLLA-bPEA. Nanoindentation, performed on individual polymer fibres, showed 
Young’s moduli within the same general range as 2D films, both before and after 
SI-ATRP treatment. This suggests that while a different medical grade polymer 
was utilised, the core mechanical properties are maintained and SI-ATRP does not 
dramatically alter this characteristic, as we have previously shown in 2D. As we 
found with the 2D characterisation the slight decrease in Young’s modulus can be 
correlated to the chemical lysis of the lactide backbone during the aminolysis 
procedure (Zhu, Gao et al. 2004). Therefore, while there is an increased amine 
group deposition comparatively to 2D surfaces, due to increased surface area, 
there is no distinguishable deterioration of mechanical stiffness. Enzymatic 
degradation, utilising proteinase K, resulted in a similar degradation profile as 
found in 2D, but the 3D scaffold were observed to degrade slightly slower than 
their 2D counterparts. Maintenance of the degradation rate is vital when 
developing an implantable scaffold as it allows for the scaffold to structurally 
support the tissue to be regenerated after implantation, while gradually 
reintroducing physical function to cells in situ through tuneable degradation 
(Armentano, Dottori et al. 2010, Ulery, Nair et al. 2011, Saito, Liao et al. 2013, 
Velasco, Narvaez-Tovar et al. 2015). The surface and bulk characterisation show 
a clear and successful translation of the SI-ATRP. Generally, the conservation of 
the bulk characteristics of the printed PLLA scaffolds suggests that SI-ATRP is able 
to facilitate the desired surface modification while maintaining both stiffness 
values and degradation profiles, therefore allowing for the continued optimization 
of the system for regenerative medicine applications. Additionally, mechanical 
testing of the full scaffold, could be performed to further evaluate bulk 
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mechanical properties. Porosity and geometry of the scaffold have been shown to 
impact on the mechanical strength and degradation and therefore modification of 
these architectural properties may provide a potential further optimisation 
potential for this system (Ravi, Shiakolas et al. 2017). Therefore, maintenance of 
these mechanical characteristics post-SI-ATRP modification, unlike photo-induced 
grafting reactions of PLLA blends (Rasal and Hirt 2009, Hoglund, Hakkarainen et 
al. 2010), provides the potential for modulation of scaffold stiffness dependant to 
polymer architecture.  
Chemical analysis via XPS confirmed successful grafting of PEA brushes 
within the entirety of the scaffold. To ensure that SI-ATRP reagents and reactions 
were able to diffuse and produce PEA brushes, cross sections of the samples were 
made, allowing for chemical analysis of the central part of the scaffold. As found 
in 2D, carbon binding regions of the surface closely resembled those of bulk PEA, 
highlighting that SI-ATRP had been performed on the outer extremities of the 
scaffold. PEA C1s spectra were also present within the scaffold, which confirmed 
that SI-ATRP is able to diffuse throughout the scaffold fibres and present PEA 
brushes in a 3D environment to enclosed cells. The presence of nitrogen and 
bromine peaks within PLLA-Br scaffolds reinforces the utility and versatility of SI-
ATRP, as these data show that all key steps of SI-ATRP occur homogenously 
throughout the scaffold. The inclusion of additional N1s and Br3D peaks on both 
PLLA and PLLA-Br, comparatively to 2D PLLA films, are suspected to be chemical 
remnants from increased aminolysis on 3D samples. This would suggest that not 
all available amine groups are utilized during bromination, potentially requiring 
longer times of initiator immobilisation. In either case, these supplementary peaks 
are removed post polymerisation and corresponding carbon peaks are not 
drastically altered as they were observed to be in 1-pot SI-ATRP. Therefore we 
are able to identify that SI-ATRP is able to successfully produce PEA binding motifs 
both on the surface and within the scaffold. The diffusion of SI-ATRP through the 
entire scaffold, producing PEA brushes within the centre, shows the viability of 
this system, allowing for the control of external and internal scaffold surface 
features, which has previously been an issue for polymeric scaffold (Kosik-Koziol, 
Graham et al. 2019). 
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Biological functionality of the PEA brushes on the 3D scaffolds was 
evaluated via AFM, and demonstrated by the presence of FN nanonetworks. Tightly 
packed FN nanonetworks were observed on 3D printed fibres from the central part 
of the scaffold. These densely packed networks may be more clustered than found 
on scPLLA-bPEA, due to the increased surface roughness or curvature of the fibre. 
However, the presence of these networks on 3D scaffolds highlights the efficient 
translation of the SI-ATRP to 3D and indicates a potentially improved modification 
allowing for the identification of FN nanonetworks from rougher polymer surfaces 
rather than on relatively smooth spin-coated PLLA, as was observed in 2D. 
Fibronectin has been shown to improve cellular adhesion on PLLA scaffolds 
previously (Cronin, Thurmond et al. 2004, Islami, Mortazavi et al. 2018), although 
these studies did not aim to define or modify the secondary structure of the ECM 
protein. Surface modification to further improve the biofunctionality of PLLA and 
similar polymers (Wan, Yang et al. 2003, Ding, Chen et al. 2004, Ho, Hou et al. 
2006), such as PCL (Declercq, Desmet et al. 2013, Cheng, Alba-Perez et al. 2019), 
has shown enhanced FN-related activity and thus growth factor presentation and 
cellular interactions. SI-ATRP, as a surface modification methodology has been 
shown to homogenously modify surfaces, producing whole PEA brushes and defined 
FN nanonetworks within the centre of the scaffolds. This has been highlighted as 
an issue for plasma polymerisation due to fragmentation of polymer (Cantini, Rico 
et al. 2012), removal of surface modification due to plasma induced etching (Ding, 
Chen et al. 2004) or penetrance of plasma treatment into 3D scaffolds (Barry, Silva 
et al. 2005, Canal, Khurana et al. 2016). Indeed, penetrance of surface 
modification techniques through scaffolds has been shown to be an issue for both 
plasma and wet-chemical deposition (Barry, Howard et al. 2006, Cools, Mota et 
al. 2018), which we have shown via XPS and the presence of FN nanonetworks on 
fibres taken from the centre of scaffolds to not apply to this SI-ATRP system. 
While we had shown a direct translation of the SI-ATRP system to a 3D 
scaffold, the ability of the bPEA-driven FN nanonetworks to sequester and 
synergistically present BMP-2 had still to be demonstrated. This is fundamental to 
further characterise the functionality of the SI-ATRP-treated samples for bone 
regeneration (Figure 5.10). Hence, the availability of the growth factor binding 
domain on FN and the binding and co-localisation of BMP-2 was examined on 2D 
scPLLA-bPEA samples. InCell Western results showed that both PEA and PLLA-bPEA 
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samples are able to drive enhanced availability of the heparin II growth factor 
binding domain. While this increased binding domain availability does not 
facilitate higher concentrations of bound BMP-2 on PEA comparatively to PLLA 
controls, on PLLA-bPEA a higher concentration of BMP-2 is found. Potentially the 
increased thickness and height of FN nanonetworks as found on PLLA-bPEA may 
allow for improved accessibility of GF binding domains on these networks 
facilitating increased concentrations of BMP-2 binding. This increase in GF binding 
comparatively to spin-coated PEA has been shown previously on PEA plasma 
coated PCL surfaces (Cheng, Alba-Perez et al. 2019), which also produced thicker 
nanonetworks than on scPEA. Suggesting that much like as plasma surface 
modification has shown to introduce enhanced GF presentation properties to PCL, 
SI-ATRP may profess similar properties to PLLA.    
 
Figure 5.10. Outline of general BMP-2 signalling transduction. From 
Beederman et al, 2013, BMP signaling in mesenchymal stem cell differentiation 
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and bone formation,  Journal of Biomedical Science and Engineering volume 6(8A): 
32–52. (2013)(Beederman, Lamplot et al. 2013) 
To characterise the localisation of BMP-2 on these nanonetworks, samples 
were fixed and stained with BMP-2 targeted immunogold particles of 15 nm 
diameter. BMP-immunogold nanoparticles were observed to bind in high densities 
on FN, identified by areas of dramatically increased height and altered phase, no 
such immunogold particles were observed on samples without BMP-2 treatment. 
This correlates with previous surface modification techniques utilised for BMP-2 
recruitment on FN (Llopis-Hernandez, Cantini et al. 2016, Cheng, Alba-Perez et 
al. 2019), however unlike on these surfaces thicker FN nanonetworks, produced 
from conglomeration of FN fibrils on individual PEA brushes may produce areas of 
BMP-2-immunogold clumping.  Generally from 2D scPLLA-bPEA samples we are 
able to show that SI-ATRP is able to increase the availability of fibronectin GF 
binding domain subsequently facilitating increased concentrations of BMP-2 co-
localisation on FN fibrils. This material solid-state presentation of GF has been 
shown to be more effective than administration of soluble GF for tissue 
engineering (Martino, Briquez et al. 2015). The site specific binding of BMP-2 on 
FN allows for synergistic crosstalk between the GFs and integrin receptors, 
enhancing osteogenic regeneration (Martino, Tortelli et al. 2011). This co-
localisation and subsequent synergistic crosstalk, resulting from surface 
modification aimed at whole FN, professes additional benefits compared to 
systems utilising heparin binding peptide fragments as it allows for the induction 
of additional signalling, such as integrin-dependant Smad signalling (Fourel, Valat 
et al. 2016, Llopis-Hernandez, Cantini et al. 2016).   
Having characterised GF binding to SI-ATRP treated FN samples, hMSCs were 
cultured on 2D surfaces and 3D scaffolds. FN and BMP-2 coated 2D PLLA-bPEA 
samples were able to drive osteogenic differentiation after 27 days, as shown via 
identification of extracellular OCN clusters showing mature bone matrix 
formation. These clusters of OCN were abundant on both PLLA-bPEA and PEA and 
not present on PLLA samples, showing that nanonetwork formation and 
subsequent BMP-2 presentation was able to drive cellular differentiation towards 
the osteogenic fate. This is in accordance with previous studies showing the 
osteogenic potential of material-driven fibrillogenesis of FN and subsequent 
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presentation of BMP-2 (Llopis-Hernandez, Cantini et al. 2016, Cheng, Alba-Perez 
et al. 2019), allowing for enhanced transduction of the BMP-2 signalling cascade 
(Figure 5.10). In the 3D scaffolds mineralisation was observed to increase 
significantly only in the presence of FN-mediated BMP-2 presentation via the PEA 
brushes, compared to unmodified PLLA scaffolds with or without FN/BMP-2 
coating or to PLLA-bPEA scaffolds coated only with FN and no BMP-2. This high 
concentration of calcium phosphates indicates formation of mineral bone matrix, 
a process performed by osteoblasts. Research has shown that while high calcium 
concentrations in scaffolds can signify osteogenic differentiation (Raghavendran, 
Puvaneswary et al. 2014, Al-Jarsha, Moulisova et al. 2018), it can also stimulate 
further osteogenic activity in PLLA scaffolds (Niu, Liu et al. 2017).  This difference 
was not measurable on 2D samples, suggesting that while PLLA-bPEA is able to 
favourably bind and present BMP-2 in 2D, this presentation is not as effective as 
in 3D. This suggests that 3D scaffolds may be a more favourable system to direct 
cellular differentiation, as the 3D presentation of PEA brushes, FN nanonetworks 
and BMP-2 molecules may enhance or quicken the osteogenic differentiation 
potential of the system. This behaviour has been shown in other polymer 
osteogenic systems, where the same surface was utilised in both 2D surfaces and 
3D scaffold (Tian, Heng et al. 2008, Persson, Lehenkari et al. 2018). These results 
indicate that osteogenic differentiation is enhanced by the improved biomimicry 
provided by the 3D architecture (Sikavitsas, Temenoff et al. 2001). Indeed, these 
results are similar to plasma polymerisation of PEA onto PCL surfaces to induce 
osteogenesis (Cheng, Alba-Perez et al. 2019). Both these systems utilise BMP-2 at 
lower concentrations than established murine osteogenic models (Shekaran, 
Garcia et al. 2014) and the current clinical gold standard (Woo 2012, Llopis-
Hernandez, Cantini et al. 2016), highlighting the potential for SI-ATRP as a 
methodology for inclusion of additional biofunctionality on established 
biomaterials. In general, long term MSCs differentiation and mineralisation of the 
surrounding extracellular matrix have shown that the 3D PLLA-bPEA scaffolds are 
able to facilitate and drive growth factor-regulated osteogenic differentiation.  
 
5.5  Conclusion  
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  In conclusion, here we have presented the translation of SI-ATRP to 3D 
scaffolds using medical grade PLLA. The PEA brushes produced from this process 
are able to induce favourable presentation of the cryptic growth factor binding 
domains on the adsorbed FN, the binding and subsequent presentation of BMP-2 
to drive mesenchymal stem cell differentiation through the osteogenic pathway. 
This results in an implantable scaffold able to drive osteogenic differentiation and 
mineralisation, further establishing the utility of SI-ATRP for the surface 
modification of biodegradable biomaterials in regenerative medicine.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6. Thesis conclusion and future perspectives 
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6.1. General discussion 
 The aim of this PhD project has been to supplement the functionality of an 
established biodegradable polymer, poly L-lactic acid with polymer brushes of 
poly (ethyl acrylate), which are able to drive fibrillogenesis of fibronectin and 
facilitate enhanced cellular interactions. In this dissertation we have presented 
the development of a surface initiated atomic transfer radical polymerisation 
procedure, utilising an activator regenerated electron transfer mechanism for 
cost-effective, quick and efficient surface modification. We have then 
demonstrated the ability of the produced polymer brushes to control protein 
organisation and growth factor presentation, consequently driving cell response 
in scaffolds for tissue engineering applications.   
 The production and optimization of this system entailed tailoring the SI-
ATRP system to drive brush formation while maintaining favourable bulk PLLA 
characteristics. Preservation of these properties, predominantly the mechanical 
strength and degradation rate, needed for tissue engineering purposes, ensures 
that produced PLLA-bPEA surfaces can be utilised as implantable functional and 
bioactive scaffolds (Ulery, Nair et al. 2011). Initially, the procedure was developed 
and established using 2D PLLA films. Bulk properties of the films were maintained. 
PEA brush formation was optimised by tuning each step of SI-ATRP; aminolysis, 
initiator immobilisation and polymerisation. Initially, aminolysis was optimised 
with respect to duration, temperature and concentration of treatment, and a 
procedure which produced a sufficient coverage of available amine groups on the 
least altered PLLA topography was established (Xu, Zhao et al. 2007, Xu, Yang et 
al. 2011). These aminolysis functionalisation parameters were observed to 
decrease the hydrophobicity of PLLA films, through the incorporation of 
hydrophilic surface amine groups (Zhu, Gao et al. 2004, Tokiwa and Calabia 2006). 
Incorporation of the bromine based initiator was observed to revert the 
hydrophobicity to similar levels as PLLA films although was noted to significantly 
increase surface roughness (Yu and Luo 2011, Kang, An et al. 2018). This change 
in topography was hypothesised to arise from the exothermic bromination 
reaction, which also increased the crystallinity of the bulk PLLA films. While 
crystallinity increased post initiator immobilisation, thermal stability of PLLA was 
not dramatically impacted by SI-ATRP treatment. Ultimately, maintenance of the 
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degradation rate and Young’s modulus of PLLA and PLLA-bPEA confirmed that SI-
ATRP is functionally able to maintain the favourable characteristics of bulk PLLA 
ideal for tissue engineering applications, while implementing controlled surface 
modification. 
Validation of polymer brush formation was performed via chemical analysis 
of SI-ATRP-treated samples. Chemical analysis confirmed the presence PEA on the 
surface of PLLA by incorporation of additional bonding domains attributed to PEA 
as observed via FT-IR, introduction of β relaxation spectra measured via DRS, like 
those found on PEA, and surface chemical composition via XPS corresponding to a 
mix of both polymers. The accumulation of hydroxyl and alkane groups attributed 
to both PLLA and PEA on PLLA-bPEA highlights the addition of similar polymer 
chains via SI-ATRP. By investigating the brominated intermediates via FT-IR, 
chemical modification during initiator immobilisation was confirmed and 
subsequent utilisation of these chemical primer sidechains confirmed post 
polymerisation. XPS surface analysis showed that aminolysis and initiator 
immobilisation were both observed to incorporate elemental nitrogen and 
bromine onto the PLLA, highlighting the efficacy of these reactions. Post 
polymerisation these elements were not present on PLLA-bPEA spectra, which 
presented carbon spectra corresponding to a combination of PEA on a PLLA 
backbone. This PEA formation was observed to be time-dependent, as longer time 
of polymerisation was estimated to increase the total PEA percentage on the 
surface (Ma, Textor et al. 2006). These spectra also confirm fully intact PEA 
polymer formation, showing that SI-ATRP does not result in fragmented or 
damaged chemical chains during polymerisation. The introduction of a β 
relaxation peak on PLLA-bPEA, at approximately -120°C at 11349 Hz, not found on 
PLLA, shows additional chemical chain mobility confirming the incorporation of 
PEA (Ribelles, Duenas et al. 1989). Additionality, it should also be noted that brush 
formation induced increased roughness and produced surfaces with increased 
chemical mobility, comparable to spin-coated PEA controls (Zhu, Zhang et al. 
2002, Liu, Du et al. 2007). We also attempted to streamline the SI-ATRP protocol 
by incorporating initial surface functionalisation and initiator immobilisation in a 
1-pot bromination procedure via pyridinolysis, but the procedure did not yield a 
functional surface modification and was not carried forward in this work.  
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To further develop this system, the SI-ATRP methodology was translated 
from 2D PLLA films to 3D printed biomedical grade PLLA scaffolds. This involved 
the establishment of polymer processing protocols to produce 3D scaffolds. Then, 
the established SI-ATRP protocol was adapted to be used on the scaffolds and the 
resulting materials analysed to ensure, once again, that while PEA brushes are 
being produced, the alterations to the PLLA backbone properties are minimized. 
3D scaffolds were observed to maintain similar mechanical strength and 
degradability to 2D PLLA even after SI-ATRP treatment and PEA brush formation 
was observed on these PLLA-bPEA scaffolds. Indeed, SI-ATRP was noted to 
penetrate the entirety of the porous scaffold, as PEA spectra were observed within 
its centre. 
The biological functionality of produced PEA brushes was assessed via their 
ability to drive fibrillogenesis of fibronectin, a unique property of PEA within this 
system (Salmeron-Sanchez, Rico et al. 2011, Llopis-Hernandez, Rico et al. 2013). 
Fibronectin was observed to form fibrils, which in turn formed nanonetworks on 
both control PEA and PLLA-bPEA, as revealed by imaging via AFM. While these 
nanonetworks possessed slightly diminished fractal dimensions to bulk PEA, their 
presence on SI-ATRP treated PLLA confirms the previously observed chemical 
similarities of brush to bulk PEA. Biologically the FN fibres formed on PLLA-bPEA 
were observed to present binding domains similarly to those exposed upon 
adsorption on conventional radically polymerised PEA (Pankov and Yamada 2002, 
Llopis-Hernandez, Rico et al. 2013). While total protein density and RGD cellular 
binding domain availability were conserved between all sample types (Vanterpool, 
Cantini et al. 2014), the exposure of the PHSRN cell binding synergy motif and of 
the HepII domain, known to recruit and regulate the activity of many growth 
factors, was upregulated on both PEA-presenting surfaces. This confirms that 
PLLA-bPEA surfaces have the potential to support enhanced cell response, via cell 
adhesion strengthening of α5β1 integrins due to PHSRN exposure and via enhanced 
differentiation through synergistic signalling between integrins and growth factors 
receptors due to the proximity of their ligands. While no significant difference 
was noted in the presentation of the synergy or growth factor binding domains 
between PLLA-bPEA and bulk PEA, the density of adsorbed growth factor, 
specifically BMP-2, on SI-ATRP-reacted samples was observed to be significantly 
higher compared to PEA. This could be attributed to the increased thickness of 
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the FN fibres on these surfaces (Rico 2014), providing a higher surface area for 
BMP-2 molecules to bind to. This presentation of the cryptic synergy integrin 
binding domain and of the growth factor binding region, not exposed on PLLA, 
highlights the biological functionality of PEA brushes.  
To confirm the ability of these functional PEA brushes to enhance cellular 
interactions on PLLA, cellular assays were performed utilising C2C12 mouse 
myoblasts and human mesenchymal stem cells. Myoblasts were observed to spread 
better and present better morphology on all PEA-presenting 2D surfaces post FN 
adsorption. While less and smaller focal adhesions were formed on pristine PLLA 
samples, PLLA-bPEA and PEA samples presented improved binding 
microenvironments due to the presence of FN nanonetworks (Keselowsky, Collard 
et al. 2003, Keselowsky, Collard et al. 2004, Keselowsky, Collard et al. 2005), and 
increased PHSRN domain binding (Vanterpool, Cantini et al. 2014). On these 
samples higher numbers of mature focal adhesion plaques were observed, 
highlighting that SI-ATRP provides the additional benefit of PEA-induced cellular 
adhesion to PLLA surfaces. Myogenic differentiation was also observed to be 
enhanced on PLLA-bPEA, with the same contractile-dependent mechanism as on 
bulk PEA (Salmeron-Sanchez, Rico et al. 2011, Bathawab, Bennett et al. 2016). 
This shows that SI-ATRP-treated surfaces can drive higher order cellular functions 
than simple adhesion (Ulery, Nair et al. 2011). Finally, osteogenic differentiation 
was investigated with MSCs on 2D PLLA-bPEA surfaces and in 3D PLLA-bPEA 
scaffolds. Prior to cell culture, these materials were coated not only with FN, but 
also with BMP2, to take advantage of the ability of the FN nanonetworks to recruit 
the GF and boost its activity via presentation in synergy with cell binding domains. 
Indeed, solid-phase presentation of the GF via FN on PLLA-bPEA induced 
osteogenic differentiation, as demonstrated by the presence of osteocalcin, a 
marker of mature osteogenic differentiation (Aubin 2001). Moreover, PLLA-bPEA 
3D scaffolds supported enhanced mineralisation of the matrix, a sign of late stage 
osteogenesis (Schindeler, McDonald et al. 2008), compared to untreated PLLA. 
These results, as well as the absence of cytotoxicity, demonstrate the ability of 
SI-ATRP-treated samples to enhance cell adhesion and facilitate differentiation 
both in 2D and within 3D scaffolds. This establishes the potential for these 
biodegradable 3D medical grade PLLA-bPEA scaffolds to be utilised in tissue 
engineering as, for example, an implantable biomaterial for bone regeneration. 
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While other techniques, plasma polymerisation and spin-coating, have previously 
been shown to provide similar functionality to biomaterials (Cantini, Gonzalez-
Garcia et al. 2012, Llopis-Hernandez, Cantini et al. 2015, Llopis-Hernandez, 
Cantini et al. 2016, Cheng, Alba-Perez et al. 2019), SI-ATRP provides a surface 
modification which is chemically bound to the surface, homogenous, produces un-
fragmented polymer chains and is fully translatable to 3D scaffolds. Due to these 
benefits and the tuneable nature of SI-ATRP, this system presents an improved 
methodology for the incorporation of thin layers of PEA and therefore enhanced 
biological functionality on established biomaterials.  
 
 6.2 Thesis conclusions 
- The developed SI-ATRP system is able to produce functional poly (ethyl 
acrylate) brushes on 2D and 3D PLLA.  
Chemical analysis highlighted the production of fully intact poly (ethyl acrylate) 
chains producing a uniform coverage over the entire film; this was shown to cover 
both 2D surfaces as well as fully penetrate 3D scaffolds. The production of PEA on 
PLLA-bPEA was shown to be dependent on the time of polymerisation.  
- The produced PLLA-bPEA samples possess similar physical properties as 
pristine PLLA.  
While new functionality was added to PLLA, the bulk polymer mechanical and 
physical properties were maintained through processing. Maintenance of bulk 
PLLA stiffness and biodegradability rate ensure that the produced scaffolds are 
able to initially provide structural support to the damaged tissue while gradually 
re-introducing physical strain to regenerating cells in situ. 
- The PEA brushes are able to drive fibrillogenesis of fibronectin, producing 
nanonetworks and favourably presenting the PHSRN synergy motif and the 
HepII growth factor binding domain. 
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The produced PEA brushes were able to drive the re-organisation of globular FN 
molecules into physiological-like nanonetworks, made of individual FN fibrils. 
These nanofibrils exposed additional cryptic binding domains and were able to 
bind growth factors in close proximity to the integrin binding region of fibronectin, 
unlike pristine PLLA, enhancing cellular interactions.   
 - PLLA-bPEA samples are able to facilitate enhanced cellular adhesion and 
drive differentiation due to the PEA brushes. 
Successful cellular cultures of both C2C12 cells and hMSCs, for 5 days and a month 
respectively, alongside cytotoxicity assays, have shown that the produced PLLA-
bPEA surfaces are viable for cellular incubation and long term culture. The 
additional functionality of the produced polymer brushes provide enhanced 
cellular adhesion and facilitate controlled myogenic and osteogenic 
differentiation. Osteogenic differentiation was induced by enhanced solid-state 
presentation, promoting GF-integrin synergy, of ultra-low concentrations of BMP-
2 due to material-driven fibrillogenesis of FN on PLLA-bPEA samples. 
 6.3 Future work 
 The addition of specific biological functionalities to established 
biomaterials presents extensive possibilities for improved regenerative medicine 
applications. Here we have achieved enhanced cellular adhesion and osteogenic 
potential on PLLA surfaces, improving the initial biological performance of the 
implant and its long term bone regenerative ability via the inclusion of PEA 
brushes. PEA driven fibrillogenesis has also been shown to enhance other tissue 
engineering regenerative applications, such as vascularisation via synergistic 
presentation of vascular endothelial growth factor (VEGF) (Moulisova, Gonzalez-
Garcia et al. 2017). Highlighting the potential for utilisation of this PLLA-bPEA 
system for more than just bone tissue engineering. However, the process that we 
have developed has the potential to be translated to modify countless other 
polymers; such as poly (lactic-co-glycolic acid), poly caprolactone or polystyrene, 
for either the enhancement of cellular interactions or to improve their 
biocompatibility. Additionally, the SI-ATRP system itself may be further developed 
to decrease the time of treatment, utilising a 1-pot methodology which has yet to 
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be optimized to a sufficient degree. Further characterisation and fine tuning of 
this 1-pot system may provide a faster, more accessible methodology for further 
scaling up of the system. In fact, the SI-ATRP treatment of different bulk backbone 
polymers, for example those possessing aromatic hydrocarbon rings like 
polystyrene, would not require the initial aminolysis step to functionalize the 
surface for initiator immobilisation (Vivek and Dhamodharan 2007). 
  With regards to the system for bone regeneration presented in this thesis, 
while PLLA-bPEA scaffolds were observed to facilitate osteogenic differentiation, 
further characterisation of the mechanisms involved and of their osteogenic 
potential should be performed. qPCR, to evaluate RNA levels of osteogenic 
factors, such as osteocalcin or osteopontin, and further 3D scaffold imaging, 
utilising histological sections and immunostaining, will further highlight the 
functionality of these surfaces. While enzymatic degradation assays have been 
performed, long-term hydrolytic degradation in simulated body fluid could be also 
studied, with analysis of the degradative products via gel permeable 
chromatography. Finally, a key development in the utilisation of this system will 
be its use in in vivo models, which would definitively show the validity of and 
enhanced functionality of PLLA-bPEA as a system for bone regeneration. 
Characterisation of this system utilising animal models, in line with current 
regulatory requirements, would aim to further establish the efficacy and 
biocompatibility shown in vitro. Demonstrating the regenerative potential of the 
system in these models would further the development of SI-ATRP system for 
production of nanoscale PEA brushes, enhancing the functionality of established 
polymer biomaterials as a potential clinical application for non-union bone defect 
healing.  
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